Keith C. Norris, M.D. CURRICULUM VITAE (3-10-12) · 2005-07 Vice President of Research, Charles Drew University 2008- Executive Vice President, Research and Health Affairs, Charles

1

Keith C. Norris, M.D. CURRICULUM VITAE (3-10-12)

PERSONAL HISTORY:

Business Address: Telephone number: Home Address:

Telephone number: Citizenship: Date of Birth:

EDUCATION:

1973-76 Undergraduate: (no degree) Cornell University, Ithaca, N.Y. Major: Biochemistry/Genetics, Minor: Mathematics 1976-80 Graduate: Medicine (M.D.), Howard University School of Medicine,

Washington, D.C. 1980-81 Internship, Howard University Hospital, Washington, D.C. 1981-83 Internal Medicine Residency, Howard University Hospital, Washington, D.C. - Chair: John Townsend, M.D. 1982-83 Chief Resident, Department of Internal Medicine, Howard University

Hospital, Washington, D.C. - Chair: John Townsend, M.D. 1983-85 Nephrology Fellowship, Department of Medicine, UCLA School of

Medicine & Wadsworth V.A. Hospital, Los Angeles, CA Division Chiefs: Kyoshi Kurokawa, M.D. (VAMC), Leon Fine, M.D. (UCLA) 1985-86 Research Fellow, Nephrology, Department of Medicine, UCLA School of

Medicine & Wadsworth V.A. Hospital, Los Angeles, CA Mentor: Jack Coburn, M.D.

2002-present College of Metaphysical Studies, Clearwater FL (Ph.D.(c)) Major: General

Religious/Metaphysical/Spiritual/Holistic Philosophy Advisor: Paul F. Daniele, Ph.D., Th.D., D.D., P.C. (President)

LICENSURE (active): State of California, USA G049995 BOARD CERTIFICATION: 1983 American Board of Internal Medicine 1986 American Board of Nephrology ADDITIONAL CERTIFICATION: 1999-2019 American Society of Hypertension

Specialist in Clinical Hypertension* (new certification initiated 1999, recertified 2009)

2

2001 Reiki Master 2004 Fellow, American College of Physicians

2007 Fellow, American Society of Nephrology PROFESSIONAL EXPERIENCE:

1977-80 Howard University College of Medicine - Tutor in Homeostasis, Pharmacology,

Biochemistry, Physiology, Pathology 1986-90 Staff Physician, Nephrology, VA Medical Center, West Los Angeles, CA 1987-89 Instructor for Fundamentals of Physical Diagnosis UCLA School of Medicine 1988-89 Assistant Director of Hypertension - VA Medical Center, West Los Angeles, CA 1986-91 Assistant Professor of Medicine, UCLA School of Medicine 1991-96 Associate Professor of Medicine, Charles Drew University 1992-95 Program Director, Department of Internal Medicine, King-Drew Medical Center

(Took program from probation to full accreditation within 1 year) 1995-98 Vice-Chair Department of Internal Medicine, Charles Drew University of

Medicine and Science 1995-02 Associate Deputy Chief, Department of Internal Medicine, King-Drew Medical

Center 1995-2007 Program Director, Clinical Research Center, Charles Drew University 1997- Professor of Medicine, Charles Drew University 1999- Associate Professor of Medicine, UCLA School of Medicine 1998-01 Director, Clinical Research, Charles R. Drew University 1998-99 Acting Chair, Department of Internal Medicine, Charles Drew University 1998-99 Acting Vice Chair, Department of Internal Medicine, UCLA School of Medicine 2000-01 Executive Vice Chair, Department of Internal Medicine, Charles Drew

University 2001-05 Associate Dean for Research, Charles Drew University 2002-03 President, Professional Staff Association, King/Drew Medical Center 2005-07 Vice President of Research, Charles Drew University 2008- Executive Vice President, Research and Health Affairs, Charles Drew

University 2008- Assistant Dean for Clinical and Translational Science, Geffen School of Medicine,

UCLA 2009-10 Interim President, Charles Drew University 2010- Executive Vice President, Research and Health Affairs, Charles Drew

University 2011- Associate Director, NIH funded UCLA Clinical and Translational Science

Institute Teaching Activities (Last fifteen years)

1993-95 Weekly Professor Rounds, Drew Medical Students 1993-95 Department of Medicine Morning Report (daily) 1993-2004 Renal Consults – 3-4 months/yr 1993-2004 Renal call (24 hours) – 1 week each month (~91 days/yr) 1993-2002 Medicine wards 2-3 months/yr 1993-2002 ICU rounds 1 month/yr 1994-95 UCLA and Drew Medical Student Blood Pressure Training Course

3

1994-2005 Department of Oral Surgery - Yearly series on office management of patients with hypertension and renal disease

1994-97 Department of Family Practice - Yearly series on the approach to acute renal failure, and fluid and electrolyte abnormalities

1997-1998 Internal Medicine Board Review Course, Medtext 1997 Co-director, Drew University Faculty Research Development course 1999-2001 Department of Medicine Morning Report (weekly) 2001 Cardiovascular Calcification: Another Risk in Peritoneal Dialysis

The Importance of Improving Calcium and Phosphorus Balance – National CME program (sponsored by Genzyme Pharmaceuticals)

1994-present Nephrology Medical Student Core Curriculum - Renal Pathophysiology, one to two lectures per month to Drew medical students, residents and fellows

1996-present UCLA Combined Renal Fellow Pathophysiology lecture series 1997-present UCLA Second Year Medical Student Renal Pathophysiology sessions

PROFESSIONAL ACTIVITIES: Committee Responsibilities (Institutional)

1987-89 Member, Research and Development Committee, VAMC West LA, CA 1988-89 Member, Human Research and Studies Committee, VAMC West LA, CA 1988-89 Chair, Human Research and Studies Committee, VAMC West LA, CA 1992-93 Member, UCLA Planning Committee on Primary Care Education 1992-96 Member, Program Directors Committee King-Drew Medical Center 1992-94 Member, Census Committee King-Drew Medical Center 1992-95 Member, UCLA Medical Education Committee 1993-94 Educational Task Force for WASC Accreditation 1992-95 Member, Dean Search Committee, Charles Drew University 1995-present Member, Harbor-UCLA CRC Advisory Committee 1995-99 Member, King-Drew Resident Research Committee 1996-present Member, King/Drew Department of Medicine Improving Organization

Performance (IOP) committee 1996 Chair, King/Drew Department of Medicine Nurse Manager committee 1996-98 Giannini Foundation Research Fellowship Faculty Mentor for Drew/UCLA

medical students 1996-98 Member, Drew University Healthy Agenda 2000 Program 1997-99 Member, Drew University Academic Senate Curriculum subcommittee 1997-99 Co-Chair, Firm System Development Committee, King/Drew Medical

Center, Department of Internal Medicine 1998-present Member, Drew University Academic Senate Budget Committee 1999-2000 Member, Research Task Force for WASC accreditation, Drew University 1999-2000 Chair, Drew University Clinical Research Strategic Plan Committee 2000 Vice-Chair Drew IRB Task Force 2000-present Charles Drew University Institutional Review Board (IRB); alternate 2000-present UCLA Faculty Executive Council; alternate 2000-2001 Member, Dean Search Committee; Charles Drew University 2000-present Member, Executive Committee, Department of Internal Medicine, Charles

Drew University

4

2001-2002 Chair, Improving Operational Performance (IOP) Committee, King/Drew Medical Center

2001-2002 Member, Professional Staff Association Executive Committee, King/Drew Medical Center

2002-present Member, Department of Medicine Peer Review Committee 2002-present Member, Department of Medicine Executive Committee 2002 Member, Vice President for Advancement Search Committee 2002-2008 Chair, Charles Drew University Research Space Community 2003-2004 Chair, Professional Staff Association Credentials Committee, King/Drew

Medical Center 2003 Member, UCLA-Drew Center of Excellence Steering Committee 2003-2008 Member, UCLA Faculty Executive Community 2005-present Member, Senior Management Committee 2007-present Member, UCLA RWJ Clinical Scholars Program Community And Policy

Advisory Committee (CPAC) 2011-present Member, CDU Senior Leadership Committee 2011-present Member, CDU Integrated Life Science Doctoral Planning Committee 2010-2011 Member, David Geffen School of Medicine at UCLA 2011-2015 Strategic

Plan design team. Committee Responsibilities (Regional)

1987-89 Member, Scientific Advisory Council, National Kidney Foundation of Southern California

1991-93 Chairman, Education Committee – Robert F. Kennedy Medical Center 1991-95 Member, Medical Advisory Board, National Kidney Foundation of

Southern California 1992-95 Chairman, Nephrology Section, Drew Medical Society 1993-94 Chairman, South Central LA Task Force of the American Heart

Association 1994 Member, Medical Advisory Board, Tribute Dinner Committee, National

Kidney Foundation of Southern California 1994-95 President, Search your Heart Program, L.A. American Heart Association 1995 Member, Medical Advisory Board, Tribute Dinner Committee, National

Kidney Foundation of Southern California 1995-96 Co-Chair, Join Hands for Health/National Kidney Foundation of Southern

California 1995-1998 Member, Board of Directors, Drew Medical Society 2001-2002 Member, California Health Interview Survey (CHIS) Steering Committee 2004 Member, UC Regents Special Advisory Committee (executive committee

member) to Drew University (Michael Drake, M.D., Vice President UC Regents and Tom Garthwaite, M.D., Director LA County Dept. Health Services)

Committee Responsibilities (National/International)

1988-89 Member, International Society of Hypertension in Blacks Committee on Ion Transport, 1992-96 Chairman, Nephrology Section, National Medical Association 1992-94 Member, Steering Committee, NIH- sponsored African American Study of

Kidney Disease and Hypertension Pilot Study. 1992-94 Member, Compliance Committee, NIH-sponsored African American Study

of Kidney Disease and Hypertension Pilot Study.

5

1992-94 Member, Recruitment Committee, NIH-sponsored African American Study of Kidney Disease and Hypertension Pilot Study.

1994 Member, Workgroup for the Consensus Management of Renal Osteodystrophy sponsored by Abbott Pharmaceuticals (chaired by Dr. Eduardo Slatopolsky)

1994-95 Member, Steering Committee, NIH-sponsored African American Study of Kidney Disease and Hypertension Full Scale Phase.

1994-95 Member, Compliance Committee, NIH-sponsored Full Scale Phase. 1994-95 Member, Recruitment Committee, NIH-sponsored African American

Study of Kidney Disease and Hypertension Full Scale Phase. 1994-96 President, Association of Minority Nephrologists 1995-present Member, Hemodialysis Adequacy Workgroup and Advisory Council,

Dialysis Outcomes Quality Initiative, National Kidney Foundation 1997-2001 Renal Physicians Association Recruitment Subcommittee 1997-2001 Member, American Kidney Fund: African American Outreach Advisory

Board 1997-98 Member, Advisory Board for the Core Curriculum for Dialysis Technician 1998-2002 Member, Cardiovascular Committee, NIH-sponsored African American

Study of Kidney Disease and Hypertension Full Scale Phase 1998-present Member, Medical Advisory Board, American Association of Kidney

Patients 1998-2002 Member, Health Care Finance Association (HCFA) - Dialysis Outcomes

Quality Initiative Hemodialysis Adequacy Subcommittee 1998-2002 Member, Health Care Finance Association (HCFA) - Dialysis Outcomes

Quality Initiative Vascular Access Subcommittee 1999-2001 Member, American Association of Kidney Patients Medal of Excellence

Dinner Committee 1999-present Member, Kidney Disease Outcomes Quality Initiative (K-DOQI) National

Advisory Board, National Kidney Foundation 1999-2002 Member, NIH/NIDDK National Kidney and Urologic Diseases Information

Clearinghouse 2000 Chair, Special RCMI Clinical Research Center Program evaluation at

Meharry Medical College 2000-2002 Baxter Health Care Early Renal Failure Community Awareness

Committee 2000-2001 Member, National Institutes of Health/National Center for Research

Resources Special Committee on Racial Disparities in Health Care 2000-present Member, Renal Physicians Association Quality Patient Care Committee 2000-2001 Member, National Institutes of Health/National Center for Research

Resources Special Committee on Human Subject Safety 2000-present Advisor, National Institutes of Health/National Center for Complimentary

and Alternative Medicine Committee on Racial Disparities in Health Care 2001-present Member, Renal Physicians Association Government Affairs Committee 2001- Member, National Institutes of Health/National Center for Research

Resources Clinical Research Workgroup 2001- Member, General Clinical Research Center Program Director’s

Association Training Subcommittee. 2002- Member, Renal Physicians Association Program Committee 2002- Member, American Kidney Fund Education Committee 2002 Member, RCMI Clinical Research Center External Advisory Committee at

Meharry Medical College

6

2002 Member, Oral Health Research Center (NIH-NIDR) External Advisory Committee at Meharry Medical College

2002- Member, NIDDK Network of Minority Research Investigators 2003 Secretary, NIH-RCMI Program Directors Committee 2003- Member, American Kidney Fund Scientific Committee 2003-2008 Member, International Society of Nephrology-Committee on Global

Advancement of Nephrology (ISN-COMGAN) Research Committee 2002 Member, UC San Diego NIH Project EXPORT External Advisory

Committee 2003 Member, Jackson State NIH Project EXPORT External Advisory

Committee 2003-present President, Association of Minority Nephrologists 2004- Member, National Kidney Foundation Kidney Learning System Editorial Board. 2004- Member, National Kidney Foundation Kidney Early Evaluation Program

(KEEP) National Steering Committee 2004- Member, National Kidney Foundation KEEP - Publication sub-committee 2004 Chair, RCMI Clinical Research Center External Advisory Committee at

Meharry Medical College 2006- President, RCMI Program Director’s Association 2007 Member, NIH National Kidney Disease Education Program (NKDEP)

Coordinating Panel 2007 Chair, National Kidney Foundation KEEP - Publication sub-committee 2008- Member, Jackson State NIH RCMI External Advisory Committee 2009-2010 Member, American Society of Nephrology (ASN), 2010 ASN Belding H.

Scribner Award Committee 2010- Member, AAMC Advisory Panel on Research 2010- Member, Meharry Medical College NIH RCMI Clinical and Translational

Research Center External Advisory Committee 2010- Member, Ponce School of Medicine NIH RCMI Biomedical Research

Center External Advisory Committee 2010- Member, University of Hawaii NIH RCMI Clinical and Translational

Research Center External Advisory Committee 2010- Member, NIH-NIDDK Data and Safety Monitoring Board Randomized

Trial of Active Vitamin D, Cholecalciferol and Placebo for CKD-MBD 2011- Member, NMA-NIH Diversity Task Force 2012- Member, NIH Resource Centers for Minority Aging Research Investigator

Development committee Board of Directors (BOD) (National) 1998-2002 Member, BOD, American Association of Kidney Patients (AAKP) 2000-2002 Member, BOD Executive Committee, American Association of Kidney

Patients 2002-2005 Member, BOD, Renal Physicians Association 2002-present Member, AAKP Medical Advisory Board 2002-2005 Member, BOD, Howard University Medical Alumni Association 2010-2011 Member, National Kidney Foundation Board of Directors 2010- Member, BOD, Association of Minority Health Professions Schools

7

PROFESSIONAL SOCIETIES 1. American College of Physicians 2. American Society of Nephrology 3. International Society of Nephrology 4. National Kidney Foundation of Southern California 5. Charles Drew Medical Society 6. American Society of Hypertension 7. International Society of Hypertension in Blacks 8. National Medical Association 9. Howard University Medical Alumni Association 10. Association of Minority Nephrologists 11. Renal Physicians Association 12. Research Centers in Minority Institutions Program Director’s Committee 13. General Clinical Research Center Program Director’s Association 14. Association for Patient Care Oriented Research

Conferences

Regional/ National Chair, Organizing Committee: American College of Physicians Southern California Regional Conference Feb 2001 Member, Organizing Committee “Diabetes throughout the Lifespan”. A community driven conference and part of the “Bridges to Optimum Health” Series of community conferences and workshops. March 4-5, 2005, Los Angeles. Director, NIH/NIDDK High School Student Summer Program (annual NIH Presentations) August 2001-2007 Co-Director, NIH/NIDDK Short-Term Education Program for Underrepresented Persons (STEP-UP) (annual NIH Presentations) August 2007- present Member, NKF 2013 Spring Clinical Meetings Program Committee International Member, Organizing Committee: International Society of Hypertension in Blacks Conference on Cardiovascular and Related Diseases, Las Vegas, NV. June 2001

Member, Organizing Committee: RCMI Program Director’s International Symposium on Health Disparities, Honolulu, Hawaii, 2002 Member, Organizing Committee: International Society of Hypertension in Blacks Conference on Cardiovascular and Related Diseases, Acra, Ghana. May 2003

Member, Organizing Committee (1 of 2 USA representatives), International Society of Nephrology-Committee on Global Advancement of Nephrology sponsored symposium “Prevention of Kidney Disease in Minority Groups and Emerging Nations.” This is a satellite to the American Society of Nephrology Satellite meeting November 2003 (Mexico) [www.isn-online.org/ensenada/]

8

Member, Steering Committee: Ninth Research Centers in Minority Institutions (RCMI) International Symposium on Health Disparities: Frontiers in Biomedical Sciences: Current Innovations and Future Trends in Alleviating Health Disparities. December 7-11, 2004, Baltimore MD. Member, Organizing Committee (1 of 3 USA representatives), International Society of Nephrology-Committee on Global Advancement of Nephrology sponsored symposium “Renal disease in minority populations and developing nations.” This is a satellite to the World Congress of Nephrology meeting June 30-July 2, 2005 (Singapore)

Member, Organizing Committee (1 of 3 USA representatives), International Society of Nephrology-Committee on Global Advancement of Nephrology sponsored symposium “Renal disease in minority populations and developing nations.” This is a satellite to the World Congress of Nephrology meeting April 2007 (Brazil) Member, Steering Committee: Tenth Research Centers in Minority Institutions (RCMI) International Symposium on Health Disparities: Translational Research. December 13-16 2006, San Juan, Puerto Rico. Member, Organizing Committee (1 of 3 USA representatives), International Society of Nephrology-Committee on Global Advancement of Nephrology sponsored symposium “Renal disease in minority populations and developing nations.” This is a satellite to the World Congress of Nephrology meeting April 25-27, 2007 (Petropolis, Brazil) Co-host (with Dr. Antonio Lopes) Post 2007 World Congress of Nephrology Symposium on Hypertension and Kidney Disease in Persons of African Ancestry, Universidad Federal De Bahia. (April 30, 2007) Member, Organizing Committee (1 of 3 USA representatives), International Society of Nephrology-Committee on Global Advancement of Nephrology sponsored symposium “Renal disease in minority populations and developing nations.” This is a satellite to the World Congress of Nephrology meeting May, 2009 (Milano, Italy) Member, Steering Committee: Eleventh Research Centers in Minority Institutions (RCMI) International Symposium on Health Disparities: Research Outcomes Accelerating Discoveries for Medical Applications & Practice. December 1-4, 2008, Honolulu, Hi. Co-Chair, “Eliminating Disparities in Hypertension, Metabolic Syndrome, Kidney Failure, and Cardiovascular Disease: Basic Science, Clinical Practice, and Community Initiatives.” International Society of Hypertension in Blacks 9-12, 2009, Chicago, Il. Member, Organizing Committee (1 of 3 USA representatives), International Society of Nephrology-Committee on Global Advancement of Nephrology sponsored 8th Conference on Kidney Disease in Disadvantaged Populations Disparities in Renal Disease - Moving Towards Solutions.” This is a satellite to the World Congress of Nephrology meeting April, 2011 (Vancouver, Canada)

Member, Scientific Program Committee for the International Society of Nephrology (ISN), World Congress of Nephrology (WCN) 2013 to be held in Hong Kong from May 31 – 4 June 2013 (Theme Co-Chair of five themes). Responsibility: To work together with Scientific Program Committee in putting together an exciting scientific program for the

9

“Conditions associated with CKD” Theme, and more formally integrating Kidney Disease in Disadvantaged Populations into the main scientific program.

Consultant Amgen Pharmaceutical, Adventis Pharmaceutical, Bone Care International, Novartis

Abbott Pharmaceutical, Sigma Tau Pharmaceutical, Pfizer, Merck, King Pharmaceutical Ortho Biotech National Minority Quality Forum Specialized Pharmaceutical Advisory Board Activities

1997-present Member, Amgen Erythropoeitin National Advisory Board 2000-present Member, Bone Care International National Advisory Board 2000 Chair, Amgen Regional Chronic Renal Insufficiency Advisory Board 2001 Chair, Amgen Regional Erythropoeitin Advisory Board 2001-present Member, Sigma Tau Advisory Board 2002-present Member, Amgen Racial Disparities in Chronic Kidney Disease Advisory

Board 2003 Aventis Pharmaceutical Advisory Board 2003 Chair, Abbott Pharmaceuticals: Chronic Kidney Disease in African

Americans, Advisory Board (July 11-12, 2003) 2004 Co-Chair, Abbott Pharmaceuticals: Early Identification and Treatment of

Chronic Kidney Disease: Reaching Patients with Co-morbidities, Advisory Board (May 11, 2004)

2006-08 Member, Amgen Nephrology Advisory Board (December 9, 2007) 2007 Chair, Roche Nephrology Advisory Board (August 5, 2007) 2008 Member, Abbott Pharmaceuticals - Exploring the Field of Vitamin D

Receptor Activators Research Program 2009 Member, Amgen Disparities Advisory Board – February 2009 2010-11 Member, Davita Clinical Research Scientific Advisory Board 2011 Member, Hematide™/peginesatide Advisory Communications Council,

Affymax, Inc. and Takeda Pharmaceuticals Ltd. 2010-11 Member, Amgen Nephrology Advisory Board 2012- Member, Reatta Nephrology Advisory Board

Journal Editorial Activities 1998-2000 Associate Editor, Journal National Medical Association 2000-present Editor-in-Chief, Ethnicity and Disease. As the official journal of the

International Society on Hypertension in Blacks Ethnicity & Disease has earned an international reputation as one of the only medical journals addressing the causal patterns of disease among ethnic minorities. It has enjoyed recognition among researchers who seek to publish their findings in Ethnicity & Disease, as well as researchers, medical professionals and others who seek information to assist them in delivering high-quality health care to minority populations (from 2000-2010, the publication experienced a >150 percent increase in submissions; its rejection rate increased from 19 percent to 41 percent; its format changed from quarterly to bi-monthly effective 2004)

1995 Guest Editor (with Dr. William Owen, M.D. Harvard University), Nephrology News and Issues; Special Series, Racial/Ethnic Disparities in Renal Disease

10

2002 Guest Editor (with Lawrence Agodoa, M.D., NIH/NIDDK), Journal National Medical Association Supplement: Racial Disparities in Chronic Kidney Disease

2005 Guest Editor (with Lawrence Agodoa, M.D., NIH/NIDDK and David Pugsley, University of Adelaide, SA, Australia), Kidney International Supplement: Spectrum and impact of kidney disease in racial/ethnic minorities and indigenous populations of the Americas.

2009- Member, editorial board, American Journal of Translational Research Journal Reviewer Activities 1996-present Reviewer, Advances in Renal Replacement Therapy 1997-2000 Editorial Review Board, Ethnicity and Disease 1998-present Reviewer, American Journal of Medical Diseases 1999-present Reviewer, American Journal of Kidney Diseases 2000-present Reviewer, Journal American Geriatric Society 2001-present Reviewer, Journal American Society Nephrology 2001-present Reviewer, Nephrology, Dialysis and Transplantation 2002- Ad Hoc Reviewer, Treatments in Endocrinology 2005-present Reviewer, Clinical Journal American Society Nephrology 2005-present Ad Hoc Reviewer, Archives of Internal Medicine 2005-present Ad Hoc Reviewer, Annals of Internal Medicine 2005- present Ad Hoc Reviewer, Kidney International 2006-present Ad Hoc Reviewer, Circulation 2006- present Ad Hoc Reviewer, Am Journal of Hypertension 2006- present Ad Hoc Reviewer, Lancet 2006- present Ad Hoc Reviewer, Journal of Investigative Medicine 2006- present Ad Hoc Reviewer, Atherosclerosis 2006- present Ad Hoc Reviewer, Clinical Drug Investigation 2006- present Ad Hoc Reviewer, Clinical Nephrology 2006- present Ad Hoc Reviewer, Kidney & Blood Pressure Research 2006- present Ad Hoc Reviewer, Nephrology Dialysis Transplantation 2006- present Ad Hoc Reviewer, British Medical Journal 2006-present Ad Hoc Reviewer, American Journal of Nephrology 2007-present Ad Hoc Reviewer, Journal American Medical Association 2008-present Ad Hoc Reviewer, Journal of the American College of Cardiology 2008-present Ad Hoc Reviewer, New England Journal of Medicine 2009- present Ad Hoc Reviewer, Heart 2009-present Ad Hoc Reviewer, Progress in Community Health Partnerships:

Research, Education, and Action 2009-present Ad Hoc Reviewer, The Journal of Clinical Endocrinology & Metabolism 2009-present Ad Hoc Reviewer, American Journal of Public Health 2009-present Ad Hoc Reviewer, Transplantation

Legal: Expert Witness Internist/Nephrologist Mayport Naval Base Jacksonville, Florida, January 26 – 27, 1999

11

NIH Study Sections 1996-2001 Member, National Institutes of Health/National Center for Research

Resources (NIH/NCRR) RCMI Biomedical and Clinical Research Programs

2000 Chair, Ad Hoc Review, Student Research Programs, National Institutes of Health/National Institute for Diabetes, Digestive and Kidney Diseases (NIH/NIDDK)

2001 Member, NIH/National Institute of Mental Health (Information Technology-based applications for improving informed consent)

2001-present Ad hoc reviewer; NIH/NCRR RCMI Biomedical and Clinical Research Programs and NIDDK

2001 Chair, special emphasis review panel, Tribal Diabetes Program, NIH/NIDDK

2002 Member, community based strategies for organ transplantation special emphasis review panel, NIH/NIDDK

2002 Member, COBRE Review panel, NIH/NCRR 2002 Chair, NIH/NCRR site visit team (July 17-18) 2002 Chair, Review panel, Tribal Diabetes Program, NIH/NIDDK (August) 2003 Member, NIH/NCRR RCMI Biomedical Research Program Review (May) 2003 Member, NIH/NIDDK Frequent Dialysis RFA Program Review (July) 2004 Member, IDEA Review panel, NIH/NCRR (February) 2005 Member, INBRE Review panel, NIH/NCRR (February) 2005 Member (ad hoc), Review panel, NIH/NIDDK (for NIDDK Pathobiology of

Kidney Disease Study Section) 2005 Co-Chair, NIH/NCRR co-chair Intra- and Inter-Institutional Collaboration

session for the meeting on Enhancing the Discipline of Clinical and Translational Science (May 23, 2005)

2005 Member, NIH/NIDDK Chronic Kidney Disease study section (July) 2005 Member, NIH/NCRR GCRC Site Visit Team (August) 2006 Member, NCRR CTSA review panel (July 2006) 2007-2011 Member, NIH/NCRR RCMI and IDeA review panel 2011 Member, NIH/NIA intramural research program review 2011 Chair, NIH/NIMHD Special Emphasis review panel 2012 Member, NIH/NIDDK Special Emphasis review panel 2012 Member, 2012 NIH Director's Pioneer Awards panel Other Grant Review Panels 2006 UK Clinical Research Center Initiatives 2006-present UK Kidney Research 2006-present South African Medical Research Council (Kidney and Hypertension

Research) 2011 Netherlands Minister of Education, Culture and Science 'National

Roadmap for Large-Scale Research Infrastructures'.

Community Activities: 1978-present Member, Kappa Alpha Psi Fraternity, Inc. 1993-94 Chairman, South Central LA Task Force of the American Heart

Association, 1994-95 President, Search your Heart Program, L.A. American Heart Association, 1994-present Ongoing Church Blood Pressure Screenings 1995-96 Co-Chair, Join Hands for Health/National Kidney Foundation,

12

1995-present Member, National Kidney Foundation of Southern California 1996-present Kidney Disease Education in the African American Community (ongoing

radio and newsprint educational health promotional series) 1996-present Mentor for high school summer students 1996- Principal Investigator, Healthy African American Families 1997-2000 Member, American Kidney Fund: African American Outreach Advisory

Board 1996-98 African Market Place health screenings 1996-98 Member, Drew University Healthy Agenda 2000 Program 1996-present Ongoing community-based talks on clinical research/common health

problems 1998-present Principal Investigator, Healthy African American Families 1998-present Member, Board of Directors American Association of Kidney Patients 1998-present Member, Service Planning Area 6 (South Central Los Angeles) 2000-present Member, Community Advisory Board, Black Women for Wellness 2001-present American Kidney Fund health screenings 2000- present Advisor, South Central Black Health Task Force 2000- present Advisor, South Senior Citizens Multipurpose Center 2002- Member, Los Angeles Parks for Health initiative 2002-present Member, Board of Directors – Healthy African American Families 2006-present Vice President, Board of Directors - The American Program for

Educational Enhancement in Developing Countries (a charitable non-profit organization dedicated to supporting basic education in developing countries).

HONORS AND SPECIAL AWARDS: 1979 Lange Book Award, Excellence in Internal Medicine, Auxiliary Medico-

Chirugical Society, Washington, D.C. 1980 Alpha Omega Alpha, Medical Honor Society 1980 Raymond P. Jackson Award (Tutorial Services) 1982-83 Daniel Hale Williams Award for Outstanding Resident of the Year 1990-91 Best Teacher of the Year Award, King/Drew Medical Center, Department

of Internal Medicine 1992-93 Award of Excellence for Outstanding Achievement, King/Drew Medical

Center, Department of Internal Medicine 1996 Charles R. Drew Special Recognition Award for Outstanding Service in

Furthering Student Affairs and the University Mission 1996 National Kidney Foundation Special Recognition Award: NKF-Dialysis

Outcomes Quality Initiative Workgroup 1997 Amgen Special Recognition Award: NKF-Dialysis Outcomes Quality

Initiative Hemodialysis Adequacy Workgroup 1998 Giannini Bank of America Faculty Mentor Award 1998 Member, Core Curriculum for the Dialysis Technician Manual 1998 Certificate of Appreciation, Department of Medicine, King/Drew Medical

Center 1999-2003 Member, NKF-Dialysis Outcomes Quality Initiative Advisory Board 1999 American Society of Hypertension Specialist in Clinical Hypertension 2000 National Black Health Leadership Initiative on Cancer Recognition Award:

Closing the Gap in the New Millennium in Community Service

13

2000 Southern Area Clergy Council “Light of our Life” Recognition Award 2000 A. Peter Lundin, M.D. Award for significant personal contributions to the

care and well-being of kidney patients 2000 Black Women for Wellness Certificate of Appreciation 2001 RCMI Award of Excellence 2001 Distinguished Service Award, from Endocrinology, Metabolism and

Molecular Medicine 2001 Chairman Award for Outstanding Contributions to the Department of

Medicine, King/Drew Medical Center 2001 Award of Appreciation, American Association of Kidney Patients - Orange

County Chapter 2001 Maureen Lundin Renalife Award for outstanding contribution to the pages

of AAKP Renalife 2001 Appreciation Award for Making the Connection Between Research and

Community, South Los Angeles Health Project, Black Infant Health 2001 Certificate of Recognition, Member, NIH/NCRR Study Section Advisory, 2002 Faculty commitment Award, Department of Medicine, King/Drew Medical

Center 2002 King-Drew Magnet High School Student Appreciation Award 2002 Alliances for Quality Education Pride in Partnership Health Award 2002 NIH/NIDDK Short-term education program for underrepresented persons

recognition award for years of distinguished leadership 2003 Inducted into the National Black College Alumni Hall of Fame (Science) 2004 Exemplary Service Award, Institute for the Advancement of Multicultural

and Minority Medicine 2004 Outstanding Volunteer Award, Healthy African American Families, LA CA 2004 Saturday Science Academy II, Appreciation Award - “It takes a village to

raise a child” 2004 Fellow, American College of Physicians 2006 American Association of Kidney Patients Medal of Honor finalist 2006 Chapter highlighting my life in “Beat of a Different Drum: The Untold

Stories of African Americans Forging Their Own Paths in Work and Life” by Dax Devlon Ross

2006 Consumers’ Research Council of America, America’s Top Physician (Nephrology and Hypertension)

2006 Certificate of Appreciation. Auxiliary to the Charles R. Drew Medical Society

2007 Appreciation Award – Association of Minority Health Professionals 2007 Fellow, American Society of Nephrology 2007 NIH-NIDDK Certificate of Appreciation– In appreciation for advancing our

understanding of chronic kidney disease in the United States by outstanding performance in conducting the African American Study of Kidney Disease and Hypertension (AASK) Trial and Cohort Study

2007 STEP-UP NIDDK Short-term education program for underrepresented persons recognition award for years of distinguished leadership

2007 NIH/NIDDK 2007 undergraduate research symposium recognition award for outstanding achievement and excellence in scientific research and education young minds


2008 Named one of America’s Leading Doctors – Black Enterprise Magazine

14

2008 King-Drew Magnet High School Medicine and Science Careers Program Recognition Award

2008 Congressional Certificate of Recognition for significant personal contributions and exemplary personal commitment to the cause of improving the health of minority women and their families (Congresswomen Diane E. Watson, 33rd Congressional District)

2008 Rogers Society Ambassador for Research!America’s Paul G. Rogers Society for Global Health Research.


2008 Certificate of Commendation, County of Los Angeles, Yvonne, Burke, Second Supervisorial District – Outstanding and dedicated service to the affairs of the community and for the civic pride for the benefit of the people of Los Angeles County

2009 Member, Board of Directors, National Kidney Foundation 2009- Member, JHS Scientific Directions Subcommittee 2009 Consumers’ Research Council of America, America’s Top Physician

(Nephrology and Hypertension) 2010 The Celes King III Prestigious Award from Estelle for Humanity and the

Congress of Racial Equality – CA (for valuable contributions to family, community and businesses)


2010 Church Health Network Certificate of Appreciation 2010 Saturday Science Academy II, Appreciation Award - “It takes a village to

raise a child” 2010-11 King/Drew Magnet High School Commitment to Excellence Award 2011 National Medical Association Meritorious Achievement Award for Lifetime

achievement in medical research and education mirroring the NMA's commitment to promote health and prevent disease, injury, disability and premature death.


2011 DHHS/NIH/NIDDK Recognition award for mentorship and invaluable contributions to the NIDDK Short Term Education Program for Underrepresented Persons (STEP-UP)

2011 NIDDK 2010 STEP-UP class recognition award for unending and tireless commitment and support of the CDU NIH/NIDDK STEP-UP Program

2011 CDU Board of Trustees an Outstanding Service Award for extraordinary leadership as interim president 2009-2010.

2012 Certificate of Appreciation for outstanding contributions to the fields of Academic Medicine, Clinical Research, and Diversity from the Diversity Council of the Department of Medicine, Johns Hopkins University School of Medicine

News and Media and Other: Local Health Segments mainly for KJLH, 92.3 Los Angeles, (occaisionally other local local radio health segments): Multiple dialogues on hypertension, kidney disease, alternative medicine, clinical research (1995-present)

15

Discovery Health Channel: “Alternative Uncovered” (2000). Special program on alternative medicine. Discussed similarities and differences in Western allopathic medicine and traditional indigenous healing practices. (Director, Dan Birman) ABC News, Los Angeles: Meditation and heart disease (July 26, 2001) LA Times: A New Front in War on Silent Killers - Health: Researchers test meditation's effect on high blood pressure among blacks. (July 27, 2001) by Jocelyn Y. Stewart, Times Staff Writer PBS Special: Chronic Kidney Disease (Filmed 10-12-04)

National Public Service Announcement: Selected as the “Face” for the National Kidney Foundation’s Public Awareness Campaign for Chronic Kidney Disease (Filmed 4-25-05: airs nationally and internationally on radio and television 2005-2011 – including NBC and CNN) Gary A. Puckrein and Keith Norris for the National Minority Quality Forum and the Association of Minority Nephrologists. Consensus Statement: Medicare End Stage Renal Disease Program: Why We Must Have a Paradigm Shift in Health Care. December 17, 2007 National Health Segments: Mainly for OnPoint with Cynthia Hardy - Radio Show in SC. Celeste Brown, Producer (803-223-4146), 2005-2007 Yellowstone Public: Radio providing service to Montana and Wyoming "Got Health? Unleashing the Potential of Community-Academic Partnerships". Advocating for partnerships between medical researchers and local communities in order to effect positive changes more quickly than traditional research methods. (Feb 2009) http://www.yellowstonepublicradio.org/programs/local/health_matters.html

Other Educational Material

• Teleconference series (1997-99): Prevention and Treatment of Secondary Hyperparathyroidism

• Teleconference series (2004): Treatment Options for Patients with Early Stage Chronic Kidney Disease

• Teleconference series (2004): Achieving Optimal Outcomes With Vitamin D: A Case Study Approach to Current Practice Guidelines

• John Hopkins CME Masters series with Quintiles Transnational (2004-05): Early Intervention in Chronic Kidney Disease for the Prevention and Treatment of Secondary Hyperparathyroidism

• Developed new Medical Student Curriculum (2004): Drew University College of Medicine Introduction to Integrative Medicine: The bridging of Complementary and Alternative Medicine (CAM) with Western Allopathic Medicine

• Diabetes Shared Decision Making Program (2007): Foundation for Informed Medical Decision Making, 40 Court Street, Boston, MA 02108– Distributed by CMS to over 3 million patients.

• The Role of the Clinician in Managing Patients with Chronic Kidney Disease-Related Anemia: Enhancing Treatment Adherence Improves Patient Outcomes. (2007) CME monograph. Postgraduate Institute for Medicine, Englewood,

16

Colorado 80112 • Epidemic of Undiagnosed Secondary Hyperparathyroidism in Early Chronic

Kidney Disease: New Therapeutic Options: Moderators: Keith Norris, MD; Stuart M. Sprague, DO; Faculty: Dennis L. Andress, MD; Daniel W. Coyne, MD; Adeera Levin, MD. Release Date: May 31, 2006; Valid for credit through May 31, 2007 [http://www.medscape.com/viewprogram/3766]

• 2011. Management of Hypertension. Doctor’s Channel video. Link: http://vimeo.com/33347908 Password: vindico

Mentoring I have successfully led research training for over 500 high school students, including the NIDDK-supported National High School Student Summer Research Apprentice Program, over the past decade. I have supported research training for over 100 students from the King/Drew Magnet High School over the last 25 years. Additionally, I have mentored over 40 medical students, residents, and fellows/junior faculty over the past decade. I remain an active mentor for CDU and UCLA junior faculty and mentor in both the Robert Wood Johnson Foundation Clinical Scholars Program at UCLA/RAND and the NIDDK Network of Minority Research Investigators (http://nmri.niddk.nih.gov/default.aspx).

Mentored Trainees

Past / Current Trainee

Where Training Occurred

Grant Training Period

Prior Academic Degree(s)

Title of Research

Project

Position at

the time

Current Position &/or

Grant Support

Kalpana Ganesan

CDU 1993-96 MD Estrogen Replacement Therapy (ERT) in an inner city Minority Elderly Population

Assistant Professor CDU

Associate Professor CDU

Merlyn Asuncion

CDU 1995-98 MD Angiographic Features Of Patients With Cocaine-Associated Chest Pain

Assistant Professor CDU


Rey Gavino CDU 1997-00 MD The relationship of blood and bone lead to blood pressure in African American men

Resident Clinical Practice

Maxine Anderson

CDU 1996-97 MD Geographic Variations in Hypertension Related End-Stage Renal Disease Among Black and White Patients

Medical Student

Clinical Practice

Shawn Hamilton

CDU 1996-99 MD New-born Lead Poisoning from Maternal Pica Behavior during Pregnancy.


17





Title of Research

Project

Position at

the time


Grant Support

Rita Pradhan CDU 1996-99 MD Effect of angiotensin converting enzyme inhibition on diabetic retinopathy

Fellow Clinical Practice

Chemene Robinson

CDU 1998-01 MD Dermatologic indicators of coronary artery disease


Ronald Fong CDU 1997-00 MD Hypertension in the African-American elderly


Monica Thornhill Joynes

CDU 1994-96 MD Cocaine and Chronic Renal Disease


Naureen Tareen

CDU 1999-03 MD CKD Risk factors in Minority Populations

Fellow Assistant Professor, CDU

David Martins CDU 1998-03 MD Hypertension in the elderly

Fellow Associate Professor, CDU

Malvin Yan CDU 2001-03 MD Association of ACE inhibitors and Mortality in ESRD Patients


Ganga Chandramohan

CDU 2003- MD Salt sensitive hypertension

Assistant Professor, CDU

Associate Professor, CDU

Stephanie Greger

CDU 2003-04 Medical Student Thesis

The Metabolic Syndrome in Adolescents

Medical Student

Clinical Practice

Ashraf Bahador

CDU 2003-05 MD CKD literacy Research Fellow

Clinical Practice

Dele Omije CDU 2003-05 MD Renal Bone Disease Residency

Eric Fleming CDU 2004 MPH Microalbuminuria self-testing to slow CKD in diabetics

Research Fellow

Doctoral Student

Miquael Cottrell

CDU 2004-05 Medical Student Thesis

25-Vitamin D and Glomerular Filtration Rate

Medical Student

Clinical Practice

Eric Cheng UCLA/VA 2006-08 MD Adapting, implementing, and evaluating a group clinic/care coordination model for stroke survivors in an underserved minority community

Assistant Professor UCLA

Associate Professor, UCLA

18





Title of Research

Project

Position at

the time


Grant Support

Jorge Artaza CDU 2008-2011 PhD

Role of Vitamin D on the prevention of diabetic nephropathy


Associate Professor, CDU

Jose Calderon CDU 2001-2005 MD Clinical Trial Research Information Access and Literacy Enhancement Project



Sheba George CDU 2002-2005 PhD A Qualitative Assessment of the Provider-Patient interaction between Indian International Medical Graduate Residents and Urban African American and Latino Immigrant Patients



Nina Harawa CDU 2006-2011 PhD Examining Associations between Sociocultural Stressors, Psychological Symptoms, and Biological Outcomes among Black Men Who Have Sex with Men and Women



Kevin Heslin CDU 2001-2007 PhD Minority men and access to care: The combined impact of race, ethnicity, and sexual orientation


Associate professor under review

Keisha Paxton CDU 2002-2005 PhD Empowerment Evaluation of the Project Export/ Community Diabetes Initiative


Associate Professor, CSDHU

Paul Robinson CDU 2002-2005 PhD Using spatial data to measure neighborhood influences on type II Diabetes mellitus


Associate professor under review

19

Summary of Key Senior University Administrative Experiences and Accomplishments CDU Interim President 2009-10 In 2009 I was asked by the CDU Board of Trustees to serve as the Interim President of the University during a tumultuous time. Over the course of sixteen months, I worked closely with the academic senate to lead the institution from the brink of closure to fiscal insolvency and from probation to full accreditation by the Western Association of Schools and Colleges (WASC). I returned to my role as EVP for Research and Health Affairs to continue to generate significant and needed research funds for sustaining the university. I was formally recognized for my institutional contributions on Dec 6, 2011 by the CDU Board of Trustees by the conferring of an Outstanding Service Award for exemplary leadership during a time of administrative and financial crisis. As interim president at CDU I created the first Provost Office to strengthen the university’s scholarly and research environment, and to coordinate all academic activities. This action was pivotal in leading CDU from probation to full accreditation by the Western Association of Schools and Colleges. Health Sciences Academic and Clinical Program Leadership Fulfilling my personal desire to teach and serve at a minority institution, I joined the CDU faculty in 1990 in my first administrative role as program director for the Department of Internal Medicine Residency Program, the largest Residency Program at the MLK, Jr. Hospital, then a 350 bed Hospital with a $400,000,000 annual budget. The program was on probation and at risk of closure. My team and I worked collaboratively with the hospital administration to restore full accreditation. I then served for the next five years as Vice Chair of the Department of Internal Medicine and two years as Interim Chair of the Department of Internal Medicine. I also served for two years as the President of the Hospital Professional Staff Association, working with the hospital Medical Director and CEO, and the Los Angeles County Director of Health Services to guide and implement key accreditation, policy and management decisions for optimizing training and clinical care systems for over 600 residents, fellows and faculty. My standing as an internationally recognized health policy leader has provided me the forum to help shape national health policy and practice guidelines, ensuring our academic and clinical programs are on the cusp of health care and health policy innovations. Key Administrative Research Experiences and Accomplishments I have five years experience as an Associate Dean for Research in the College of Medicine, two years experience as Vice President for Research, and since 2006 have served as the executive vice president for research and health affairs at CDU, and assistant dean for clinical and translational science at the Geffen School of Medicine, UCLA. I have been successful in leading a three-fold increase in annual university NIH research funding, establishing a high performing research reputation for CDU, now ranking in the top 50 private research universities, as rated by the 2006-11 Center for Measuring University Performance reports.

20

Certified Research Training: CITI Collaborative Institutional Training Initiative

Exam ID Module Completed 1416 About the Course 1363 Audits and Inspections in Clinical Trials 2 Basic Institutional Review Board (IRB) Regulations and Review Process 1127 Belmont Report and CITI Course Introduction 13398 Charles Drew University of Medicine and Science Courses 1364 Completing the CITI GCP Course 1434 Completing the Privacy and Security Course 1358 Conducting Clinical Trials of Medical Devices 1355 Conducting Investigator-Initiated Studies According to FDA Regulations and Good

Clinical Practices 488 Conflicts of Interest in Research Involving Human Subjects 1360 Detection and Evaluation of Adverse Events 1353 FDA Regulated Research and ICH for Investigators 12 FDA-Regulated Research 1350 GCP Introduction 6 Genetic Research in Human Populations 11 Group Harms: Research With Culturally or Medically Vulnerable Groups 498 History and Ethical Principles 3 Informed Consent 1359 Informed Consent-An Ongoing Process 1354 International Conference on Harmonization - ICH for Investigators 1352 International Conference on Harmonization (ICH): GCP Requirements 971 International Studies 1356 Investigator Obligations in FDA-Regulated Clinical Research 1357 Managing Investigational Agents According to GCP Requirements 1362 Monitoring of Clinical Trials by Industry Sponsors 1351 Overview of New Drug Development 1419 Privacy Rules and Research 1418 Privacy Rules: Clinicians 1417 Privacy Rules: Introduction to Federal and State Requirements 1420 Privacy Rules: Students and Instructors 5 Records-Based Research 1361 Reporting Serious Adverse Events 14 Research and HIPAA Privacy Protections 7 Research With Protected Populations - Vulnerable Subjects: An Overview 1423 Security Rules: Basics of Being Secure, Part 1 1433 Security Rules: Issues for Work/Workers Off-Site 1449 Security Rules: Picking and Protecting Passwords 1425 Security Rules: Protecting your Computer 1428 Security Rules: Protecting your identity 1427 Security Rules: Protecting your Portables 4 Social and Behavioral Research for Biomedical Researchers 9 Vulnerable Subjects - Research Involving Minors 10 Vulnerable Subjects - Research Involving Pregnant Women and Fetuses in Utero 8 Vulnerable Subjects - Research with Prisoners 483 Workers as Research Subjects-A Vulnerable Population

21

RESEARCH GRANTS Overview - Since 1995: Awarded over $175 million in NIH grant funding (total costs) for projects as PI or PD. From 2007-2011 average rank was among the top 50 (0.001%) of the most highly funded NIH investigators in the nation (from over 35,000 funded principal investigators; http://www.brimr.org/NIH_Awards/2010/NIH_Awards_2010.htm, http://www.brimr.org/NIH_Awards/2011/NIH_Awards_2011.htm). Active Active/Pending: Active Project Number (Principal Investigator): 1U54RR026138 (Norris, KC) Source: NIMHD/NIH Title of Project (and/or Subproject): Accelerating Excellence in Translational Science

(AXIS) Dates of Approved/Proposed Project: 09/28/2009 – 06/30/2014 Annual Direct Costs / Percent Effort: $2,975,000/30% Summary: The Accelerating Excellence in Translational Science Center promotes translational research approaches with a focus on reducing health disparities, enhance the training and career development of young investigators committed to health disparities related health disparities and promote community engagement. The overall goal is to create both scientific advances and advance health policies that will improve patient outcomes. Active/Pending: Active Project Number (Principal Investigator): U54 RR022762 (Norris, KC) Source: NIH - RCMI/NIMHD Title of Project (and/or Subproject): RCMI Translational Research Network Dates of Approved/Proposed Project: 7/01/07-6/31/12 Annual Direct Costs / Percent Effort: $2,800,000 / 33% Summary: The Research Centers in Minority Institutions (RCMI) Translational Research Network (RTRN) is a national consortium of basic, behavioral, clinical and translational researchers in the RCMI Centers, working in collaboration with investigators from other academic health centers, community health providers, and the public to focus their collective efforts on addressing health disparities. RTRN facilitates innovative multi- and cross-disciplinary translational research to generate evidence-based new knowledge and techniques to prevent, diagnose, and treat a host of diseases that are Healthy People 2020 Priorities. Active/Pending: Active Project Number (Principal Investigator): 2P20MD000182-06 (Norris, KC) Source: NIH/NCMHD Title of Project (and/or Subproject): Project EXPORT Dates of Approved/Proposed Project: 9/1/07-8/30/12 Annual Direct Costs / Percent Effort: $950,000 / 15% Summary: Excellence in Partnerships for Community Outreach, Research on Health Disparities and Training (EXPORT) Center. The CDU/UCLA Project EXPORT mission is to establish the knowledge base necessary to reduce diabetes, depression and other related health disparities among low-income African Americans and Latinos. This center will accomplish its mission by bringing new vitality to the field of health disparities research via in-depth community participation alongside academia. The EXPORT team consists of physicians, researchers, and community leaders who are committed to serving under-resourced minority communities with poor health outcomes.

22

Role: Oversee the EXPORT Center in collaboration with Dr. Martin Shapiro (UCLA) monitoring center progress, assisting in faculty development and building community partnerships. Active/Pending: Active Project Number (Principal Investigator): S21MD000103 (Norris, KC) Source: NIH-NCMHD Title of Project (and/or Subproject): Charles Drew Life Sciences Institute Dates of Approved/Proposed Project: 9/30/11-8/31/16 Annual Direct Costs / Percent Effort: $5,000,000 / 5% Summary: The mission of the 5-Year CDU Life Sciences Institute Strategic Plan is to guide the university in its allocation of endowment funds to support activities that maximize the university’s efforts to substantially improve the health status of underserved communities through supporting biomedical and behavioral research and its translation into high-quality clinical outcomes, improved community health, and progressive health policy. The specific aims of this application are to 1) establish a Minority Health and Health Disparities Research Faculty Retention Fund, as a means of successfully transitioning junior faculty from career development grant support to independent investigator-initiated research grant support, 2) recruit, retain, and support “community faculty” within the Division of Community Engagement through a novel academic track designed to create a transformational learning environment at CDU and a model of Community-Academic partnership immersion for the nation, and 3) continue effective management of the endowment portfolio at a level consistent with the highest fiduciary standards in the nation. Active/Pending: Active Project Number (Principal Investigator): UL1 RR033176 (S. Dubinett) Source: NIH-NCRR Title of Project (and/or Subproject): Clinical and Translational Research Institute Dates of Approved/Proposed Project: 6/1/11-2/28/16 Annual Costs / CDU Subcontract: $15,000,000 / $1,200,000 Summary: UCLA CTSI is a four-institute partnership that includes UCLA, Charles R. Drew University of Medicine and Science, the Los Angeles Biomedical Institute at Harbor UCLA Medical Center, and the Burns and Allen Research Institute at Cedars-Sinai Medical Center) dedicated to enhance the efficiency and quality of clinical and translational studies initiated by the NIH's Clinical and Translational Science Awards. Its overall mission is to create a borderless clinical and translational research institute that brings UCLA innovations and resources to bear on the greatest health needs in Los Angeles. Role: I serve within the central leadership as the CDU Site Director and co-leader of the Community Engagement Research Program (CERP) across all sites. Active/Pending: Active Project Number (Principal Investigator): 1R13DK079709 (Norris, KC) Source: NIDDK/NIH Title of Project (and/or Subproject): Conference Grant: Prevent/Kidney

Disease/Minority Groups/Emerging Nations Dates of Approved/Proposed Project: 3/1/2007 - 2/29/2012 Annual Direct Costs / Percent Effort: $30,000/1% Summary: To provide support for and help to develop a Chronic Kidney Disease Satellite meeting to the International Society of Nephrology Committee on CKD in Disadvantaged Populations and Developing Nations. The meeting focuses on renal disease in minority populations and developing nations with carefully selected global participants and abstract presentations by junior investigators. Main topics will include etiology and prevalence of chronic

23

kidney disease and end stage renal disease, as well as their main causes and complications. The conferences focus on innovative cost effective prevention and early treatment strategies.

Active/Pending: Active Project Number (Principal Investigator): 1R25DK078386-06 (Norris, KC) Source: NIH/NIDDK Title of Project (and/or Subproject): NIH National High School Student Summer

Research Program Dates of Approved/Proposed Project: 4/1/12-3/31/2017 Annual Direct Costs / Percent Effort: $158,000/ 5% Summary: To provide an in-depth health sciences immersion experience each summer to 20-25 promising high school students from racial/ethnic groups underrepresented in biomedical, clinical, and behavioral research, and/or from disadvantaged backgrounds who would otherwise likely not have access to a career path in science. This education and training experience encompasses exposure to critical methodologies and principles of biomedical and clinical research in the NIDDK mission areas and in disease areas identified by Healthy People 2020 as disproportionately prevalent among underrepresented minority communities. The CDU program includes an introductory web-based training curriculum in the Responsible Conduct of Research, an informal mentor-led laboratory and research orientation, opportunities for attendancemat various research forums, specialized student-specific research assignments and activities, and the annual NIH/NIDDK student research symposium where students present their research findings to their peers. Active/Pending: Active Project Number (Principal Investigator): 1RC4AG038182 (SARKISIAN, CA) Source: NIH/NIA Title of Project (and/or Subproject): UCLA-DREW/City of Los Angeles area agency on

aging center for community research Dates of Approved/Proposed Project: 1-JUL-2010 / 30-JUN-2013 Annual Direct Costs / Percent Effort: $500,000/1% Summary: The Los Angeles Community Academic Partnership for Research in Aging (L.A. CAPRA) Center is a collaboration between the University of California Los Angeles (UCLA), Charles Drew University (CDU), City of Los Angeles Department of Aging (DOA), and Partners in Care Foundation. Our unusual academic – community partnership is rooted in deep mutual respect and a shared vision for implementing and testing practical evidence-based interventions to empower older adults to stay as active and healthy as possible. L.A. CAPRA Center provides critical infrastructure to facilitate and implement community-partnered research across the (arguably) largest and most ethnically diverse urban center in the United States. Role: Assist in implementing an ethnically diverse urban "community empowered testbed" for deploying and testing behavioral research among lower income seniors and translating research findings into practical community-based interventions improving their quality of life.

Active/Pending: Active Project Number (Principal Investigator): (Norris, KC) Source: Doris Duke Title of Project (and/or Subproject): Student Training in Research Involving Disparity

Elimination Dates of Approved/Proposed Project: 1/1/12-12/31/2015 Annual Direct Costs / Percent Effort: $68,000/ 2%

24

Summary: To provide an in-depth health sciences immersion experience each summer to 20-25 promising high school students from racial/ethnic groups underrepresented in clinical research. The CDU program includes an introductory web-based training curriculum in the Responsible Conduct of Research, an informal mentor-led clinical research orientation, opportunities for attendancemat various research forums, specialized student-specific research assignments and activities, and a local student research symposium where students present their research findings to their peers.

Active/Pending: Active Project Number (Principal Investigator): 3P30AG021684 (Mangione, C) Source: NIH/NIA Title of Project (and/or Subproject): The Center for Health Improvement of Minority

Elderly Dates of Approved/Proposed Project: 9/30/07-6/30/12 Annual Direct Costs / Percent Effort: $862,966/2% Summary: The UCLA/Drew Center for Health Improvement for Minority Elders (CHIME) is a research and mentoring program that ultimately contributes to the reduction in health disparities for African American and Latino Elders by training and mentorship of minority faculty who advance their careers by conducting research on minority elders. Role: Drew lead in the UCLA/Drew Center for Health Improvement for Minority Elders (CHIME) which provides research and mentoring to reduce health disparities affecting African American and Latino Elders by training and mentorship of minority faculty who will advance their careers by conducting research on minority elders. Active/Pending: Active Project Number (Principal Investigator): #99IPA06350 (Norris KC) Source: CDC Title of Project (and/or Subproject): Healthy African American Families Dates of Approved/Proposed Project: 9/28/2011 - 9/27/2012 Annual Direct Costs / Percent Effort: $97,000/1% Role: Support Ms. Loretta Jones and HAAF to provide technical assistance on community participatory research and on African American public health issues and to make presentations on the HAAF process and results at local, state, and national levels. Ms. Jones will also be responsible for continuing the protection of Human Subjects data collected by HAAF and/or Charles Drew University and any other collaborating institutions. Pending Active/Pending: Pending Project Number (Principal Investigator): 3P30AG021684 (Mangione, C) Source: NIH/NIA Title of Project (and/or Subproject): The Center for Health Improvement of Minority

Elderly Dates of Approved/Proposed Project: 7/1/12-6/30/17 Annual Direct Costs / Percent Effort: $500,000/2% Role: Drew lead in the UCLA/Drew Center for Health Improvement for Minority Elders (CHIME) which provides research and mentoring to reduce health disparities affecting African American and Latino Elders by training and mentorship of minority faculty who will advance their careers by conducting research on minority elders.

25

Active/Pending: Active Project Number (Principal Investigator): 2P20MD000182 (Norris, KC) Source: NIH/NCMHD Title of Project (and/or Subproject): Project EXPORT Dates of Approved/Proposed Project: 9/1/12-8/30/17 Annual Direct Costs / Percent Effort: $950,000 / 15% Summary: Excellence in Partnerships for Community Outreach, Research on Health Disparities and Training (EXPORT) Center. The CDU/UCLA Project EXPORT mission is to establish the knowledge base necessary to reduce diabetes, depression and other related health disparities among low-income African Americans and Latinos. This center will accomplish its mission by bringing new vitality to the field of health disparities research via in-depth community participation alongside academia. The EXPORT team consists of physicians, researchers, and community leaders who are committed to serving under-resourced minority communities with poor health outcomes. Role: Oversee the EXPORT Center in collaboration with Dr. Martin Shapiro (UCLA) monitoring center progress, assisting in faculty development and building community partnerships.

26

2009-2011 Grant Portfolio Summarized (~ $20M/yr; among top 50 NIH funded researchers in the nation)

27

SPECIALIZED INSTITUTIONAL ENHANCEMENT GRANTS Grant Source Project Title Project Period 1C06RR018925-NIH/NCRR Construction Grant 9/1/03 (Francis/Norris/Friedman) $4,000,000 Role: Led the writing and preparation of the grant application for the second floor of a 40,000 sq ft research building. NIH/NCRR Master’s of Clinical Research Program 9/1/03-8/31/08 (Yoshikawa) $500,000 Role: Led the writing and preparation of the grant application. NIH/GIMS MBRS 7/1/03-6/30/07 (P.I.-Friedman) Minority Biomedical Research $550,000 Faculty development program This is a program project designed to develop academic careers for junior faculty interested in biomedical research. Role: co-wrote the application and will function as a mentor and part of the MBRS advisory board. 1C06RR017599-01-NIH/NCRR Construction Grant 9/1/02 (Francis/Norris/Friedman) $3,000,000 Role: Led the writing and preparation of the grant application to construct a 40,000 sq ft research building. 3G12RR003026-16S1-NIH/NCRR Animal facility Enhancement Grant 9/1/02-8/30/03 (Francis/Esfandiari/Norris/Friedman) $200,000 Role: Co-Leader in the writing and preparation of the grant application that included the development of a transgenic animal facility.

28

Inactive: Active/Pending: Inctive Project Number (Principal Investigator): 1R25DK078386-06 (Norris, KC) Source: NIH/NIDDK Title of Project (and/or Subproject): NIH National High School Student Summer

Research Program Dates of Approved/Proposed Project: 4/1/07-3/31/2012 Annual Direct Costs / Percent Effort: $131,000/ 5% Summary: To provide an in-depth health sciences immersion experience each summer to 20-25 promising high school students from racial/ethnic groups underrepresented in biomedical, clinical, and behavioral research, and/or from disadvantaged backgrounds who would otherwise likely not have access to a career path in science. This education and training experience encompasses exposure to critical methodologies and principles of biomedical and clinical research in the NIDDK mission areas and in disease areas identified by Healthy People 2010 as disproportionately prevalent among underrepresented minority communities. The CDU program includes an introductory web-based training curriculum in the Responsible Conduct of Research, an informal mentor-led laboratory and research orientation, opportunities for attendancemat various research forums, specialized student-specific research assignments and activities, and the annual NIH/NIDDK student research symposium where students present their research findings to their peers. Active/Pending: Inactive Project Number (Principal Investigator): U01 DK065455-S03 (Norris, KC) Source: NIH/NIDDK Title of Project (and/or Subproject): NIH National High School Student Summer

Research Program Dates of Approved/Proposed Project: 3/30/04-8/31/2009 Annual Direct Costs / Percent Effort: $283,000 (for this supplement) / 5% To provide a rewarding research experience to 65 high school students nationally over the summer under the mentorship of funded NIH investigators, culminating in a student research symposia on the NIH campus. Active/Pending: Inactive Project Number (Principal Investigator): 1-SO-GM068510-01 (Friedman, T) Source: NIH/GIMS Title of Project (and/or Subproject): Minority Biomedical Research Faculty

development program Dates of Approved/Proposed Project: 7/1/2003 - 8/31/2007 Annual Direct Costs / Percent Effort: $550,000/1% Role: This is a program project designed to develop academic careers for junior faculty interested in biomedical research. Role: co-wrote the application and function as a mentor and advisory board member. Active/Pending: Inactive Project Number (Principal Investigator):

S21MD000103 (Norris, KC)

Source: NIH-NCMHD

29

Title of Project (and/or Subproject): Charles Drew Life Sciences Institute

Dates of Approved/Proposed Project: 9/30/08-8/31/11 Annual Direct Costs / Percent Effort: $5,000,000 / 5% Summary: The mission of the 3-Year CDU Life Sciences Institute Strategic Plan is to guide the university in its allocation of endowment funds to support activities that maximize the university’s efforts to substantially improve the health status of underserved communities through supporting biomedical and behavioral research and its translation into high-quality clinical outcomes, improved community health, and progressive health policy. The specific aim of this application was to create an infrastructure for support of recruitment and retention of research faculty through a tenure type system and research endowments.

Active/Pending: Inactive Project Number (Principal Investigator): U54 RR019234-04 (Norris, KC) Source: NCRR/NIH Title of Project (and/or Subproject): Comprehensive Center for Health Disparities - CKD

Dates of Approved/Proposed Project: 9/30/2003 - 8/31/2009 Annual Direct Costs / Percent Effort: $500,000/15% year one; 2,000,000/20% years 2-6 Comprehensive Center for Health Disparities for Chronic Kidney Disease (CKD) that will recruit an emerging junior researcher, address innovative ways to engage community around CKD risk factor reduction, screening and early treatment, enhance the training of young investigators committed to reducing CKD related health disparities and integrate CKD related health outcomes into public policy.

Active/Pending: Project Number (Principal Investigator): 1 P20 RR11145-02 (P.I. – Kelly/ P.D. - Norris) Source: NIH - RCMI/NCRR Title of Project (and/or Subproject): Clinical Research Center Infrastructure Award Dates of Approved/Proposed Project: 9/30/05-9/29/10 Annual Direct Costs / Percent Effort: $1,449,520 / 25% Summary: The Clinical Research Center is designed to support activities that maximize the university’s efforts to substantially improve the health status of underserved communities through supporting clincial and translation research to generate high-quality clinical outcomes and improved community health. The specific aim of this program is to develop, enhance and expand institutional clinical research infrastructure and develop novel community partnerships for advancing clinical research. Active/Pending: Project Number (Principal Investigator): U01 DK065455-01 (Norris, KC) Source: NIH/NIDDK Title of Project (and/or Subproject): African- American Study of Kidney Disease and

Hypertension Cohort Follow-up Dates of Approved/Proposed Project: 7/1/2003 - 6/30/2008 Annual Direct Costs / Percent Effort: $133,000 / 5% NIH An observation cohort follow-up to examine predictors of clinical outcomes of this unique group of African Americans with mild-moderate renal failure due to hypertension followed closely and treated with evidenced based therapy. This is the largest randomized controlled trial ever to examine hypertenisive CKD in African Americans.

30

Active/Pending: Project Number (Principal Investigator): U54 RR14616 (Davidson, Mayer) Source: NIH – RCMI/NCRR Title of Project (and/or Subproject): Center of Excellence in Clinical Research Dates of Approved/Proposed Project: 9/30/04-9/29/09 Annual Direct Costs / Percent Effort: $1,200,000 / 15% This is an Infrastructure Award to develop a focused program of research in Diabetes and Metabolism. This program enhances clinical research infrastructure and expands institutional clinical research activities. Helped to write the competitive renewal and lead the translational research core. Active/Pending: Project Number (Principal Investigator): 1R-25-RR019488-01 (Yoshikawa T) Source: NIH/NCRR Title of Project (and/or Subproject): Clinical Research Education Development Dates of Approved/Proposed Project: 9/1/2003 - 8/31/2008 Annual Direct Costs / Percent Effort: $500,000/1% Role: Project co-investigator. Led the writing and preparation of the grant application. This is an institutional infrastructure program to provide formalized structured training in clinical research for senior post-doctoral research fellows and faculty committed to academic careers. Active/Pending: 1-D1DHP06513-01-00 Project Number (Principal Investigator): Norris, KC Source: HRSA Title of Project (and/or Subproject): The Drew Clinical Care Quality Enhancement

Project Dates of Approved/Proposed Project: 9/30/05-8/31/07 Annual Direct Costs / Percent Effort: $275,000 / 10% The specific aim of this program is to enhance the number of health care providers to improve diabetes outcomes Active/Pending: MPCMP06101 1-01-00 Project Number (Principal Investigator): Norris, KC Source: DHHS (Morehouse Subcontract) Title of Project (and/or Subproject): Health Professions Leadership Development

Program Dates of Approved/Proposed Project: 7/1/06-6/30/07 Annual Direct Costs / Percent Effort: $250,000 / 5% The objectives of this university leadership development program are to: 1) Implement a professional, academic, and leadership development program directed toward department chairs and other senior staff; and 2) Enhance the support for Graduate Medical Education. Active/Pending: S21MD000103 Project Number (Principal Investigator): Norris, KC Source: NIH-NCMHD Title of Project (and/or Subproject): The Drew Medical Sciences Institute Dates of Approved/Proposed Project: 9/30/05-8/31/08 Annual Direct Costs / Percent Effort: $5,000,000 / 5%

31

The specific aim of this program is to create an infrastructure for support of recruitment and retention of research faculty through a tenure type system and research endowments Active/Pending: Active Project Number (Principal Investigator): 1 P20 MD00182-05 (Norris) Source: NIH/NCMHD Title of Project (and/or Subproject): Project EXPORT Dates of Approved/Proposed Project: 9/30/02-8/30/07 Annual Direct Costs / Percent Effort: $771,000 / 15% Summary: Excellence in Partnerships for Community Outreach, Research on Health Disparities and Training (EXPORT) Center. The CDU/UCLA Project EXPORT mission is to establish the knowledge base necessary to reduce diabetes, depression and other related health disparities among low-income African Americans and Latinos. This center will accomplish its mission by bringing new vitality to the field of health disparities research via in-depth community participation alongside academia. The EXPORT team consists of physicians, researchers, and community leaders who are committed to serving under-resourced minority communities with poor health outcomes. Role: Oversee the EXPORT Center in collaboration with Dr. Martin Shapiro (UCLA) monitoring center progress, assisting in faculty development and building community partnerships. Active/Pending: Active Project Number (Principal Investigator): 1 R13 DK067027-01 (Norris, KC) Source: NIDDK/NIH Title of Project (and/or Subproject): Conference Grant: Prevent/Kidney Disease/Minority

Groups/Emerging Nations Dates of Approved/Proposed Project: 7/1/2005 - 6/31/2006 Annual Direct Costs / Percent Effort: $30,000/1% Summary: To provide support for and help to develop a Chronic Kidney Disease Satellite meeting to the 2005 World Congress of Nephrology meeting as part of the International Society of Nephrology Committee on CKD in Disadvantaged Populations and Developing Nations. The meeting focuses on renal disease in minority populations and developing nations with carefully selected global participants and abstract presentations by junior investigators. Main topics will include etiology and prevalence of chronic kidney disease and end stage renal disease, as well as their main causes and complications. The conferences focus on innovative cost effective prevention and early treatment strategies. Active/Pending: Active Project Number (Principal Investigator): U01 DK065455-S02 (Norris, KC) Source: NIH/NIDDK Title of Project (and/or Subproject): NIH National High School Student Summer

Research Program Dates of Approved/Proposed Project: 3/30/01-8/31/2003 Annual Direct Costs / Percent Effort: $283,000 (for this supplement) / 5% Summary: To provide an in-depth health sciences immersion experience each summer to 65 promising high school students from racial/ethnic groups underrepresented in biomedical, clinical, and behavioral research, and/or from disadvantaged backgrounds who would otherwise likely not have access to a career path in science. This education and training experience encompasses exposure to critical methodologies and principles of biomedical and clinical research in the NIDDK mission areas and in disease areas identified by Healthy People 2010 as disproportionately prevalent among underrepresented minority communities. The CDU

32

program includes an introductory web-based training curriculum in the Responsible Conduct of Research, an informal mentor-led laboratory and research orientation, opportunities for attendancemat various research forums, specialized student-specific research assignments and activities, and the annual NIH/NIDDK student research symposium where students present their research findings to their peers. Active/Pending: Active Project Number (Principal Investigator): K30 HL04526 (P.I. Lucinio, Julio – UCLA) Source: NIH/NCRR Title of Project (and/or Subproject): Clinical Research Curriculum K-30 Award:

(Role: Co-investigator) Dates of Approved/Proposed Project: 9/1/00-8/30/05 Annual Direct Costs / Percent Effort: $200,000 / 1% The specific aim of this program is to develop a clinical research curriculum leading to a Masters degree in Clinical Research and Methodology Active/Pending: Active Project Number (Principal Investigator): 2R01HL51 (P.I. – Schneider; Drew P.I. – Myers) Source: NIH/NHLBI Title of Project (and/or Subproject): The effects of transcendental meditation vs. JNC 6

lifestyle modification on CVD morbidity and mortality in Blacks

Dates of Approved/Proposed Project: 9/30/99-8/31/2004 (One year no cost extension) Annual Direct Costs / Percent Effort: $205,000 (Subcontract) / 2% A trial to compare the effects of transcendental meditation vs. JNC 6 lifestyle modification on CVD morbidity and mortality in Blacks using carotid IMT as a marker of vascular progression. Active/Pending: Active Project Number (Principal Investigator): P50ATOO (P.I. – Schneider, Robert; Drew P.I. -

Myers) Source: NIH/NHLBI Title of Project (and/or Subproject): Transcendental meditation on brachial artery

reactivity in older Blacks Dates of Approved/Proposed Project: 9/30/99-8/31/2004 (One year no cost extension) Annual Direct Costs / Percent Effort: $140,000 (Subcontract) / 2% This study examines the effects of transcendental meditation on brachial artery reactivity in older Blacks. Active/Pending: 1R01DK5962-01 Project Number (Principal Investigator): P.I. Bhasin, Shalender – Drew Source: NIH/NIDDK Title of Project (and/or Subproject): Testosterone and muscle function in ESRD

patients: 240,000/yr (Role: Co-investigator)

Dates of Approved/Proposed Project: 08/01/2001- 06/30/2005 Annual Direct Costs / Percent Effort: $285,000 / 4%

33

A study to assess the role of testosterone supplementation on muscle function and well being in dialysis patients with low testosterone levels. Active/Pending: Approved Project Number (Principal Investigator): 1RO1DK/NR59527 (P.I. Carol Mangione, UCLA) Source: NIH/NIDDK Title of Project (and/or Subproject): A self-care intervention designed to enhance the

self-management skills of older African Americans with diabetes (Role: Co-investigator; Drew P.I.)

Dates of Approved/Proposed Project: 7/1/01-6/30/04 Annual Direct Costs / Percent Effort: 185,000 / 3% A study to assess the role of a culturally competent self-care curriculum to improve patient related clinical outcomes in older diabetics. Active/Pending: Approved Project Number (Principal Investigator): (P.I. Carol Mangione, UCLA) Source: NIH/NIA Title of Project (and/or Subproject): A self-care intervention designed to enhance the

self-management skills of older Hispanics with diabetes (Role: Co-investigator; Drew P.I.)

Dates of Approved/Proposed Project: 7/1/01-6/30/05 Annual Direct Costs / Percent Effort: 255,000 / 3% A study to assess the role of a culturally competent self-care curriculum to improve patient related clinical outcomes in older diabetics. Active/Pending: Active Project Number (Principal Investigator): U54 RR14616 (Norris, Keith) Source: NIH – RCMI/NCRR Title of Project (and/or Subproject): Center of Excellence in Clinical Research Dates of Approved/Proposed Project: 9/30/99-9/29/004 Annual Direct Costs / Percent Effort: $1,200,000 / 15% This is an Infrastructure Award to develop a focused program of research in Diabetes and Metabolism. This program enhances clinical research infrastructure and expands institutional clinical research activities. There is a body composition and metabolism core at Drew and a translational research core that is based upon collaboration with the UCLA Division of General Internal Medicine and Health Services Research. Active/Pending: Project Number (Principal Investigator): DK45426-04 (P.I. - Massry) (Drew P.I. - Norris;

subcontract through USC) Source: NIH/NIDDK Title of Project (and/or Subproject): African- American Study of Kidney Disease and

Hypertension Dates of Approved/Proposed Project: 7/1/94 - 6/30/2003 Annual Direct Costs / Percent Effort: $228,749 / 5% NIH

34

A Double-Blind Placebo-Controlled, Multicenter, study to determine the most effective level of blood pressure and class of blood pressure medication to prevent hypertensive renal disease in a well defined and closely followed cohort of African Americans with mild-moderate renal failure due to hypertension. 1 R21 AR48050-0 Master’s of Clinical Research Program 7/1/01-8/30/02 NIH/NIAMS (Norris) at Minority Institutions Planning Award $150,000 5% NIH (Todd – Mount Sinai) African Americans, Hypertension 3/1/00-2/31-02 Co-investigator and Lead Exposure $286,815 10% (Drew subcontract) Role: Drew PI for this multi-center study that is an ancillary R0-1 project to the larger AASK grant. The role of this project is to evaluate the association of lead (measuring both blood and bone) with hypertensive renal disease. P20 RR11145-S4 (Norris) Clinical Research Center 9/30/98-8/31/01 NIH - RCMI/NCRR Faculty Development Mentor $89,500 Role: I function in the capacity of faculty mentor. I assist in designing short and long-term career goals, participate in didactic education, research training, and academic advancement. CDC #99IPA06350 (Norris) Healthy African American Families 1/1/00 - 9/30/2000 Interagency Personnel Agreement $45,000 Searle. Epleranone on BP 4/1/00 – 9/1/00 P.I. - Drew in African Americans $80,000 4% P20 RR11145-05 (Francis/Norris) Clinical Research Center 9/30/95-9/29/00 NIH - RCMI/NCRR $740,500 Role: Program Director 50% UO1-DK54047 (Norris) Clinical Trials Unit 9/97-9/03 NIH - NIDDK $1,490,000 6 year grant to develop infrastructure for clinical trials research Role: I was responsible for planning, organizing and writing the grant and was interim director for one year until a permanent director was recruited. Merck. The Effect of Endothelin Receptor 9/1/98 –9/1/99 P.I. - Drew Antagonist on Blood Pressure in $75,000 4% African Americans. Bone Care Int. Intravenous 1-alpha-hydroxyvitamin 9/1/97-5/1/98 P.I. - Drew D2 in reducing elevated PTH in $80,000 ESRD patients on hemodialysis Bone Care Int. Oral 1-alpha-hydroxyvitamin D2 9/1/96-9/1/98 P.I. - Drew in reducing elevated PTH in ESRD $80,000 patients on hemodialysis

35

RO1HL51519 (Myers) Stress Reduction & Education 3/1/94-2/28/98 NIH in the Control of Hypertension $911,000 Co-investigator RFA-DK-91-06 Recruitment supplement for 7/1/94-6/30/95 NIH Black Women and Men for AASK $49,957 P.I. - Drew Sandoz Pharm. Calcium channel blockers & 7/1/93-6/30/95 P.I. salt sensitive hypertension $190,000 R51/ATU398004 (Yoshikawa) Inner City Environmental Lead 5/1/92-4/30/97 ATSDR/CDC Exposure and Hypertension $520,821 Co-P.I. DK-91-06 (Massry – USC) African American Study 7/1/92-3/31/95 NIH/NIDDK of Kidney Disease and $226,876 Co-investigator Hypertension (AASK): Pilot Neurex: P.I. – Levine, Bart The Effect of Fenoldopam on 1989 – 1992 Co-investigator progressive renal failure 2% Merck. P.I. – Levine, Bart The Effect of Carvedilol on 1985 – 1987 Co-investigator patients with mild-moderate Hypertension 2% Abbott: P.I. – Kraut, Jeff The Effect of Hytrin on patients 1985 – 1987 Co-investigator with moderate-severe Hypertension 2% LECTURES AND PRESENTATIONS: April 1986 Medical Grand Rounds, Wadsworth VA Hospital, Nephrolithiasis May 1986 Medical Grand Rounds, Howard University Hospital, Update in renal

osteodystrophy. August 1986 National Medical Association, Approach to the patient with mild-moderate renal

failure. April 1987 Renal Grand Rounds, Cedars-Sinai Medical Center Indications for and

applications of bone biopsy in dialysis patients. June 1988 Rheumatology Grand Rounds -UCLA, Bone disease in CRF May 1988 Medical Grand Rounds, Howard University Hospital, Pathophysiology of

secondary hyperparathyroidism August 1988 National Medical Association, - Prevention of progressive renal failure July 1990 National Medical Association, - Early renal failure in diabetic and hypertensive

nephropathy July 1991 National Medical Association, - Symposium on Renal Transplantation

(Chairperson/Discussant)

36

March 1991 Medical Grand Rounds, Wadsworth VA Hospital, - Nephrolithiasis Nov. 1991 American Society of Nephrology, - Symposium on Hypertension in Blacks

(Chairperson/Discussant) Oct. 1990 National Kidney Foundation of Southern California. Palm Springs, CA., New

advances in the treatment of bone disease April 1991 Drew Medical Society, Santa Barbara, CA, Advances in Peritoneal Dialysis. July 1992 National Medical Association, - Symposium on Clinical Issues in Nephrology

(Chairperson/Discussant) Sept. 1991 American Diabetes Association, Los Angeles; Renal disease in patients with

diabetes mellitus April 1992 Robert F. Kennedy Medical Center; The use of antihypertensive therapy in

patients with renal disease August 1992 Daniel Freeman Hospital; The role of cellular calcium in essential hypertension July 1993 Department Family Practice, King-Drew Medical Center Acute renal failure August 1993 National Medical Association (San Antonio, Texas), (Moderator for Renal

Symposium: SLE, ARF, HTN in Diabetes, Non Dialysis uses of EPO) March 1992 Medical Grand Rounds, King-Drew Medical Center, Genetic and cellular

mechanisms of essential hypertension Sept. 1992 Medical Grand Rounds, King-Drew Medical Center: Approach to the patient with

hyperkalemia Nov. 1993 Medical Grand Rounds, King-Drew Medical Center, Renovascular hypertension April 1994 National Kidney Foundation, Chicago, Baseline characteristics of patients

entering the pilot African-American Study of Kidney Disease (Pilot-AASK) Nov. 1994 Minority Health Institute Medical Symposium: Marina Del Rey, CA, Osteoporosis Nov. 1994 Challenges for the 21st Century. Drew University, Cardiovascular Seminar: Los

Angeles CA. Prevention of cardiovascular disease/stroke due to hypertension in the African American male

March 1994 Wadsworth VA Hospital, Renal Pathophysiology Lecture Series: Molecular and cellular mechanisms of essential hypertension

July 1994 Medical Grand Rounds, Gardena Community Hospital, The use of antihypertensive therapy in patients with renal disease

July 1994 Department Family Practice, King-Drew Medical Center The approach to the patient with acute renal failure

July 1994 National Medical Association (Orlando, Florida), (Moderator for Renal Symposia) Nov. 1994 Hubert Humphrey Medical Clinic: The approach to the patient with mild renal

insufficiency Nov. 1994 Charles Drew University School of Allied Health Preventive Medicine

Symposium. Risk factors for heart disease in the African American community Jan. 1995 Orthopedic Grand Rounds; King-Drew Medical Center. Renal osteodystrophy Feb. 1995 Wadsworth VA Hospital, Renal Pathophysiology Lecture Series: Molecular and

cellular mechanisms of essential hypertension May 1995 UCLA Student Renal Pathophysiology Lecture Series: Approach to the patient

with hypertension May 1995 UCLA Student Renal Pathophysiology Lecture Series: Approach to the patient

with hyperkalemia June 1995 International Society of Hypertension in Blacks. (St. Thomas, U.S. Virgin Islands)

Cross Cultural Perspectives in Hypertension, Cardiovascular and Renal disease: Emerging Paths. Moderator/discussant

July 1995 National Medical Association (Atlanta, GA), (Moderator for Nephrology Symposia: Aids Nephropathy; RPGN; Insulin resistance, hypertension and

37

ethnicity) Presentation: Overview and baseline characteristics of the AASK trial Jan. 1996 Endocrine Grand Rounds; King-Drew Medical Center. Pathophysiology and

Management of Renal Osteodystrophy Feb. 1996 Wadsworth VA Hospital, Renal Pathophysiology Lecture Series: Epidemiology of

Essential Hypertension. April 1996 Clinical Nephrology Meetings, Anaheim CA Moderator - Special Problems in the

treatment of hypertension July 1996 National Medical Association (Atlanta, GA), Co-Chair for Nephrology Symposia:

Diabetes and the Kidney July 1996 Grand Rounds, E. Royal Comprehensive Health Center Emerging Concepts for

First-Line Antihypertensive Therapy Aug 1996 Grand Rounds, Watts Health Center: Hypertensive and diabetic related chronic

renal failure Dec. 1996 Noon Lecture, Wadsworth VA Hospital, Treatment strategies in hypertension. Feb. 1996 Wadsworth VA Hospital, Renal Pathophysiology Lecture Series: Epidemiology of

Essential Hypertension. May 1996 The role of angiotensin II in hypertension. Merck Pharmaceuticals, Los Angeles

CA. Feb. 1997 American College of Physicians, Los Angeles, CA. Hypertension and renal

failure: An epidemic in African American. Physiology and Therapeutic Approach June 1997 Improving Renal Treatment Outcomes in a Diverse Community: Improving

outcomes for African-Americans. American Kidney Fund, New York, New York Sept 1997 Hemodialysis Adequacy. American Association of Kidney Patients. Ft.

Lauderdale, Fl Oct 1997 Improving renal treatment outcomes in a diverse community: Improving

outcomes for African-Americans. American Kidney Fund, Baltimore, MD Oct 1997 Advances in renal bone disease Renal Nurses Association: Denver, CO March 1998 Cocaine, hypertension and renal disease. Renal Grand Rounds Harbor-UCLA March 1998 Hypertension in the elderly. Geriatric Grand Rounds, Drew Univ. June 1998 Coronary artery disease in African American men. T.H.E. Community Clinic, Los

Angeles, CA June 1998 Clinical research in African American community, African American Community

Coalition, Los Angeles, CA Sept 1998 Preventing problems for the hemodialysis patient. American Association of

Kidney Patients, Ft. Lauderdale, FL, Sept 10-13 Sept 1998 NKF/DOQI patient impact/professional responsibility. American Association of

Kidney Patients, Ft. Lauderdale, FL, Sept 10-13 Sept 1998 Long Term care issues in dialysis. American Association of Kidney Patients, Ft.

Lauderdale, FL, Sept 10-13 Oct 1998 Update on renal osteodystrophy. ESRD Network 13 annual meeting Oklahoma

City, OK Nov 1998 Clinical research in the African American community, Friends of Drew, Los

Angeles, CA Nov 1998 Case presentations in renal osteodystrophy: The role of novel vitamin D analogs.

Regional American Nephrology Nursing Association meeting, Seattle, WA Nov 1998 Case presentations in renal osteodystrophy: The role of novel vitamin D analogs.

Oregon council on renal nutrition, Portland, OR Dec 1998 Evolving concepts in hypertension. Noon Lecture, Wadsworth VA Hospital Jan 1999 Update in renal osteodystrophy: The role of novel vitamin D analogs, Regional

American Nephrology Nursing Association meeting, Oakland, CA

38

Jan 1999 Update in renal osteodystrophy: The role of novel vitamin D analogs. Regional American Nephrology Nursing Association Mtg, Galveston, TX

Feb 1999 Hypertension in the African American community, 100 Black Men Organization, Los Angeles, CA

Feb 1999 Clinical research in the community, Watts SPA 8 sub chapter, Los Angeles, CA March 1999 Complications of hyperphosphatemia in dialysis patients, Oakland, CA March 1999 Clinical research in the Community, SPA 8 meeting, Los Angeles, CA April 1999 Update in renal osteodystrophy, The role of novel vitamin D analogs, Regional

American Nephrology Nursing Association meeting, Helena, MT April 1999 DOQI Update: Hemodialysis Adequacy, Eighth Annual NKF Clinical Nephrology

meeting, Washington, DC April 1999 Clinical effects of hyperphosphatemia and new therapeutic approaches. (Special

Symposium) Eighth Annual NKF Clinical Nephrology meeting, Washington, DC May 1999 Clinical effects of hyperphosphatemia and new therapeutic approaches.

Honolulu, HI May 1999 Clinical trials: The consent form and the FDA review. Speaker and panel

discussant, FDA sponsored meeting on Ethics, IRB, Regulatory Issues and Clinical Research, Los Angeles, CA

May 1999 DOQI Update, Hemodialysis adequacy, NKF Regional meeting, Honolulu, HI May 1999 Clinical effects of hyperphosphatemia and new therapeutic approaches, Dallas,

TX June 1999 Stress and Heart disease in African Americans, Congressional Health Coalition,

Washington, D.C. (Panel with Surgeon General Dr. David Satcher) June 1999 Hyperphosphatemia in chronic renal failure: New therapeutic approaches,

Orange County, CA (Renal Dietician Association) July 1999 Hyperphosphatemia in chronic renal failure: New therapeutic approaches,

Orange County, CA (TRC Renal Dietician) Aug 1999 Epidemiology and demographics of chronic renal failure, Amgen, Thousand

Oaks, CA (Senator Conyers and Amgen clinical managers) Sept 1999 Understanding Dialysis – Prescription for success. American Association of

Kidney Patients, Phoenix, AZ Sept 1999 DOQI Update, American Association of Kidney Patients, Phoenix, AZ Sept 1999 Renal osteodystrophy and new Vitamin D analogs. Harbor-UCLA, Endocrine

Grand Rounds Sept 1999 Clinical effects of hyperphosphatemia the ESRD patient. San Diego American

Nephrology Nursing Association meeting San Diego, CA Sept 1999 Chronic renal insufficiency workgroup, Chicago, IL Sept 1999 Cultural implications of diabetes and heart disease: issues in the African

American population, (Swedish Medical Center, Seattle, WA., Sept. 24, 1999) Nov 1999 PTH and ESRD: Where are we heading in the 21st Century (American Society of

Nephrology Nov. 6, 1999) Nov 1999 Treatment strategies for early renal disease in special populations (American

Society of Nephrology Nov. 6, 1999) Nov 1999 Clinical research in our community, Southern California Clergy Council April 2000 Clinical trials, Keynote Speaker, National Black Leadership Initiative on Cancer,

Las Vegas, NV April 2000 Clinical trials in the community, Service Planning Area 6, Los Angeles, CA May 2000 Community partnership in public health programs, Jackson Heart Study

Symposium on Building Community Capacity, Jackson, MS May 2000 Clinical research in our community, Women’s Wellness Foundation, Los

39

Angeles, CA July 2000 Building culturally competent aging networks, 5th Annual North Carolina

Symposium on Aging, Asheville NC July 2000 Shrinking our multicultural world (plenary session special panel), 5th Annual

North Carolina Symposium on Aging, Asheville NC Sept 2000 DOQI dialysis guidelines, American Association of Kidney Patients, Tampa FL Sept 2000 DOQI hemodialysis guidelines, Directions in Dialysis, Portland, OR Sept 2000 Chair, Amgen Regional Nephrology Advisory Board: Early renal failure, Focus on

anemia, Los Angeles, CA Sept 2000 Host and Moderator: Clinical Research and Research Ethics in Multicultural

Communities, LA, CA Sept 2000 What is clinical research and its role in addressing health disparities: Clinical

Research and Research Ethics in Multicultural Communities, LA, CA Oct 2000 Hyperphosphatemia the ESRD patient. Dallas TX Nov 2000 Renal Failure: Defining the issues, Renal Failure Disease Management.

Phoenix, AZ Nov 2000 Achieving quality outcomes: therapeutic variables, NKF-DOQI guidelines, Renal

Failure Disease Management, Phoenix AZ Nov 2000 Hypertensive renal disease, Fifth Congress on the Treatment of Cardiovascular

disease in African Americans Feb 2001 Stress and health, City of Angels, Church of Religious Science, Los Angeles, CA Feb 2001 Program Chair, Southern California Regional Meeting American College

Physicians, Addressing Health Disparities April 2001 “Know your numbers” American Association of Kidney Patients Orange County

Chapter April 2001 The role of thought in health and well-being, City of Angels, Church of Religious

Science, Los Angeles, CA April 2001 The importance of clinical research, Black Infant Health, Los Angeles, CA May 2001 Workgroup Presenter, Research methodologies in health disparities (Strategies

for performing community based research), Society of General Internal Medicine, San Diego, CA

June 2001 Understanding hypertension, Reach 2010, Los Angeles, CA June 2001 Stress and heart disease, Black Infant Health, Los Angeles, CA June 2001 Host and Moderator, Clinical Research and Research Ethics in Multicultural

Communities II “The Mental Health of the Disadvantaged” June 2001 Keynote Lecture, Spirituality, mental and community health, “What’s love got to

do with it,” Clinical Research and Research Ethics in Multicultural Communities II Aug 2001 Stress and health, Firestone Community Center, Los Angeles, CA Aug 2001 Hypertension, diabetes and kidney disease, Blacks in Government, national

meeting, Los Angeles, CA Aug 2001 Optimizing dialysis: A plan for success, AAKP national meeting, Memphis, TN Sept 2001 The role of spirituality in medical education, Charles Drew University President’s

Medical Student Symposium, Los Angeles, CA Sept 2001 Impact of culture on compliance among African American patients, NKF

Southern California meeting, Rancho Mirage, CA Sept 2001 DOQI Hemodialysis Clinical practice guidelines & HCFA/CMS continuous

performance measures update: Is more dialysis better? 41st Southern California National Kidney Foundation 41st Annual Scientific Symposium on Kidney Disease. Rancho Mirage, CA

Sept 2001 Preventing chronic kidney disease: “What’s love got to do with it,” 41st Southern

40

California National Kidney Foundation Annual Scientific Symposium on Kidney Disease, Rancho Mirage, CA

Sept 2001 The role of spirituality in chronic kidney disease: African American Women on Tour on behalf of the American Kidney Fund, Los Angeles, CA

Sept 2001 Host and Moderator: Clinical Research and Research Ethics in Multicultural Communities III “Addressing Violence in the SPA 6 Community”

Sept 2001 Chair, Amgen Regional Nephrology Advisory Board, Los Angeles, CA Nov 2001 Treatment strategies for chronic kidney disease, Los Angeles, CA Jan 2002 Treatment strategies for chronic kidney disease, Sacramento, CA Jan 2002 Hypertensive renal disease, San Diego, CA Feb 2002 The use of Vitamin D analogs for secondary hyperparathyroidism, Thousand

Oaks, CA March 2002 Host and Moderator: Clinical Research and Research Ethics in Multicultural

Communities III “Impact of the Environment on Health” March 2002 Treatment strategies for chronic kidney disease, Fresno, CA March 2002 Community Partnership in Public Health Programs, CDC partnering meeting,

Atlanta, GA March 2002 Strategies for Developing Culturally and Linguistically Appropriate Dissemination

Materials, CDC partnering meeting, Atlanta, GA April 2002 Beyond the Myths of Angiotensin Converting Enzyme Inhibitors (ACEI): Use in

Chronic Kidney Disease (CKD), Drew Grand Rounds, Los Angeles, CA April 2002 Treatment strategies for chronic kidney disease, Fresno, CA April 2002 NCRR career development programs, white paper presentation (Fukagawa,

Norris, Smith, Stacpoole, Wilde) June 2002 Role of calcium channel blockers in chronic kidney disease, International Society

of Hypertension in Blacks (ISHIB) Conference, Hypertension Academy, Miami FL

June 2002 Moderator, Renal and heart disease: A fatal attraction. Conference: International Society of Hypertension in Blacks (ISHIB) Conference, Miami FL

June 2002 2002 Where is the Love? The role of love in heart disease in our community, Sisters at Eight, Los Angeles, CA

July 2002 2002 The use of Vitamin D analogs for secondary hyperparathyroidism, Woodland Hills, CA

Aug 2002 Racial and Ethnic Disparities in the Occurrence of Diabetic Nephropathy, Honolulu, HI

Sept 2002 Update on Hypertension Treatment: Focus on Chronic Kidney Disease (CKD); UCLA Nephrology Visiting Professor Series

Oct 2002 The Interactions of Proteinuria with BP Control and Drug Selection, American Society of Nephrology, Philadelphia, PA

Nov 2002 Management of High Risk HD and PD patients, ESRD Network of Florida, 24th annual meeting, Tampa, FL

Jan 2003 Hypertensive renal disease, Cedars Sinai Medical Center Renal Grand Rounds Feb 2003 Strategies for minority recruitment in Clinical Trials, REACH 2010 Symposium,

Long Beach, CA February 28, 2003 March 2003 Resident Research Poster Judge. American College of Physicians Southern

California Regional Meeting, March 1, 2003 April 2003 Chronic Kidney Disease (CKD) as a Cardiovascular Disease (CVD) Mortality

Risk Factor: Implications for Clinical Care, Drew University, Medical Grand Rounds, Los Angeles, CA, April 1, 2003

April 2003 CKD and CVD in Minority Populations: Lessons Learned from Clinical Trials,

41

NKF Spring Clinical meetings, Dallas, TX, April 4, 2003 April 2003 The Impact of Early Intervention in Renal Bone Disease, NKF Spring Clinical

meetings, Dallas TX, April 4, 2003 April 2003 Vitamin D Analogs in Renal Bone Disease, California Dialysis Council, Palm

Springs, CA, April 10, 2003 April 2003 Managing Renal Patients in the Inner City: Understanding Key Risk Factors,

Outcomes & Challenges from CKD to ESRD, California Dialysis Council, Palm Springs, CA, April 12, 2003

May 2003 Data and Research: The role of data in community collaborations, California Black Health Network, Los Angeles, CA, May 2, 2003

July 2003 Witness for Depression. Drew/RAND/UCLA/Community conference Aug 2003 Kidney disease in minority communities, AAKP Annual Meeting, New Orleans,

LA, August 29-31 Sept 2003 ESRD and CKD: Special challenges in Minority Populations: National Renal

Administrators Association September 12. Denver, CO Sept 2003 Challenges Facing Nephrologists in the 21st Century, What you need to know To

start out in Nephrology practice: A Workshop for Renal Fellows September 26, Atlanta, GA

Sept 2003 Overview of ESRD/CKD. Improving Outcomes in CKD and ESRD Patients: Carrying the Torch from Training to Practice. Scottsdale, AZ. October 3rd–5th

Nov 2003 Preventing the Complications of Chronic Kidney Disease; Multiethnic Issues. Skirball Cultural Center Los Angeles, California. Nov 6.

Nov 2003 Health disparities in CKD. Harbor Renal Grand Rounds, Los Angeles, California. Nov 2003 Epidemiology of CKD among African Americans and Mexican Americans.

International Society of Nephrology Satellite Mtg, Ensenada, CA Nov 2003 CKD Treatment strategies for Indigenous populations. International Society of

Nephrology Satellite Mtg, Ensenada, CA Feb 2004 Vitamin D analogs in CKD/ESRD. Pasadena, CA Feb 2004 Love and spirituality in the principals and practices of alternative medicine,

King/Drew Nursing Society, LA CA March 2004 Vitamin D analogs in CKD/ESRD. Pasadena, CA April 2004 Lessons From the Dialysis Outcomes and Practice Patterns Study. California

Dialysis Council, Palm Springs, CA April 2004 Prevention and early treatment of chronic kidney disease. Primed.

Ft. Lauderdale, Fl April 2004 Policy Session: The Impact of racial/ethnic disparities on the Cost of the ESRD

Program: Data and Health Disparities: Shifting the Paradigm in Communities. National Minority Health Month: National Leadership Summit and Third Annual Awards Dinner, Washington, DC

April 2004 Racial/ethnic disparities in CKD – Importance for the dietitian. NKF Spring Clinical Meeting. Chicago, Illinois

May 2004 Biomedical Careers, National Library of Medicine High School Education Program, Los Angeles, CA

May 2004 Racial and Ethnic Disparities in CKD. Kaiser Permanente 7th Annual Nephrology Symposium, Anaheim, CA.

May 2004 Selecting and succeeding in academic careers. UCLA/Drew center of Excellence in minority education resident and faculty reception, LA, CA

June 2004 Diagnosis and early treatment of CKD – American Diabetes Association. NKF Satellite Program, Orlando, Fl

June 2004 Diagnosis and management of CKD – American Association Physician

42

Assistants. NKF Satellite Program, Las Vegas, NV June 2004 The role of calcium channel blocker in CKD. International Society of

Hypertension in Blacks, Detroit, MI June 2004 Effective management of patients with hypertension. International Society of

Hypertension in Blacks, Detroit, MI June 2004 What does the future high-risk CVD patient look like now? International Society

of Hypertension in Blacks, Detroit, MI June 2004 Diagnosis and early treatment of CKD – Primed Midwest, NKF Satellite Program,

Chicago, Il Aug 2004 CKD and CVD in Minority Populations: Lessons Learned From Clinical Trials,

NMA, San Diego, CA Sept 2004 NCMHD Project Export P-20 Challenges & Success. NCMHD Project Export

National Meeting, Bethesda, MD Sept 2004 The Essential Role of Vitamin D in Treating CKD, Costa Mesa, CA Oct 2004 Multicultural Issues in Chronic Kidney Disease – UCSF Renal Grand Rounds Oct 2004 NIH Director’s Council of Public Representatives Public Trust Initiative working

group Nov 2004 Epidemiology and Progression of Chronic Kidney Disease – Johns Hopkins CME

program, Bethesda, MD Nov 2004 Partnering with Community Based Organizations: An Academic Institution’s

Evolving Perspective. Gerontology Society of America, Washington, DC Nov 2004 Epidemiology and Progression of Chronic Kidney Disease – Johns Hopkins CME

program, Philadelphia, PA Nov 2004 Anemia as a Complication in CKD – Johns Hopkins CME program, Philadelphia,

PA Nov 2004 Preparing the Patient for Dialysis or Transplantation – Johns Hopkins CME

program, Philadelphia, PA Dec 2004 Epidemiology and Progression of Chronic Kidney Disease – Johns Hopkins CME

program, Philadelphia, PA Dec 2004 Multicultural Issues in Chronic Kidney Disease – UCI Renal Grand Rounds,

Irvine, CA Dec 2004 The Essential Role of Vitamin D in Treating CKD, Irvine, CA Jan 2005 Secondary Databases as a research tool, ENT Grand Rounds, Drew Univ., LA March 2005 Community Diabetes Conference (moderator & co-host) LA Convention Center March 2005 Epidemiology and Progression of Chronic Kidney Disease – Johns Hopkins CME

program, San Francisco, CA April 2005 “Missing Persons: Minorities in the Health Profession” Implications of the

Sullivan Commission On Diversity In The Biomedical Sciences. Annual meeting American Society of Andrology, Seattle, Wash

April 2005 Multicultural Issues in Chronic Kidney Disease (CKD): Implications for Achieving Healthy People 2010 Goals, Annual National Hispanic Medical Association, Los Angeles, CA

April 2005 Building a translational research Network. NIH/RCMI Program Directors Meeting, Houston, Texas

April 2005 Managing Renal Disease Health Disparities. Annual National Minority Health Month Foundation, Washington, DC

May 2005 Overview of Chronic Kidney Disease, Abbott Labs training meeting, Phoenix, Az May 2005 Epidemiology and Progression of Chronic Kidney Disease – Howard University

Grand Rounds, Wash DC May 2005 Inter-Institutional Collaborations. Special NIH meeting “Enhancing Discipline of

43

Clinical and Translation Research”, Crystal City, VA Working group co-chair; http://www.ncrr.nih.gov/clinicaldiscipline.asp

June 2005 Epidemiology and Progression of Chronic Kidney Disease – Santa Clara Medical Center Grand Rounds, Santa Clara CA

June 2005 Evidence-Based Treatment of Renal Osteodystrophy in Patients with CKD: From Theory to Practice: Emory Renal Grand Rounds, Atlanta, GA

June 2005 Conflict of Interest in Academia: Drew MBRS Lecture Series, Los Angeles, CA June 2005 Epidemiology and Progression of Chronic Kidney Disease – Johns Hopkins CME

program, Los Angeles, CA July 2005 “Missing Persons: Minorities in the Health Profession” Implications of the

Sullivan Commission On Diversity In The Biomedical Sciences. NIH-Minority Institution Drug Abuse Program, Los Angeles, CA

Sept 2005 Your Options, Your Choice: Treating Kidney Failure – American Association of Kidney Patients, Nevada, Las Vegas

Sept 2005 Vitamin D and Cardiovascular Risks in Early Chronic Kidney Disease – Southern California NKF

Oct 2005 Chronic Kidney Disease – Kaiser-Johns Hopkins CME program, Anaheim, CA Nov 2005 Diagnosis and Treatment of Refractory Hypertension, In Special Populations

(ASN Dinner symposium), ASN annual meeting Phila, PA Nov 2005 Hypertension in Special Populations (ASN Postgraduate Education Course),

ASN annual meeting, Phila, PA Nov 2005 ASN Session co-Chair: CKD progression ASN annual meeting, ASN annual

meeting, Phila, PA Nov 2005 Vitamin D and Cardiovascular Risks in Early Chronic Kidney Disease.

Greenwich Connecticut Dec 2005 Targeting the Epidemic of CKD and Bone Mineral Disorders in Patients with

Diabetes and Hypertension. American Society of Health-System Pharmacists (ASHP). Las Vegas, NV

Dec 2005 Overview of Chronic Kidney Disease, USC Pharmacy Program, Pasadena, Ca Dec 2005 25 Vitamin D in Early CKD: Emerging Implications for Cardiovascular Disease,

Renal Grand Rounds, UCLA. Jan 2006 Vitamin D and Cardiovascular Risks in Early Chronic Kidney Disease. St. Louis,

Missouri Jan 2006 Understanding and Reducing Disparities in Diabetes Care. Center for Health

Policy Research at the University of California, Irvine Feb 2006 Translational Research Strategies for Improving HIV outcomes: Enhancing

Community-Academic Partnerships. Inaugural Convening of the Global HIV/AIDS Alliance: Charting Healthy Pathways for Vulnerable Populations Hyderabad, India

April 2006 Duke University Clinical Research Training Program: Conducting research with minority populations

April 2006 CKD and Health Disparities. Alliance Minority Medical Associations Consensus meeting on Minority Health, Washington, DC.

April 2006 Identifying High-Risk Communities with Chronic Disease Disparities: Geographical Variations in ESRD. Thought Leaders in Minority Health: Reducing Health Status Disparities Through Enhanced Care Management: 3rd Annual Leadership Summit on Healthcare Disparities. Washington, DC.

April 2006 What are the Changes in the KEEP Program? National Kidney Foundation 2006 Spring Clinical Meetings

April 2006 Research Centers in Minority Institutions (RCMI) Translational Research

44

Network (RTRN). Supporting Connectivity for Biomedical Research, NIH-NCRR, 4-24-06, Crystal City, VA.

May 2006 Racial and Ethnic Disparities in Chronic Kidney Disease. NMA Regional Meeting, Montego Bay, Jamaica.

May 2006 Integrating Research into Medical records databases: The State of the Art and its Limitations. Ensuring Inclusion of the Clinical Research Nationwide Health Information System. NIH, May 9, 2006

Aug 2006 25 Vitamin D in Early CKD: Emerging Implications for Cardiovascular Disease Scripps Mercy Hospital, Internal Medicine Resident Conference

Aug 2006 Vitamin D in CKD. Davita Health Provider Update, Long Beach California Aug 2006 NMA Renal Symposium: 25 Vitamin D in Early CKD: Emerging Implications for

Cardiovascular Disease. Annual National Medical Association, August 2006 Aug 2006 NMA Endocrine Symposium: Non-Glycemic Complications of Diabetic

Nephropathy. Annual National Medical Association, August 2006 Sept 2006 Diabetes and the Kidney. AAKP annual Conference. Orlando, Fl Sept 2006 Vitamin D in CKD. Harbor-UCLA Renal Grand Rounds. Los Angeles, CA Sept 2006 Addressing CKD Disparities with Small Area Analysis. Southern Calif NKF

annual Symposium. Los Angeles, CA. Nov 2006 Understanding Diabetes. Auxiliary to the Charles R. Drew Medical Society. Los

Angeles, CA Nov 2006 Publishing Your Science – Getting Published. NIDDK Network of Minority

Research Investigators Western Regional Meeting, Seattle, Washington. Nov 2006 Diabetic Nephropathy. 5th Annual Symposium on Advanced Diabetes

Management for Endocrine Fellows. Scottsdale, AZ. Nov 2006 Publishing Your Science. National Institute of Diabetes and Digestive and Kidney

Diseases (NIDDK) - Network of Minority Research Investigators Regional Meeting, Seattle WA.

Nov 2006 Cocaine related Renal Injury (invited speaker), ASN annual meeting San Diego, CA

Nov 2006 Hypertension in Special Populations (ASN Postgraduate Education Course), ASN annual meeting, San Diego, CA

Nov 2006 ASN Session co-Chair: secondary hyperparathroidism, ASN annual meeting, San Diego, CA

Dec 2006 Disparities in CKD. Amgen Nephrology Advisory Board Meeting. San Francisco, CA. (no CME, 20 participants, 6 speakers in this session)

Dec 2006 Update on the RCMI Translational Research Network. 10th International RCMI Symposium, San Juan, Puerto Rico (CME, 275 participants, 2 speakers in this session)

Jan 2007 Global HIV/AIDS Alliance Asia Regional Planning Convening - Developing a Country-Based Strategic Planning Process. Tainan, Taiwan

Feb 2007 Publishing Your Science. Project Export Disparities Conference. Honolulu, Hawaii (CME, 90 participants, 2 speakers in this session)

March 2007 Clinical Trials and Hypertension Treatment in CKD. UCLA Renal Fellows Lecture Series Los Angeles, CA. (no CME, 10 participants, 1 speaker in this session)

March 2007 Emerging Advances in Vitamin D in Early CKD. Maui, Hawaii (CME, 10 participants, 1 speaker in this session)

March 2007 Emerging Advances in Vitamin D in Stage 5 CKD. Honolulu, Hawaii (CME, 15 participants, 1 speaker in this session)

March 2007 World Kidney Day. Community Approach to Addressing CKD. Los Angeles, CA (CME, 250 participants, 8 speakers)

45

April 2007 Biomedical Science and Health Professional Careers. Keynote Address: 21st Annual Symposium on Career Opportunities in the Biomedical Sciences and Health Professions. Orlando, FL. (no CME, 650 participants, 1 speaker in this session)

April 2007 Hypertension, Chronic Kidney Disease, and Cardiovascular Disease: Strategies to Evaluate and Reduce Risks in Ethnic Minorities. UCLA Renal Fellows Lecture Series Los Angeles, CA. (no CME, 10 participants, 1 speaker in this session)

April 2007 Vitamin D Therapy in Early CKD: Emerging Implications for Cardiovascular Disease. Cedars Sinai, Renal Grand Rounds Los Angeles, CA. (CME, 25 participants, 1 speaker in this session)

April 2007 Publishing Your Science – Getting Published. NIDDK Network of Minority Research Investigators National Meeting, Bethesda, MD. (no CME, 50 participants, 2 speakers in this session)

April 2007 Vitamin D and Hyperparathyroidism in CKD. Implications for developing nations. World Congress of Nephrology Satellite Meeting. Petropolis, Brazil (CME, 130 participants, 25 speakers)

April 2007 Hypertension and Kidney Disease in Populations of African Ancestry: Results of Clinical Trials. Hypertension and Kidney Disease in Populations of African Ancestry: A World Congress of Nephrology Post Satellite Meeting. Bahia, Brazil (CME, 400 participants, 4 speakers)

June 2007 25-hydroxy and 1,25 dihydroxy Vitamin D Therapy: Role in PD. The 2nd North American Chapter Meeting and The 1st Latin American Chapter Meeting of the International Society of Peritoneal Dialysis June 1-3, 2007/ Hollywood, FL (CME, 200 participants, 4 speakers)

June 2007 Abbott Regional Advisory Board Meeting on Secondary Hyperparathyroidism - Chair, San Francisco, CA. June 12, 2007

June 2007 Proteinuria Reduction - Disease Marker or Outcome - Racial Differences in Nephropathy Progression. American Diabetes Association Concurrent Session. Chicago. IL. June 24, 2007 (CME, 600 participants, 4 speakers)-

July 2007 Strategies for Preventing, Treating, and Managing Kidney Disease (Concurrent Session) Inaugural Eastern Caribbean Conference on Health: Cooperating to Build Healthy Communities. Nevis, July 16-20, 2007.

July 2007 Alternative Medicine, Spirituality & Healing (Concurrent Session) Inaugural Eastern Caribbean Conference on Health: Cooperating to Build Healthy Communities. Nevis, July 16-20, 2007. (CME, 50 participants, 2 speakers in this session)

July 2007 The Health Workforce Dilemma --Training and Capacity Building (Plenary Session) Inaugural Eastern Caribbean Conference on Health: Cooperating to Build Healthy Communities. Nevis, July 16-20, 2007. (CME, 50 participants, 3 speakers in this session)

Aug 2007 CKD Breakfast Symposium: New Advances in the Management of Anemia. NMA August 4-9, 2007, Honolulu, Hawaii (CME, 150 participants, 3 speakers in this session)

Aug 2007 Benefits of Early Identification and Current Trends in the magnitude of CKD in African Americans. Lessons from the NKF Kidney Early Evaluation Program. NMA August 4-9, 2007, Honolulu, Hawaii (CME, 200 participants, 5 speakers in this session)

Aug 2007 Cardiovascular effects of Vitamin D. Charles Drew University Life Science Lecture series. Los Angeles, CA

Sept 2007 Diabetes and Kidney Disease: A Balancing Act: AAKP 2007 Annual Meeting,

46

Aug. 30 - Sept. 2 St. Louis, MO. (150 participants, 2 speakers) Sept 2007 Diabetes and Your Kidneys: Understanding the Connection (Lunch with the

Experts) AAKP 2007 Annual Meeting, Aug. 30 - Sept. 2 St. Louis, MO Sept 2007 The RCMI Translational Research Network Update. RCMI Principal

Investigator’s Meeting, Bethesda MD Sept 2007 Academia-Community Partnered Participatory Research: Considerations

for Navigating the "Road Less Traveled". NCRR Symposium entitled “Fostering Collaborative Community-Based Clinical and Translational Research”. Los Angeles, CA. September 14, 2007 (125 participants, 8 speakers)

Sept 2007 Hypertension in Older Ethnic Minorities. 24th Annual UCLA Intensive Course in Geriatric Medicine/Pharmacy and Board Review. Los Angeles, CA. (CME, 350 participants, 3 speakers in this session)

Oct 2007 Global HIV/AIDS Alliance- Translational research Strategies for Improving HIV outcomes: Enhancing Community-Academic Partnerships. Durban, South Africa

Oct 2007 20th Annual California State Conference of the NAACP. Diabetes, Obesity & Health Disparities: What do these mean for Californians? Manhattan Beach, CA

Nov 2007 Race, Gender, and Socioeconomic Disparities in CKD in the United States. ASN Symposium Health Disparities In Nephrology. Sunday November 4, 2007 (CME, 500 participants, 4 speakers in this session)

Nov 2007 Health Disparities In Chronic Kidney Disease. ASN Satellite meeting. Saturday November 3, 2007 (50 participants, 1 speaker in this session)

Nov 2007 Moderator, CKD Abstract session. ASN Saturday November 3, 2007 (CME, 300 participants, 8 speakers in this session)

Dec 2007 NCRR Strategic Planning Forum: "Harnessing Innovation to Advance Human Health" December 3-4, 2007 Rockville, MD (Discussion Leader) http://www.ncrr.nih.gov/strategic_plan/agenda.pdf

Dec 2007 The RCMI Translational Research Network: A unique Resource to Address Health Disparities 5th Hispanic Congress of Health Professions & 2nd Multidisciplinary Conference in Clinical Research, Education, Practice and Research towards Children and Youth Health: Trends and Perspectives in the Health Professions. December 6 - 7, 2007 Condado Plaza Hotel, San Juan, Puerto Rico

Dec 2007 Cardio Renal Metabolic Syndrome in African Diaspora: Rationale for Including CKD in the Metabolic Syndrome. Ohio State University, Columbus, Ohio

Feb 2008 Academia-Community Partnered Participatory Research: Considerations for Navigating the "Road Less Traveled". NIH Community-Based Participatory Research Technical Assistance Workshop. Bethesda, MD.

March 2008 American College of Cardiology – Association of Black Cardiologist Symposium. Journal Editors Panel. Saturday March 29, 2008 (CME, 150 participants, 3 speakers in this session)

April 2008 Overcoming Barriers to Minority Involvement in Health Research: Engaging and Educating the Minority Research Subject. NIH-NIDDK Network of Minority Research Investigators Annual Workshop. Washington DC. April 24-25, 2008 (5 speakers [morning session], 80 participants)

April 2008 Developing a Career in Academic Administration. NIH-NIDDK Network of Minority Research Investigators Annual Workshop. Washington DC. April 24-25, 2008 (1 speaker, 15 participants)

May 2008 The Research Centers in Minority Institutions Translational Research Network: Minority Involvement in Health Research. Duke University. May 27, 2008. Durham NC. (1 speaker, 50 participants)

47

July 2008 Diabetes and Chronic Kidney Disease (CKD) in African Americans: Should CKD be a Component of the Metabolic Syndrome? International Society on Hypertension in Blacks, New Orleans, LA. July 18 - 20, 2008 (4 speakers [afternoon session], 150 participants, CME)

July 2008 Clinical and Translational Research: Future Opportunities - NIH/NMA Academic Career Development Program. National Medical Association, Atlanta GA. July 28-Aug 2, 2008 (2 speakers [morning session], 50 participants, CME)

July 2008 CKD in the Metabolic Syndrome. National Medical Association, Atlanta GA. July 28-Aug 2, 2008 (4 speakers [afternoon session], 250 participants, CME)

July 2008 Differences in Race for CKD and Dialysis Patients and the Outcomes for Survival. National Medical Association, Atlanta GA. July 28-Aug 2, 2008 (3 speakers [afternoon session], 75 participants, CME)

Aug 2008 Overcoming Barriers to Minority Involvement in Health Research: Strategies for Engaging & Educating Minority Communities. 2nd Biennial IDeA Symposium of Biomedical Research Excellence. August 6-8, 2008. Washington DC. (2 speakers [afternoon session], 100 participants, CME)

Sept 2008 Academia-Community Partnered Participatory Research. University of California, Irvine Institute for Clinical and Translational Science Community. Irvine, CA Workshop Sept 10, 2008. (4 speakers [afternoon session], 100 participants)

Sept 2008 Hypertension Management in the Older Patient. 25th Annual UCLA (2 speakers [afternoon session], 450 participants, CME)

Sept 2008 The Research Centers in Minority Institutions Translational Research Network: Overcoming Barriers to Minority Involvement in Health Research. Harvard Catalyst Lecture, Harvard Medical School. Sept 23 - 24, 2008 (1 speaker [afternoon session] 100 participants); 6 working sessions with 5-15 people.

Sept 2008 Management of HTN and Proteinuria in CKD Patients. Healthcare Consensus Conference: Cardiovascular Disease and Chronic Kidney Disease. Chicago, Il. Sept 26, 2008

Sept 2008 Strategies for Educating & Engaging Diverse Communities in Research. Harbor-UCLA Clinical Research Day, Torrance, CA. Sept 29, 2008

Oct 2008 Understanding Disparities in CKD: The Way Forward. Trans-Atlantic Renal Council, ESRD Network # 3, Newark, NJ. October 22, 2008

Oct 2008 Disparities in CKD. NKDEP Coordinating Panel meeting. Washington, DC Oct 2008 CVD and CKD in under-represented minorities. Harvard University CeDAR

Symposium: Vitamin D and Cardiovascular Disease Oct 2008 Vitamin D and Cardiovascular disease: “To D or not to D”. Renal Grand Rounds,

Cedars Sinai Medical Center, Los Angeles, CA Dec 2009 Hypertension, CVD and Disparities. NIH Summit - The Science Of Eliminating

Health Disparities. National Harbor, MD. (4 speakers [afternoon session], 50 participants, no CME)

Feb 2009 "Got Health? Unleashing the Potential of Community-Academic Partnerships". Montana State Café’ Scientifique (1 speaker, 80 participants, CME)

March 2009 Translational Research at CDU: What All Faculty and Students Need to Know. Los Angeles, CA (1 speaker, 100 participants, CME)

March 2009 Cardiovascular System and Vitamin D. Univ. Alabama, Birmingham Vitamin D Symposium (4 speakers, 70 participants, CME)

March 2009 Race, Gender, and Socioeconomic Disparities in CKD in the United States. ASN Renal Weekend Chicago, Il. (4 speakers [morning session], 120 participants, CME)

48

March 2009 Overcoming Barriers to Minority Involvement in Health Research: Engaging and Educating the Minority Research Subject. New Investigators Academic Development Course, Cedars Sinai Medical Center (1 speakers, 12 participants, no CME)

March 2009 Special Population Differences in CKD and Dialysis Patients: Impact on Survival. NKF Spring Clinical, Nashville, TN (3 speakers [dinner session], 400 participants, CME)

March 2009 Clinical trials in hypertension. VA Medical Center, Los Angeles, CA. (1 speakers, 12 participants, no CME)

April 2009 Pathogenesis of essential hypertension. VA Medical Center, Los Angeles, CA. (1 speakers, 12 participants, no CME)

April 2009 Overcoming Barriers to Minority Involvement in Health Research: Engaging and Educating the Minority Research Subject. Harbor-UCLA Medical Grand Rounds, Los Angeles, CA

April 2009 Reciprocal IRB Agreement Model. CTSA-NICHD Workshop on Comparing Institutional Review Board (IRB) Models for Multisite Pediatric Studies (3 speakers on panel, webcast)

April 2009 Vitamin D and the Cardiovascular System. 2009 FMS Medical Directors’ Symposium (4 speakers [afternoon session], 1500 participants, CME)

April 2009 Disparities in CKD Healthcare. 2009 Annual American Nephrology Nurses Association Mtg. San Diego, CA (3 speakers [afternoon session], 400 participants, CME)

April 2009 Networking/Collaboration. NIDDK Network of Minority Research Investigators Annual Workshop. Bethesda, MD (4 speakers, 50 participants, no CME)

May 2009

Clinical Trials in minority communities. (1 of 6 panelists – 250 people; 1 speaker in break out session, 30 participants, no CME) 9th Annual Women's Health Forum on KJLH’S Saturday Morning Public Affairs Program, “L.A. SPEAKS OUT”

May 2009

Community and Academic Partners for Collaborative Translation: Success Stories NIH-NCRR Improving Health WITH Communities: The Role of Community Engagement in Clinical and Translational Research. Bethesda, MD (4 speakers, 750 participants, no CME)

May 2009

The Paths to Health Care Reform, One Day Conference at TOWN HALL LA Containing Costs through Alternative Programs. Panelists: Dr. Elaine Batchlor, Chief Medical Officer, LA Care Health Plan; Cathy Fogliano, Executive Vice President, Sales, TelaDoc, Inc; Dr. Keith Norris, Executive Vice President for Research and Health Affairs, Charles Drew University of Medicine and Science; Jack Reid, President and CEO, Physicians Care and moderator, Ronald C. Mason, CEBS, Principal, Towers Perrin.

May 2009 Preparing for a career in Biomedical Research. UCLA Minority Access to Research Careers and McNair Students. (35 students)

June 2009 Keynote Address - Bridging the Health Disparities Gap: Social Justice: the Human Face of Health Disparities in Urban California. United Negro College Fund Special Programs Corporation (UNCFSP) 2008 eHealth ACCESS Conference for HBCUs and their Communities. National Library of Medicine, Bethesda, MD. (120 participants)

July 2009 Clinical and Translational Research: Future Opportunities - NIH/NMA Academic Career Development Program. National Medical Association, Atlanta GA. July 28-Aug 2, 2008 (2 speakers [morning session], 50 participants, CME)

49

August 2009 Techniques to Elicit Ideas from and Refine Research Questions with Community Stakeholders. NIH Summer Institute on Community-Based Participatory Research Targeting the Medically Underserved <http://conferences.thehillgroup.com/si2009/index.html>, August 2-7, 2009.

August 2009 Health Care Reform. Townhall Meeting with Congresswoman Diane Watson and California Speaker of the House Karen Bass, First AME Church, Los Angeles. (200 participants)

Sept 2009 Hypertension Management in the Older Patient. 26th Annual UCLA (2 speakers [afternoon session], 450 participants, CME)

Sept 2009 New Approaches in Preventing and Treating Kidney Disease Wednesday, September 23. 2009 Congressional Black Caucus, Cannon Caucus Room (Cannon 345), Washington DC (100 participants)

Oct 2009 Is It More Than Economics – Taking a Hard Look at Healthcare Disparities. ESRD Network 8, Birmingham AL (2 speakers [afternoon session], 200 participants, CME)

Oct 2009 Environmental Components of Racial Disparities in CKD. Invited Lecture ASN, San Diego, CA (450 participants, CME)

Oct 2009 Overcoming Barriers to Minority Involvement in Health Research: Engaging and Educating the Minority Research Subject. Loma Linda Medical Grand Rounds (1 speaker, 50 participants, CME)

Nov 2009 To D or not to D: Vitamin D and the Cardiovascular System Nutritional Genomics Conference. Cal Poly Pomona. Pomona, CA. (100 participants)

Nov 2009 Keynote address - PRIM&R’s 2009 Advancing Ethical Research Conference, Nashville Tenn. Community Health Research Reform: Ensuring IRB Members are Aligned with Evolving Strategies for Engaging Underserved Communities (3,000 participants)

Nov 2009 2009 USC/UCLA/CDU Minority Health Conference on Saturday, November 21st at the University of California, Los Angeles Campus. (150 participants)

Dec 2009 Is It More Than Economics? – Taking a Hard Look at Healthcare Disparities. CMS Quality, Value and Health Care: Making the Pieces Fit - QualityNet Conference Dec 1-3 2009 (75 participants)

Dec 2009 Panelist. First Summit on Urban Health. University Coopoerative Summit on Urban Health – Tulsa, OK.

April 2010 Environmental Components of Racial Disparities in CKD. 2010 CBC Spring Health Braintrust and National Minority Quality Forum Seventh Annual Health Disparities Leadership Summit. Washington DC (95 participants)

April 2010 “Translational Research at CDU: What All Faculty and Students Need to Know”. Los Angeles, CA. (125 participants)

May 2010 Partnering to Improve Health: the Science of Community Engagement. CTSA/ NCRR third annual Community Engagement conference (300 participants). Arlington, VA

May 2010 CTSA Strategic national research “network of networks” Meeting. Natcher Conference Center, NIH Campus, Bethesda, MD. (50 participants)

June 2010 To D or Not to D: Vitamin D and Cardiovascular Disease. VA Medical Center, Los Angeles CA. (75 participants – CME)

50

June 2010 Public Engagement In Research And Policy: Presentation to the Institute of Medicine’s Board on Health Sciences Policy. Washington, DC

July 2010 Health Care Reform: How it Affects Health Disparities, ISHIB 2010, Crystal City, VA, July 9-11, 2010 (125 participants – CME)

August 2010 The Role of Thought in Health. NMA 2010 Orlando, FL August 1-4 (125 participants – CME)

August 2010 Translational Research. University of Hawaii, Honolulu, HI. August 26, 2010 (50 participants)

Sept 2010 Future research direction for the Jackson Heart Study. Jackson Heart Study Scientific Conference, September 23-24, 2010, Jackson, Mississippi. (450 participants)

Oct 2010 Reducing Health Disparities: The Role of Effective Communication Church Health Network – Medical School for Pastors. San Pedro, CA. (200 participants)

Oct 2010 Holistic Approach to High Blood Pressure. Church Health Network – Medical School for Pastors. San Pedro, CA. (200 participants)

Oct 2010 Environmental Causes of CKD: Mechanisms and Emerging Interventions. Cedars Sinai Renal Grand Rounds. Los Angeles, CA. October 12, 2010 (35 participants – CME)

Oct 2010 Medical Science Is Tentative. UCLA 11th Annual Health Disparities Symposium Controversies In Cancer Science: Translating The Science Into Community Practice To Improve Health Equity, October 27th, 2010. Los Angeles, CA (350 participants – CME)

Nov 2010 Abstract Moderator with Dr. Sharon Adler: Mechanisms of CKD Progression and Uremia Complications- Free Communications. American Society of Nephrology 43rd Annual Meeting & Scientific Exposition November 16-21, 2010. Denver, CO. (200 participants – CME)

Nov 2010 Race and Gender and Hemodialysis Treatment Outcomes: Do We Need to Individualize Treatment Prescriptions and Guidelines? American Society of Nephrology 43rd Annual Meeting & Scientific Exposition November 16-21, 2010. Denver, CO. (1500 participants – CME)

Nov 2010 Mechanism of Renal Protection with Vitamin D Analogues American Society of Nephrology 43rd Annual Meeting & Scientific Exposition November 16-21, 2010. Denver, CO. (600 participants – CME)

Jan 2011 Nephrology Session (moderator) - 2011 Western Regional Meeting of the American Federation for Medical Research. Jan 26-29; Carmel, CA.

Jan 2011 Mentoring: Key strategies in Minority Serving Institutions. Charles Drew University, Los Angeles CA. (35 participants)

Feb 2011 A novel cystine based antioxidant attenuates high fat diet-induced oxidative stress and hepatic steatosis in apolipoprotein E knockout mice. Invited Lecture – 3rd International Conference on Drug Discovery & Therapy, Dubai, UAE Feb 7-10

Feb 2011 3rd Annual African American Men's Health & Empowerment Summit on Saturday, February 26, 2011 at the LA Convention Center. Health Policy Panel (with Mr. Michael Blake, Deputy Associate Director of the Office of Intergovernmental Affairs and Dr. Garth Graham, Deputy Assistant Secretary for Minority Health in the Office of Minority Health) (600 participants)

Feb 2011 3rd Annual African American Men's Health & Empowerment Summit on Saturday, February 26, 2011 at the LA Convention Center. Ask The

51

Doctor Panel (100 participants)

March 2011 Thought and Health. Charles Drew University, Los Angeles CA. (55 participants) April 2011 How to Budget and Manage Your Funds: Basic and Clinical Research. Invited

Lecture – NIDDK/NIH. NMRI (Network of Minority Research Investigators) National Workshop. April 21-22, 2011. Bethesda, MD.

April 2011 Mock Study Section (chair) – NIDDK/NIH. NMRI (Network of Minority Research Investigators) National Workshop. April 21-22, 2011. Bethesda, MD.

April 2011 Chairperson - Oral Communications Section. The 8th International Workshop On Kidney Disease In Disadvantaged Populations. Satellite conference to the International Society of Nephrology. April 12-14, Victoria BC, Canada.

April 2011 Thought and Health – Part 2. Charles Drew University, Los Angeles CA. (45 participants)

April 2011 Health Disparities and CKD. Healthy Lifestyles Initiative Conference - The California Legislative Black Caucus In Collaboration with Kaiser and Healthy African American Families. April 29, Los Angeles. (250 participants)

May 2011 Thought and Health – Part 3. Charles Drew University, Los Angeles CA. (45 participants)

May 2011 Translational Research. Charles Drew University Conference on Translational Research and Cardiovascular Disease. May 18, Los Angeles. (60 participants)

June 2011 Complementary & Alternative Medicine Workshop “Energy Medicine”. The Role of Thought in Health & Health Disparities: Friday, June 17, 2011 Charles Drew University, Los Angeles CA. (25 participants)

July 2011 To D or Not to D: Vitamin D in CKD: Emerging Implications for Cardiovascular Disease. NMA - Wednesday, July 27, 2011, Washington, DC. (200 participants, CME)

Aug 2011 How to Listen: The Importance of Listening in Medical Education and Science. August 4, 2011. Charles Drew University, Los Angeles CA. (95 participants)

Aug 2011 CKD disparities. AAKP Public Policy Forum: Health Care Disparity and Patient Employment. William J. Clinton Presidential Center. Little Rock, AK. 8-26-11

Sept 2011 RCMI Translational Research Network: A Platform for Collaborative Research. NIH-NCRR Council September 13, 2011. Bethesda, MD

Sept 2011 From silos to teams: Tackling Risks for Cardiovascular Disease. September 17th, 2011. Los Angeles. NKF symposium (Keynote: 200 participants, CME)

Oct 2011 University of Cincinnati Center for Clinical and Translation Science and Training speaker series: “Partnering with Communities to Improve Health through Translational Science”. Medical Grand Rounds, Tuesday, October 4 (With Loretta Jones) (80 participants, CME)

Oct 2011 University of Cincinnati Center for Clinical and Translation Science and Training speaker series: Interactive session/panel discussion on how to: implement the principles of community engaged research. Tuesday, October 4 (With Loretta Jones) (80 participants, CME)

Oct 2011 University of Cincinnati Center for Clinical and Translation Science and Training speaker series: Community Forum and Dinner, Tuesday, October 4, "Improving Health through Effective Community Partnerships: What We Know and What We Don't Know." Cincinnati History Museum (With Loretta Jones) (100 participants)

Oct 2011 University of Cincinnati Center for Clinical and Translation Science and Training speaker series: "Building On Assets to Improve Health in Our Communities." Community Forum and Coffee Hour, Wednesday, October 5, United Way of Greater Cincinnati (With Loretta Jones) (150 participants, CME)

52

Oct 2011 Hypertension and Health Care Management. Guangdong Provincial Institute of Nephrology; Nanfang Hospital Southern Medical University October 24, 2010. Guangzhou, Guangdong, P. R. China

Oct 2011 Providing Cutting-Edge Care for Underserved Communities. University of Chicago Pritzker School of Medicine Second Annual Comprehensive Review of the Management of Hypertension, October 29, 2011. Chicago, Illinois (700 participants, CME)

Oct 2011 How to Improve Communication in a Culturally Diverse Practice Setting (workshop). University of Chicago Pritzker School of Medicine Second Annual Comprehensive Review of the Management of Hypertension, October 29, 2011. Chicago, Illinois (50 participants, CME)

Nov 2011 How to Design and Propose Trials to Examine Artificial Kidneys. American Society of Nephrology 43rd Annual Meeting & Scientific Exposition November 9-13, 2011. Phila, CPA. (250 participants – CME)

Nov 2011 Community Faculty. University Coopoerative Summit on Urban Health November 16 – 17, 2011. Los Angeles, CA

Nov 2011 Community Engagement. University Coopoerative Summit on Urban Health November 16 – 17, 2011. Los Angeles, CA

Dec 2011 Translational Research With Proven Results In Reducing Health Disparities. Medical University of South Carolina Fifth Annual National Conference on Health Disparities: Reducing Health Disparities Through Strengthening and Sustaining Healthy Communities. Nov 30 – Dec 3, 2011; Charleston, SC

Dec 2011 Complementary & Alternative Medicine “Energy Medicine”. National Library of Medicine High School Student series. King-Drew Magnet High School with Hawaii and Alaska (85 participants)

Jan 2012 Community Engagement and the Future of Health Care Research. UCLA CTSI Community Engagement Retreat. Los Angeles, CA

Jan 2012 To D or Not to D: Emerging insights in Vitamin D and Cardiovascular Disease. Internal Medicine Medical Grand Rounds. Wayne State University, Detroit MI.

Jan 2012 Diversity Council of the Department of Medicine and the Office of Diversity and Cultural Competence of the Johns Hopkins University School of Medicine 9th Annual Visiting Professor 2012

Jan 2012 “Let’s Get It Right: Straight Talk About Kidney Disease”. Community Forum on the Johns Hopkins Hospital Campus, co-sponsored by the NKF of Maryland. Wednesday, January 25, 2012. Johns Hopkins University School of Medicine Office of Diversity 9th Annual Visiting Professor 2012

Jan 2012 Strategies for Improving Communication to Advance Hypertension Care in Culturally Diverse Practice Settings: Residents’ Morning Report at Bayview. Thursday, January 26, 2012. (~30 people). Johns Hopkins University School of Medicine Office of Diversity 9th Annual Visiting Professor 2012

Jan 2012 Community Forum on the Johns Hopkins Bayview Campus: “I’m Still Waiting: Addressing the Myths of Kidney Donation”. Johns Hopkins University School of Medicine Office of Diversity 9th Annual Visiting Professor 2012

Jan 2012 Providing Cutting-Edge Hypertension Care for Underserved Communities. Johns Hopkins Hospital housestaff noon conference. Johns Hopkins University School of Medicine Office of Diversity 9th Annual Visiting Professor 2012

Jan 2012 Annual Visiting Professor Dinner Lecture. Where science and innovation intersect with inspiration and hope. Johns Hopkins University School of Medicine Office of Diversity 9th Annual Visiting Professor 2012

Jan 2012 From Novel Therapeutics to Community Engagement: Lessons from Cardio-

53

Renal Diseases. Medical Grand Rounds at Johns Hopkins Hospital. Johns Hopkins University School of Medicine Office of Diversity 9th Annual Visiting Professor 2012

Jan 2012 Hopkins URM fellows/residents luncheon: Roundtable discussion on the experience of being a URM in academic medicine. Johns Hopkins University School of Medicine Office of Diversity 9th Annual Visiting Professor 2012

Jan 2012 Johns Hopkins Renal Disease Interest Group. Vitamin D, Vascular Function and Cardiovascular Risk Factors: Preliminary findings of a randomized controlled trial. Johns Hopkins University School of Medicine Office of Diversity 9th Annual Visiting Professor 2011-2012

Feb 2012 Keynote Address: Malaviya Memorial lecture on “Community Engagement in Translational Research” 150th anniversary of the Banaras Hindu University founder Pundit Madan Mohan Malaviya (Banaras Hindu University is ranked #1 University in India by India Today) Varanasi, India. February 6, 2012.

Feb 2012 Keynote Address: Translating Science to Improve Patient Outcomes: Emerging Perspectives in Hypertension - Current Trends in Translational Medicine and Therapeutics. International Symposium by the Molecular Biology Unit (MBU) of the Institute of Medical Sciences. Banaras Hindu University, Varanasi, India. February 7, 2012

Feb 2012 CKD, Cardiovascular Risks, and the Potential Role of Team Approaches. Kasier Permanente, Los Angeles. Renal Grand Rounds.

Feb 2012 The History of Blacks in Medicine and Nursing. Black History Month Special Forum. Charles Drew University, Los Angeles CA. (75 participants)

March 2012 Keynote: Defining the Spectrum of Community Engaged Research: What it is? Who are the stakeholders and their roles, and Discussion of Ethical Considerations? at the South Atlantic National Research Conference “Engaging the Community for Research Success: What Scientists and IRBs Need to Know”. (sponsored by the National Institute of Environmental Health Sciences and Office of Human Research Protections) Raleigh Convention Center 500 South Salisbury Street Raleigh, NC 27601 March 21-22, 2012

April 2012 Cutting-Edge Hypertension Care for Underserved Communities. University of Chicago. 2012 Bowman Society Lecture Series, named in honor of Dr. James E. Bowman, the first African-American Faculty member at the University of Chicago and former Dean of Minority Affairs.

April 2012 Role of the Environment in CKD and CKD Related Racial Disparities. University of Alabama at Birmingham (1 of four speakers at the Festschrift to honor the research career of Dr. Stephen Rostand on Friday, April 13th, 2012)

54

PUBLICATIONS As determined by Collexis (leading developer of knowledge management and discovery software), for each of the last five years I ranked ranked between the leading and top three most cited scientist in the world in the area of chronic kidney disease and health disparities. PAPERS – IN PEER REVIEWED JOURNALS 1. Norris KC, Crooks PW, Nebeker HG, Hercz G, Milliner DS, Gerzi K, Slatopolsky E,

Andress DL, Sherrard DJ, Coburn JW: Clinical and laboratory features of aluminum-related bone disease: Differences between sporadic and “epidemic” forms of the syndrome. Am J Kid Dis 1985;6:342-348.

2. Coburn JW, Norris KC, Nebeker HG: Osteomalacia and bone disease arising from

aluminum. Seminars in Nephrology 1986;6:68-89. 3. Norris KC, Goodman WG, Howard N, Nugent ME, Coburn JW: The iliac crest bone biopsy

for the diagnosis of aluminum toxicity and a guide to the use of deferoxamine. Seminars in Nephrology 1986;4:22-26.

4. Coburn JW, Norris KC: The diagnosis of aluminum-related bone disease and the

treatment of aluminum toxicity with deferoxamine. Seminars in Nephrology 1986;4:12-21. 5. Hercz G, Salusky I, Norris KC, Fine RN, Coburn JW: Aluminum Removal by Peritoneal

Dialysis: Effect of Intravenous versus Intraperitoneal Desferrioxamine. Kidney Internat 1986;30:944-948.

6. Norris KC, Kraut JA, Reyes G, Shinaberger JH: The use of Intracatheter Instillation of

Streptokinase in the Treatment of Recurrent Peritonitis in Continuous Ambulatory Peritoneal Dialysis. Am J Kidney Dis 1987;1(July):62-65.

7. Klein Gl, Norris KC, Forman SJ, Zaia JA, Wright CL, Spallone PA, Lee TC, Slatopolsky E,

and Coburn JW. Effect of Parenterally administered 1,25 (OH)2 - Vitamin D on lymphocyte proliferation and T lymphocyte helper-suppressor cell ratios in dialysis patients with secondary hyperparathyroidism: failure to confirm in vitro actions. Hormones and Metabolism 1987;1:15-21.

8. Andress DA, Hercz G, Knopp JB, Endress DB, Norris KC, Coburn JW, Sherrard JW. Bone

Histomorphometry of Renal Osteodystrophy in Diabetic Patients. J Bone Min Res 1987;2:525-531.

9. Kleeman CR, Norris KC, Coburn JW. Is the Clinical Expression of Primary

Hyperparathyroidism a Function of the Long-Term Vitamin D Status of the Patient? Mineral and Electrolyte Metabolism 1987;13(5):305-310.

10. Coburn JW, Norris KC, Sherrard DJ, Bia M, LLach F, Alfrey AC, and Slatopolsky E. Toxic

effects of aluminum in end-stage renal disease: Discussion of a case. Am J Kidney Dis 1988;12(3):171-184.

11. Hercz G, Andress DL, Norris KC, Shinaberger JH, Slatopolsky E, Sherrard DJ and Coburn

JW. Improved bone formation in dialysis patients after substitution of calcium carbonate for aluminum gels. Trans Assoc Amer Phys 1988;100:139-146.

55

12. Robertson JA, Salusky IB, Goodman WG, Norris KC, Coburn JW. Sulcralfate, intestinal

aluminum absorption, and aluminum toxicity in a patient on dialysis. Ann Int Med 1989;111:179-181.

13. Andress DL, Norris KC, Coburn JW, Slatopolsky EA and Sherrard DJ. Intravenous

calcitriol in refractory osteitis fibrosa of chronic renal failure. N Eng J Med 1989;321:274-279.

14. Salusky IB, Goodman WG, Horst R, Segre G, Kim L, Norris KC, Adams JS, Holloway M,

Fine RN, and Coburn JW. Pharmacokinetics of calcitriol in ambulatory and cycling peritoneal dialysis patients. Am J Kid Dis 1990;16:126-132.

15. Norris KC, Nemeh M, CJ Kert, Muallem S and Levine BS: Basal and stimulated cytosolic

platelet calcium in essential hypertension. Journal Human Hypertension 1990;4:110-112. 16. Coburn JW, Salusky IB, Norris KC and Goodman WG: Oral and parenteral calcitriol for the

management of end-stage renal disease. Contrib Nephrol. 1991;90:166-82. 17. Owen WF and Norris KC: Why the nephrologist should be the primary care physician for

dialysis patients. Nephrology News & Issues. 1994;8(6):54-58. 18. Norris KC and Owen WF. The dilemma of hypertension in the ESRD African American

Community. Nephrology News & Issues. 1995;9(3):14-16. 19. Norris KC and Owen WF. Minorities and ESRD: An Overview. Nephrology News & Issues.

1995;9(9):33. 20. Norris KC, Levine B, Ganesan K. Thyrotoxic periodic paralysis associated with both

hypokalemia and hypophosphatemia. Am J Kidney Dis 1996;28(2):270-273. 21. Lee JY, Kusek JW, Green PG, Bernhard S, Norris KC, Smith D, Wilkening B and Wright

JT for the AASK Pilot Study Investigators. Assessing medication adherence by pill count and electronic monitoring in the African-American Study of Kidney Disease and Hypertension Pilot Study. Am J Hypertens 1996;9:719-725.

22. Kusek JW, Lee JY, Charleston J, Faulkner M, Lovell B, Milligan S and Norris KC for the

AASK Pilot Study Investigators: Reasons for Joining and Barriers to Participation in the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Controlled Clinical Trials 1996; 16:47S-54S.

23. Whelton PK, Lee JY, Kusek JW, Charleston J, Debruge J, Douglas M, Faulkner M,

Greene P, Jones C, Keefer S, Kirk Katherine, Lovell B, Norris K, Peng S, Powers S, Retta T, Smith D, and Ward H for the AASK Pilot Study Investigators: Recruitment experience in the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Controlled Clinical Trials 1996;16:17S-33S.

24. Ganesan K, Norris KC. Prevalence of Estrogen Replacement Therapy (ERT) in an inner

city Minority Elderly Population. Gerontologist 1996;36(1):129-130.

56

25. Norris KC and Owen WF. Minorities and ESRD: Have we seen improvements in care. Nephrology News & Issues. 1997;11(2):66-68.

26. Norris KC. Toward a New Treatment Paradigm for Hyperphosphatemia in Chronic Renal

Disease. Dialysis and Transplantation 1998:27(12);767-773. 27. Norris KC. Secondary Hyperparathyroidism: Defining a Model of Optimal Management.

Dialysis and Transplantation 1999;28:630-640. 28. Robinson C, Flowers C, Alperson BL and. Norris KC. Computers, the Internet, and the

Disadvantaged Patient. JAMA 1999; 281:988-989 (research letter). 29. Ganesan K, Teklehaimanot S, Norris K. Estrogen replacement therapy use in minority

postmenopausal women. Ethn Dis. 2000;10:257-261. 30. Martins D, Pan D, Karami N, Das D, Norris KC. The Relationship Between Body weight

and the Prevalence of Isolated Systolic Hypertension in Older Subjects. J Clin Hypertension 2000;2(4):248-252.

31. Frazao JM, Elangovan L, Chesney RW, Acchiardo SR, Bower JD, Kelley BJ, Rodriquez

HJ, Norris KC, Robertson JA, Levine BS, Goodman WG, Coburn JW. Intermittent doxercalciferol (1-alpha-hyroxyvitamin D2) therapy for secondary hyperparathyroidism: Am J Kidney Dis 2000:36(3);550-561.

32. Norris KC, Baker R. Underrepresented Minority Physicians as Biomedical Researchers

and Academic Role Models: Impact of Recent Medical School and Residency Primary Care Initiatives. Minority Health Today 2000;1(4);46-49.

33. Norris KC. The Value of the AAKP Patient Plan: A Nephrologist’s Perspective. Nephrology

News & Issues 2000;14:32-34. 34. Maung HM, Elangovan L, Frazao JM, Bower JD, Kelley BJ, Acchiardo SR, Rodriquez HJ,

Norris KC, Sigala JF, Rutkowski M, Robertson JA, Goodman WG, Levine BS, Chesney RW, Mazess RB, Kyllo DM, Douglass LL, Bishop CW, Coburn JW. Efficacy and side effects of Intermittent intravenous and oral doxercalciferol (1-alpha-hyroxyvitamin D2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison. Am J Kidney Dis 2001:37;532-543.

35. Martins D, Gor D, Teklehaimanot S, and Norris KC. High Blood Pressure knowledge in an

Urban African-American Community Ethn Dis 2001;11:90-96. 36. Henry M, Jones L and Norris KC. Seniors Identified Barriers to Health Care. Ethn Dis

2001;11(suppl):167-169. 37. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J,; Cheek

D, Cleveland W,. Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller III ER, Norris K, O’Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright, Jr, JT, Xu S, for the African American Study of Kidney Disease and Hypertension (AASK) Study Group. Effect of

57

Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis A Randomized Controlled Trial. JAMA 2001;285:2719-2728.

38. Norris KC, Thornhill Joynes, M, Tareen N. Cocaine use and chronic renal failure.

Seminars in Nephrology 2001;21(4);362-366. 39. Singh AB, Norris K, Davidson T, Sinha-Hikkim I, Shen R, Bhasin S: Pharmacokinetics of a

Transdermal Testosterone System in Men with End Stage Renal Disease Receiving Maintenance Hemodialysis and Healthy Hypogonadal Men. The Journal of Clin Endocrinol and Metab 2001; 86 (6):2437-2445.

40. Norris KC, Thornhill-Joynes M, Robinson C, Strickland T, Alperson BL, Witana SC, and

Ward HJ. Cocaine use, hypertension and end-stage renal disease. Am J Kidney Dis 2001;38(3):523-528.

41. Hamilton S, Rothenberg SJ, Khan FA, Manalo M, and Norris KC. New-born Lead

Poisoning from Maternal Pica Behavior during Pregnancy. J Nat Med Assoc 2001;93:317-319.

42. Martins D, Nelson K, Pan D, Tareen N and Norris K. The Effect of Gender on Age-Related

Blood Pressure Changes and the Prevalence of Isolated Systolic Hypertension Among Older Adults: Data From NHANES III. J Gend Specif Med 2001;4:10-13.

43. Schneider RH, Castillo-Richmond A, Alexander CN, Myers HF, Kaushik V, Aranguri C,

Norris K, Haney C, Rainforth M, Calderon R, Nidich S. Behavioral treatment of hypertensive heart disease in African Americans: Rationale and design of a randomized controlled trial. Behavioral Medicine 2001;27(2);83-95. PMID: 11763829

44. Nelson K, Norris K, Mangione CM. Disparities in the diagnosis and treatment of high blood

cholesterol by race and ethnicity. Data from NHANES III. Archives Int Med 2002;162:929-935.

45. Martins, D, Tareen N, Pan D, Norris KC. The Relationship Between Body Mass Index and

Pulse Pressure in Older Adults with Isolated Systolic Hypertension. Am J Hypertens 2002;15(6):538-43

46. Norris KC and Agodoa LY. Race and Kidney Disease: The Scope of The Problem. J Natl

Med Assoc. 2002;94(8):39S-44S. 47. Pogue VA, Norris KC, Dillard MG. Kidney disease physician workforce: where is the

emerging pipeline? J Natl Med Assoc. 2002;94(8):1S-6S. 48. Pradhan R, Fong D, Scott C, Jack R, Rezapour G, Norris KC, and Davidson MB.

Angiotensin converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive type 2 diabetic patients: A pilot study. J Diabetes Complications. 2002;16:377-381.

49. McQuirter JL, Rothenberg SJ, Dinkins GA, Norris K, Kondrashov V, Manalo M, Todd AC.

Elevated blood lead resulting from maxillofacial gunshot injuries with lead ingestion. J Oral Maxillofac Surg. 2003 May;61(5):593-603.

58

50. Sarkisian CA, Brown AF, Wintz RL, Norris KC, Mangione CM. Self-care interventions targeting older, African American or Latino Adults with diabetes: a systematic review. Diabetes Educ. 2003;29(3):467-479.

51. Appel L, Middleton J, Lipkowitz M, Norris K, Agodoa LY, Bakris G, Douglas-Baltimore J,

Charleston J, Gasssman J, Greene T, Jamerson K, Lewis JA, Miller E III, Phillips RA, Rostand SG, Wright J. The Design and Rationale of the AASK Cohort Study. J Am S Neph 2003 Jul;14(7 Suppl 2):S166-72.

52. Martins D, Tareen N, Pan D, Norris K. The relationship between body mass index, blood

pressure and pulse rate among normotensive and hypertensive participants in the third National Health and Nutrition Examination Survey (NHANES). Cell Mol Biol (Noisy-le-grand). 2003 Dec;49(8):1305-9.

53. Phillips R, Faulkner M, Gassman J, Jaen L, Kusek J, Norris K, Ojo A, Richardson A.

Recruitment of African Americans Into a Clinical Trial of Blood Pressure Control; African American Study of Hypertension and Kidney Disease (AASK). J Clin Hyperten. 2004 Aug;6(8):430-6.

54. Nissenson AR, Agarwal R, Allon M, Cheung AK, Clark W, Depner T, Diaz-Buxo JA,

Kjellstrand C, Kliger A, Martin KJ, Norris K, Ward R, Wish J. Improving Outcomes in CKD and ESRD Patients: Carrying the Torch from Training to Practice. Semin Dial. 2004 Sep-Oct;17(5):380-397.

55. Mehrotra R, Budoff M, Christenson P, Ipp E, Takasu J, Gupta A, Norris K, Adler S.

Determinants of coronary artery calcification in diabetics with and without nephropathy. Kidney Int. 2004 Nov;66(5):2022-31.

56. Calderon JL, Zadshir A, Norris K. Structure and content of chronic kidney disease

information on the World Wide Web: barriers to public understanding of a pandemic. Nephrol News Issues. 2004 Oct;18(11):76, 78-9, 81-4.

57. Calderón JL, Zadshir A, Norris KC. A Survey of Kidney Disease and Risk Factor

Information on the World Wide Web. MedGenMed. 2004 Nov 11;6(4):3. 58. Sarkisian CA, Brusuelas RJ, Steers WN, Brown AF, Davidson MB, Norris KC, Anderson

RM, Mangione CM. Using Focus Groups of Older African Americans and Latinos with Diabetes to Modify a Self-Care Empowerment Intervention. Ethn Dis 2005;15(2):283-291.

59. Ganesan K, Teklehaimanot S, Tran TH, Asuncion M, Norris K. Relationship of C-reactive

protein and bone mineral density in community dwelling elderly females. J Natl Med Assoc. 2005 Mar;97(3):329-33.

60. Mehrotra R, Westenfeld R, Christenson P Budoff M, Ipp E, Takasu J, Gupta A, Norris K,

Ketteler M, Adler S. Serum Fetuin-A in Non-Dialyzed Patients with Diabetic Nephropathy: Relationship With Renal Function and Coronary Artery Calcification. Kidney Int. 2005 Mar;67(3):1070-7.

61. Ogunyemi D, Jones-Quaiduo, Edelstein R, Wolf K, Calmes D, Bazargan M, Baker R,

Norris K, Davidson E, Jr. Developing leaders to reduce health care disparities: A

59

mandatory medical thesis in an urban minority medical school. Teach Learn Med. 2005 Fall;17(4):363-9.

62. Bazargan M, Norris K, Akhanjee L, Bazargan S, Savfati S, Baker RS. Alternative Health

Care Use among Underserved Hispanic and African Americans. Ethn Dis. 2005 Autumn;15(4):531-9.

63. Easa D, Norris KC, Kim K, Hammatt Z, Hernandez E, Kato K, Balaraman V, Ho T,

Shomaker S. The Research Subjects Advocate at Minority Clinical Research Centers: An Added Resource for Protection of Human Subjects. Ethn Dis. 2005 Autumn;15(4 Suppl 5):S5-107-10

64. Zadshir A, Tareen N, Pan D, Norris KC, Martins D. The Prevalence of Hypovitaminosis D

among US Adults: Data from the NHANES III. Ethn Dis. 2005 Autumn;15(4 Suppl 5):S5-97-101.

65. Ganesan K Pan D, Teklehaimanot S, Norris KC. Racial Ethnic Differences In

Institutionalization after Hip Fractures. Ethn Dis. 2005 Autumn;15(4 Suppl 5):S5-30-3. 66. Tareen N, Martins D, Zadshir A, Pan D, Norris KC. Routine vitamin supplementation on

serum levels of 25 (OH) D3 among the general adult population and patients with chronic kidney disease. Ethn Dis. 2005 Autumn;15(4 Suppl 5):S5-102-6.

67. Wells KB, Staunton A, Norris KC, Bluthenthal R, Chung B, Gelberg L, Jones L, Kataoka S,

Koegel P, Miranda J, Mangione CM, Patel K, Rodriguez M, Shapiro M, Wong M. Building an academic-community partnered network for clinical services research: the community health improvement collaborative (CHIC). Ethn Dis. 2006;16:S3–S17.

68. Calderón JL, Hays RD, Conde JG, Baker RS, Fabrega H, Fleming E, Norris K. Ethno-

medical Perspectives on Research Participation: A Qualitative Pilot Study. MedGenMed. 2006 Apr 25;8(2):23. PMID: 16926762

69. Martins D, Tareen N, Zadshir A, Pan D, Vargas R, Nissenson A, Norris K. The association

of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2006 Jun;47(6):965-71.

70. Norris K, Greene T, Kopple J, Lea J, Lewis J, Lipkowitz M, Miller P, Richardson A,

Rostand S, Wang X, and Appel L for the AASK Study Group. Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol. 2006 Oct;17(10):2928-36.

71. Norris K, Bourgoigne J, Gassman J, Hebert L, Middleton J, Phillips R, Randall O, Rostand

S, Sherer S, Toto R, Wright J, Wang X, Greene T, Appel L, Lewis J; for the African American Study of Kidney Disease and Hypertension (AASK) Study Group. Cardiovascular Outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis. 2006 Nov;48(5):739-51.

72. Duru OK, Vargas RB, Kermah D, Pan D, Norris KC. Health Insurance Status and

Hypertension Monitoring and Control in the United States. Am J Hypertens. 2007 Apr;20(4):348-53.

60

73. McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ, Chen SC, Li S, Singh A, Norris KC, Klag MJ, Bakris GL; for the KEEP Investigators. Independent Components of Chronic Kidney Disease as a Cardiovascular Risk State: Results From the Kidney Early Evaluation Program (KEEP). Arch Intern Med, Jun 2007; 167: 1122 - 1129.

74. Martins D, Wolf M, Pan Deyu, Zadshir A, Tareen N, Thadhani, R, Felsenfeld A, Levine B,

Mehrotra R, and Norris K. The Prevalence of Cardiovascular Risk Factors and the Serum Levels of Vitamin D in the United States: Data from the NHANES III. Arch Intern Med. 2007;167:1159-1165.

75. Norris KC, Brusuelas R, Jones L, Miranda J, Duru K, Mangione C. Partnering with

Community Based Organizations: An Academic Institution’s Evolving Perspective. Ethn Dis 2007 Winter;17(1 Suppl 1):S27-32.

76. Mehrotra R, Kermah D, Fried L, Kalantar-Zadeh K, Khawar O, Norris K, Nissenson A..

Chronic Peritoneal Dialysis in the United States: Improving Outcomes but Declining Utilization. J Am Soc Nephrol. 2007; Oct;18(10):2781-8.

77. Bhatnagar V, O'Connor DT, Schork NJ, Salem RM, Nievergelt CM, Rana BK, Smith DW,

Bakris GL, Middleton JP, Norris KC, Wright JT, Cheek D, Hiremath L, Contreras G, Appel LJ, Lipkowitz MS. Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial. J Hypertens. 2007;25(10):2082-2092.

78. Chandramohan G, Bai Y, Norris K, Rodriguez-Iturbe B, Vaziri ND. Effects of Dietary Salt

on Intrarenal Angiotensin System, NAD(P)H Oxidase, COX-2, MCP-1 and PAI-1 Expressions and NF-kappaB Activity in Salt-Sensitive and -Resistant Rat Kidneys. Am J Nephrol. 2007 Oct 19;28(1):158-167.

79. Asuncion M, Shaheen M, Ganesan K, Velazques J, Teklehaimanot S, Pan D, Norris K.

Increase in Hypoglycemic Admissions: California Hospital Discharge Data. Ethn Dis. 2007 Summer;17(3):536-40.

80. Li S, Chen SC, Shlipak M, Bakris G, McCullough PA, Sowers J, Stevens L, Jurkovitz C,

McFarlane S, Norris K, Vassalotti J, Klag MJ, Brown WW, Narva A, Calhoun D, Johnson B, Obialo C, Whaley-Connell A, Becker B, Collins AJ. Low birth weight is associated with chronic kidney disease only in men. Kidney Int. Kidney Int. 2008 Mar;73(5):637-642.

81. Duru OK, Jurkovitz C, Narva A, McGill J, Bakris G, Chen S-C, Li S, Pergola P, McCullough

P, Singh A, Klag M, Collins A, Brown W, Norris K. Racial And Gender Differences In Hypertension Control In Chronic Kidney Disease: Results From The Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2008 Feb;51(2):192-8.

82. Vargas RB, Jones L, Terry C, Nicholas S, Kopple J, Forge N, Griffin A, Louis M, Barber L,

Small L, Norris KC. Community partnered approaches to enhance chronic kidney disease awareness, prevention and early intervention. Adv Chronic Kidney Dis. 2008 Apr;15(2):153-61.

83. Whaley-Connell A, Sowers JR, McFarlane SI, Stevens L, Shlipak M, Norris K, Chen S-C,

Li S, Vassaloti J, Collins A, on Behalf of the KEEP Investigators. CKD in the United States:

61

Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kid Dis. 2008; 51 (4), S13-S20.

84. Whaley-Connell A, Sowers JR, McFarlane SI, Shlipak M, Norris K, Chen S-C, Li S,

Stevens L, Vassaloti J, Collins A, and Kidney Early Evaluation Program Investigators. Diabetes Mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004. Am J Kid Dis. 2008; 51 (4), S21-S29.

85. McCullough PA, Li S, Jurkovitz CT, Stevens LA, Wang C, Collins AJ, Chen SC, Norris KC,

McFarlane SI, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti JA, Whaley-Connell AT; Kidney Early Evaluation Program Investigators. CKD and Cardiovascular Disease in Screened High-Risk Volunteer and General Populations: The Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kid Dis. 2008; 51 (4), S38-S45.

86. McFarlane SI, Chen SC, Whaley-Connell AT, Sowers JR, Vassalotti JA, Salifu MO, Li S,

Wang C, Bakris G, McCullough PA, Collins AJ, Norris KC; Kidney Early Evaluation Program Investigators. Prevalence and Associations of Anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kid Dis. 2008; 51 (4), S46-S55.

87. Vassalotti JA, Uribarri J, Chen SC, Li S, Wang C, Collins AJ, Calvo MS, Whaley-Connell

AT, McCullough PA, Norris KC; Kidney Early Evaluation Program Investigators. Trends in Mineral Metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kid Dis. 2008; 51 (4), S56-S68.

88. Calderón JL, Fleming E, Gannon M, Chen S-C, Vassaloti J, Norris K. Applying an

Expanded Set of Cognitive Design Principles to Formatting the Kidney Early Evaluation Program (KEEP) Longitudinal Survey. Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S83-92 PMID: 18359412.

89. Mehrotra R, Kermah D, Fried L, Adler S, and Norris K.. Racial Disparities in Mortality

Outcomes in Chronic Kidney Disease. J Am Soc Nephrol. 2008 Jul;19(7):1403-10. 90. Wolf M, Betancourt J, Chang Y, Shah A, Teng M, Camargo CA, Melamed M, Norris K,

Stampfer MJ, Powe NR, Thadhani R. Impact of Activated Vitamin D and Race on Survival among Hemodialysis Patients. J Am Soc Nephrol. 2008;19: 1379-1388.

91. Appel LJ, Bakris G, Gabbai F, Gassman J, Greene T, Kopple J, Kusek JW, Lipkowitz M,

Norris K, Rahman M, Rostand S, Schulman G, Wang X, Wright J, for the African-American Study of Kidney Disease and Hypertension Investigators. Progression of Hypertensive Chronic Kidney Disease Is Common Among African Americans with Excellent Blood Pressure Control and High Rates of Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers. Arch Intern Med, 2008;168(8): 832 - 839.

92. Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, Takasu J, Adler S, and

Norris K. Hypovitaminosis D In Chronic Kidney Disease. Clin J Am Soc Nephrol. 2008;3: p. 1144-1151.

62

93. Martins D, Tareen N, Ogedegbe G, Pan D, Norris K. The Relative Risk of Cardiovascular Death among Racial and Ethnic Minorities with Metabolic Syndrome: Data from the NHANES-II Mortality Follow-Up. J Natl Med Assoc. 2008;May;100(5):565-71.

94. Fleming ES, Perkins J, Easa D, Conde J, Baker R, Southerland W, Dottin R, Bond C,

Benabe J, Ofili E, Beanan M, Sayre M, McClure S, Norris KC. The role of translational research in addressing health disparities: A conceptual framework. Ethnicity & Disease. 2008 Spring; 18(2 Supplement 2):155-160.

95. Fleming ES, Perkins J, Easa D, Conde J, Baker R, Southerland W, Dottin R, Bond C,

Benabe J, Ofili E, Beanan M, Sayre M, McClure S, Norris KC. Addressing health disparities through multi-institutional, multi-disciplinary collaboratories. Ethnicity & Disease. 2008 Spring; 18(2 Supplement 2):161-167.

96. Maddirala JS, Gumbi RV, Perkins J, Ousepperampil S, Moore PD, Jones L, McNairy S,

Norris KC. Global-World HIV/AIDS Alliance (GHAA): charting healthy pathways for vulnerable populations. Ethn Dis. 2008 Spring;18(2 Suppl 2):S2-185-8.

97. McCullough PA, Li S, Jurkovitz CT, Stevens L, Collins AJ, Chen SC, Norris KC, McFarlane

S, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassaloti J, Whaley-Connell AT, Brenner RM, Bakris GL; KEEP Investigators. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J. 2008 Aug;156(2):277-83

98. Rettig RA, Norris KC, Nissenson AR. Chronic Kidney Disease in the United States: A

Public Policy Imperative. Clin J Am Soc Nephrol. 2008 Nov;3(6):1902-10. PMID: 18922986

99. Omije D, Norris K, Wang J, Ward HJ, Pan D, Gupta A. Race is a major determinant of

secondary hyperparathyroidism in uremic patients. Clin Nephrol. 2008 Oct;70(4):312-8. PMID: 18826856

100. Duru OK, Vargas RB, Kermah D, Nissenson AR, Norris KC. High Prevalence of Stage 3

Chronic Kidney Disease in Older Adults Despite Normal Serum Creatinine. J Gen Intern Med. 2009 Jan;24(1):86-92

101. Jolly S, Li S, Chen S-C, Jurkovitz C, Norris K, Shlipak MG. Risk Factors for Chronic

Kidney Disease Among American Indian and Alaska Natives. Am J Nephrol 2009;29:440-446.

102. Artaza JN, Norris KC.. Vitamin D promotes an anti-fibrotic/ anti-inflammatory phenotype in C3H

10T1/2 mesenchymal multipotent cells. J Endocrinol. 2009 Feb;200(2):207-21. 103. Bhatnagar V, O'Connor DT, Brophy VH, Schork NJ, Richard E, Salem RM, Nievergelt CM,

Bakris GL, Middleton JP, Norris KC, Wright J, Hiremath L, Contreras G, Appel LJ, Lipkowitz MS. The AASK Study Investigators. G-Protein-Coupled Receptor Kinase 4 Polymorphisms and Blood Pressure Response to Metoprolol Among African Americans: Sex-Specificity and Interactions. Am J Hypertens. 2009 Mar;22(3):332-8.

104. Moradi H, Yuan J, Ni Z, Norris K, Vaziri ND. Reverse cholesterol transport pathway in

experimental chronic renal failure. Am J Nephrol 2009;30:147–154. PMID: 19321994

63

105. Kim HJ, Moradi H, Yuan J, Norris K, Vaziri ND. Renal mass reduction results in

accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol. 2009 Jun;296(6):F1297-306. PMID: 19357177

106. Mehrotra R, Khawar O, Duong U, Fried L, Norris K, Nissenson A, Kalantar-Zadeh K.

Ownership Patterns of Dialysis Units and Chronic Peritoneal Dialysis in the United States: Utilization and Outcomes. Am J Kid Dis. 2009;54(2):289-98.

107. Chandramohan G, Durham N, Sinha S, Norris K, Vaziri ND. Role of gamma melanocyte-

stimulating hormone-renal melanocortin 3 receptor system in blood pressure regulation in salt-resistant and salt-sensitive rats. Metabolism. 2009 Oct;58(10):1424-1429. Epub 2009 Jul 1. PMID: 19570553.

108. Mehrotra R, Kermah D, Salusky I, Wolf M, Thadhani R, Chiu, Y-W, Martins D, Adler S,

Norris K. Chronic Kidney Disease, Hypovitaminosis D and Mortality in the United States. Kidney Int. 2009 Nov;76(9):977-83. PMID: 19359081

109. Norris KC, Baker RS, Taylor R, Montgomery-Rice V, Higginbotham EJ. Riley WJ, Maupin

J, Drew-Ivie S, Reede JY, Gibbons G. Historically Black Medical Schools: Addressing the Minority Health Professional Pipeline and the Public Mission of Care For Vulnerable Populations. J Natl Med Assoc. 2009;101:864-872

110. Bhatnagar V, Garcia EP, O'Connor DT, Brophy VH, Alcaraz J, Richard E, Bakris GL,

Middleton JP, Norris KC, Wright J, Hiremath L, Contreras G, Appel LJ, Lipkowitz MS. CYP3A4 and CYP3A5 Polymorphisms and Blood Pressure Response to Amlodipine among African-American Men and Women with Early Hypertensive Renal Disease. Am J Nephrol. 2009 Nov 12;31(2):95-103. [Epub ahead of print] PMID: 19907160

111. Kim HJ, Yuan J, Norris K, Vaziri N. High calorie diet partially ameliorates dysregulation of

intra-renal lipid metabolism in the remnant kidney. J Nutr Biochem. 2009 Nov 30. [Epub ahead of print] PMID: 19954950

112. McCullough PA, Whaley-Connell A, Brown WW, Collins AJ, Chen SC, Li S, Norris KC,

Jurkovitz C, McFarlane S, Obialo C, Sowers J, Stevens L, Vassalotti JA, Bakris GL; on Behalf of the KEEP Investigators. Cardiovascular risk modification in participants with coronary disease screened by the kidney early evaluation program. Intern Med J. 2010 2010 Dec;40(12):833-41. doi: 10.1111/j.1445-5994.2009.02158.x. PMID: 20059608

113. Artaza JN, Sirad F, Ferrini MG, Norris KC. 1,25(OH)(2)vitamin D(3) inhibits cell

proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells. J Steroid Biochem Mol Biol. 2010 Mar;119(1-2):73-83. PubMed PMID: 20064609; PubMed Central PMCID: PMC2828517.

114. Jones L, Wells K, Norris K, Meade B, Koegel P. The vision, valley, and victory of

community engagement. Ethn Dis. 2009 Autumn;19(4 Suppl 6):S6-3-7. PubMed PMID: 20088076.

115. Jones L, Meade B, Forge N, Moini M, Jones F, Terry C, Norris K. Begin your partnership:

the process of engagement. Ethn Dis. 2009 Autumn;19(4 Suppl 6):S6-8-16. PubMed PMID: 20088077.

64

116. Jones L, Meade B, Norris K, Lucas-Wright A, Jones F, Moini M, Jones A, Koegel P.

Develop a vision. Ethn Dis. 2009 Autumn;19(4 Suppl 6):S6-17-30. PubMed PMID: 20088078.

117. Jones L, Meade B, Koegel P, Lucas-Wright A, Young-Brinn A, Terry C, Norris K. Work

through the valley: plan. Ethn Dis. 2009 Autumn;19(4 Suppl 6):S6-31-8. PubMed PMID: 20088079.

118. Jones L, Wells K, Meade B, Forge N, Lucas-Wright A, Jones F, Young-Brinn A, Jones A,

Norris K. Work through the valley: do. Ethn Dis. 2009 Autumn;19(4 Suppl 6):S6-39-46. PubMed PMID: 20088080.

119. Sinha-Hikim I, Shen R, Kovacheva E, Crum A, Vaziri ND, Norris KC. Inhibition of apoptotic

signaling in spermine-treated vascular smooth muscle cells by a novel cystine based glutathione precursor. Cell Biology International. 2010, Apr 1;34(5):503-11. PubMed PMID: 20121705.

120. Stevens LA, Li S, Wang C, Huang C, Becker BN, Bomback AS, Brown WW, Burrows NR,

Jurkovitz CT, McFarlane SI, Norris KC, Shlipak M, Whaley-Connell AT, Chen SC, Bakris GL, McCullough PA. Prevalence of CKD and Comorbid Illness in Elderly Patients in the United States: Results From the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2010 Mar;55(3S2):S23-S33. PubMed PMID: 20172445.

121. Jolly SE, Burrows NR, Chen SC, Li S, Jurkovitz CT, Narva AS, Norris KC, Shlipak MG.

Racial and Ethnic Differences in Albuminuria in Individuals With Estimated GFR Greater Than 60 mL/min/1.73 m(2): Results From the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2010 Mar;55(3S2):S15-S22. PubMed PMID: 20172444.

122. Fischer MJ, Kimmel PL, Greene T, Gassman JJ, Wang X, Brooks DH, Charleston J,

Dowie D, Thornley-Brown D, Cooper LA, Bruce MA, Kusek JW, Norris KC, Lash JP; the AASK study group. Sociodemographic factors contribute to the depressive affect among African Americans with chronic kidney disease. Kidney Int. 2010 Mar 3. [Epub ahead of print] PubMed PMID: 20200503.

123. Releford BJ, Frencher SK Jr, Yancey A, and Norris K. Cardiovascular Disease Control

through Barbershop Outreach. J Natl Med Assoc. 2010;Apr;102(4):336-45. 124. Martins D, Ani C, Ogunyemi O, Pan D and Norris K. Renal Dysfunction, Metabolic

Syndrome and Cardiovascular Disease Mortality. J Nutr Metab. 2010;2010. pii: 167162. Epub 2010 Mar 24. PMC2911619

125. Ferre´ CD, Jones L, Norris KC, Rowley DL. The healthy African American families (HAAF)

project: from community based participatory research to community-partnered participatory research. Ethn Dis. 2010;20 [Suppl 2]:s2-1–s2-8.

126. Chung B, Jones L, Terry C, Jones A, Forge N, Norris KC. Story of stone soup: a recipe to

improve health disparities. Ethn Dis. 2010; 20[Suppl 2]:s2-9–s2-14. 127. Jones L, Lu MC, Lucas-Wright A, Dillon-Brown N, Broussard M, Wright K, Maidenberg M,

Norris KC, Ferre´ C. One hundred intentional acts of kindness toward a pregnant woman:

65

Building reproductive social capital in Los Angeles. Ethn Dis. 2010;20 [Suppl 2]:s2-36–s2-40.

128. Sinha-Hikim I, Shen R, Paul Lee WN, Crum A, Vaziri ND, Norris KC. Effects of a novel

cystine based glutathione precursor on oxidative stress in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2010 Sep;299(3):C638-42. PubMed PMID: 20592243; PubMed Central PMCID: PMC2944321.

129. Kalantar-Zadeh K, Miller JE, Kovesdy CP, Mehrotra R, Lukowski LR, Streja E, Ricks J,

Jing J, Nissenson AR, Greenland S, Norris KC. Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D and survival in hemodialysis patients. J Bone Miner Res. 2010 Jul 7 [Epub ahead of print]. PMID: 20614473

130. Alves TP, Wang X, Wright JT Jr, Appel LJ, Greene T, Norris K, Lewis J; for the AASK

Collaborative Research Group. Rate of ESRD Exceeds Mortality among African Americans with Hypertensive Nephrosclerosis. J Am Soc Nephrol. 2010 Jul 22 [Epub ahead of print]. PMID: 20651163

131. Jessica E Miller, MPH1,2; Csaba P Kovesdy, MD3; Keith C Norris, MD; Rajnish Mehrotra,

MD; Allen R Nissenson, MD4; Joel D Kopple, MD1; and Kamyar Kalantar-Zadeh, MD MPH PhD1,2. Association of Cumulatively Low or High Serum Calcium Levels with Mortality in Long-Term Hemodialysis Patients. Am J Nephrol. 2010 Sep 3;32(5):403-413. [Epub ahead of print]

132. Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH,

Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010 Sep 2;363(10):918-29. PMID: 20818902

133. Kim HJ, Vaziri ND, Norris K, An WS, Quiroz Y, Rodriguez-Iturbe B. High-calorie diet with

moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease. Clin Exp Nephrol. 2010 Sep 7. [Epub ahead of print]. PMID: 20820841

134. McCullough PA, Steigerwalt S, Tolia K, Chen SC, Li S, Norris KC, Whaley-Connell A; on

behalf of the KEEP Investigators. Cardiovascular Disease in Chronic Kidney Disease: Data from the Kidney Early Evaluation Program (KEEP). Curr Diab Rep. 2011 Feb;11(1):47-55. PubMed PMID: 21076895.

135. Kalantar-Zadeh K, Golan E, Shohat T, Streja E, Norris KC, Kopple JD. Survival Disparities

within American and Israeli Dialysis Populations: Learning from Similarities and Distinctions across Race and Ethnicity. Seminars in Dialysis, 2010. 23: 586–594. doi: 10.1111/j.1525-139X.2010.00795.x

136. Streja E, Kovesdy CP, Molnar MZ, Norris KC, Greenland S, Nissenson AR, Kopple JD,

Kalantar-Zadeh K. Role of nutritional status and inflammation in higher survival of African American and Hispanic hemodialysis patients. Am J Kidney Dis. Jun 2011;57(6):883-893. Jan 14. [Epub ahead of print]

66

137. Noori N, Kovesdy CP, Dukkipati R, Feroze U, Molnar MZ, Bross R, Nissenson AR, Kopple JD, Norris KC, Kalantar-Zadeh K. Racial and ethnic differences in mortality of hemodialysis patients: Role of dietary and nutritional status and inflammation. Am J Nephrol. 2011 Feb 4;33(2):157-167. [Epub ahead of print]

138. Feroze U, Noori N, Kovesdy CP, Molnar MZ, Martin DJ, Reina-Patton A, Benner D, Bross

R, Norris KC, Kopple JD, Kalantar-Zadeh K. Subjective Quality of Life Scores and Nutritional Status and Mortality in Long-Term Hemodialysis Patients. Clin J Am Soc Nephrol. 2011 May;6(5):1100-11. PMID: 21527646

139. Choi AI, Weekley CC, Cheng Chen S, Li S, Kurella Tamura M, Norris KC, Shlipak MG.

Association of Educational Attainment With Chronic Disease and Mortality: The Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2011 58(2):228-234.PubMed PMID: 21601328.

140. Fischer MJ, Kimmel PL, Greene T, Gassman JJ, Wang X, Brooks DH, Charleston J,

Dowie D, Thornley-Brown D, Cooper LA, Bruce MA, Kusek JW, Norris KC, Lash JP. Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease. Kidney Int. 2011 Jun 1.[Epub ahead of print] PubMed PMID: 21633409.

141. Ricks J, Molnar MZ, Kovesdy CP, Kopple JD, Norris KC, Mehrotra R, Nissenson AR, Arah

OA, Greenland S, Kalantar-Zadeh K. Racial and Ethnic Differences in the Association of Body Mass Index and Survival in Maintenance Hemodialysis Patients. Am J Kidney Dis. 2011 Oct;58(4):574-82. Jun 7. [Epub ahead of print]. PMID: 21658829

142. Kurella Tamura M, Anand S, Li S, Chen SC, Whaley-Connell AT, Stevens LA, Norris KC.

Comparison of CKD awareness in a screening population using the Modification of Diet in Renal Disease (MDRD) study and CKD Epidemiology Collaboration (CKD-EPI) equations. Am J Kidney Dis. 2011 Mar;57(3 Suppl 2):S17-23. PubMed PMID: 21338846; PubMed Central PMCID: PMC3075598.

143. Stevens LA, Li S, Kurella Tamura M, Chen SC, Vassalotti JA, Norris KC, Whaley-Connell

AT, Bakris GL, McCullough PA. Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2011 Mar;57(3 Suppl 2):S9-16.PubMed PMID: 21338849.

144. McFarlane SI, McCullough PA, Sowers JR, Soe K, Chen SC, Li S, Vassalotti JA, Stevens LA, Salifu MO, Kurella Tamura M, Bomback AS, Norris KC, Collins AJ, Bakris GL, Whaley-Connell AT; KEEP Steering Committee. Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2011 Mar;57(3 Suppl 2):S24-31. PubMed PMID: 21338847

145. Stacey E. Jolly, MD, MS1 ; Nilka Ríos Burrows, MPH2; Shu-Cheng Chen, MS3 ; Suying Li,

PhD3; Claudine T. Jurkovitz, MD4; Keith C. Norris, MD5 ; Michael G. Shlipak, MPH, MD6. Racial and Ethnic Differences in Mortality among Individuals with Chronic Kidney Disease: Results from the Kidney Early Evaluation Program (KEEP). CJASN published 22 July

67

2011,10.2215/CJN.00500111 http://cjasn.asnjournals.org/cgi/content/abstract/CJN.00500111v1

146. Sinha-Hikim I, Sinha-Hikim AP, Shen R, Kim H, French SW, Vaziri ND, Crum A,

Rajavashisth TB, Norris KC. A Novel Cystine Based Antioxidant Attenuates Oxidative Stress and Hepatic Steatosis in Diet-Induced Obese Mice. Exp Mol Pathol. 2011 Aug;91(1):419-28. Epub 2011 May 3. PMID: 21570964

147. Garcia LA, King KK, Ferrini MG, Norris KC, Artaza JN. Vitamin D Stimulates Myogenic

Differentiation by Inhibiting Cell Proliferation and Modulating the Expression of Pro-myogenic Growth Factors and Myostatin in C2C12 Skeletal Muscle Cells. Endocrinology. 2011 Jun 14. [Epub ahead of print] PMID: 21673099

148. Molnar MZ, Streja E, Kovesdy CP, Nissenson AR, Krishnan M, Norris KC, and Kalantar-

Zadeh K. High Platelet Count as a Link between Renal Cachexia and Cardiovascular Mortality in End-Stage Renal Disease Patients. Am J Clin Nutr. 2011 Aug 3. [Epub ahead of print] PMID: 21813809

149. Peralta CA, Norris KC, Li S, Chang TI, Tamura MK, Jolly SE, Bakris G, McCullough PA,

Shlipak M; for the KEEP Investigators. Blood Pressure Components and End-stage Renal Disease in Persons With Chronic Kidney Disease: The Kidney Early Evaluation Program (KEEP). Arch Intern Med. 2012 Jan 9;172(1):41-47. PubMed PMID: 22232147.

150. Rattanasompattikul M, Feroze U, Molnar MZ, Dukkipati R, Kovesdy CP, Nissenson AR,

Norris KC, Kopple JD, Kalantar-Zadeh K. Charlson Comorbidity Score is a Strong Predictor of Mortality in Hemodialysis Patients. Int Urol Nephrol. 2011 Nov 30. [Epub ahead of print]

151. Porter A, Fischer MJ, Brooks D, Bruce M, Charleston J, Cleveland WH, Dowie D, Faulkner

M, Gassman J, Greene T, Hiremath L, Kendrick C, Kusek JW, Thornley-Brown D, Wang X, Norris K, Unruh M, Lash J.for the AASK Study Group. Quality of Life and Psychosocial Factors in African Americans with Hypertensive Chronic Kidney Disease. Transl Res. 2012 Jan;159(1):4-11. Epub 2011 Oct 12.

152. Saab G, Whaley-Connell A, Bombeck A, Kurella Tamura M, Li S, Chen SC, McFarlane SI,

Sowers JR, Norris K, Bakris GL, McCullough PA; for the Kidney Early Evaluation Program Investigators. The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease. Cardiorenal Med. 2011;1(2):123-130. Epub 2011 Apr 15. PMID: 22258399 [PubMed]

153. Whaley-Connell A, Bomback AS, McFarlane SI, Li S, Roberts T, Chen SC, Collins AJ,

Norris K, Bakris GL, Sowers JR, McCullough PA; on behalf of the Kidney Early Evaluation Program Investigators. Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program. Cardiorenal Med. 2011 Jan;1(1):45-52.

154. Nosratola D. Vaziri, Jun Yuan, Zhenmin Ni, Susanne B. Nicholas, Keith C. Norris.

Lipoprotein lipase deficiency in chronic kidney disease is compounded by downregulation of endothelial GPIHBP1 expression. Clin Exp Nephrol. 2011 Oct 19. [Epub ahead of print]. PMID: 22009636

68

155. Saab G, Chen SC, Li S, Bomback AS, Whaley-Connell AT, Jurkovitz CT, Norris KC,

McCullough PA; KEEP Investigators. Association of Physician Care With Mortality in Kidney Early Evaluation Program (KEEP) Participants. Am J Kidney Dis. 2012 Mar;59(3 Suppl 2):S34-9. PubMed PMID: 22339900.

156. Jurkovitz CT, Elliott D, Li S, Saab G, Bomback AS, Norris KC, Chen SC, McCullough PA,

Whaley-Connell AT; KEEP Investigators. Physician Utilization, Risk-Factor Control, and CKD Progression Among Participants in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2012 Mar;59(3 Suppl 2):S24-33. PubMed PMID: 22339899.

157. Shah A, Fried LF, Chen SC, Qiu Y, Li S, Cavanaugh KL, Norris KC, Whaley-Connell AT,

McCullough PA, Mehrotra R; KEEP Investigators. Associations Between Access to Care and Awareness of CKD. Am J Kidney Dis. 2012 Mar;59(3 Suppl 2):S16-23. PubMed PMID: 22339898.

PAPERS - PEER REVIEWED JOURNALS (IN PRESS) 158. Georges Saab, MD, Adam Whaley-Connell, DO, MSPH, Mike Shlipak, MD, MPH, Keith

Norris, MD, Samy I McFarlane, MD, MPH, Shu-Cheng Chen, Suying Li, James R Sowers, MD1, Allan Collins, MD, George Bakris, MD and Kidney Early Evaluation Program Investigators. Low Awareness of Chronic Kidney Disease in the US: Results of the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis.

159. Adam Whaley-Connell, DO, MSPH,1 Brian Pavey, MS, DO,1 Peter A. McCullough, MD,

MPH2, Georges Saab, MD,1 Samy I. McFarlane, MD, MPH,3 Mike Shlipak, MD,4 Keith Norris, MD, 5 Shu-Cheng Chen, MS,6 Suying Li, PhD,6 Joseph A. Vassalotti, MD,7 Allan J. Collins, MD,6 George Bakris, MD, 8 James R. Sowers, MD,1 on Behalf of the KEEP Investigators. Dysglycemia Predicts Cardiovascular and Kidney Disease Risk in the Kidney Early Evaluation Program (KEEP). Journal of the CardioMetabolic Syndrome.

160. Nazanin Noori, MD, PhD1,2; Csaba P Kovesdy, MD4; Ramanath Dukkipati, MD1; Usama

Feroze, MD1,2; Rachelle Bross, RD, PhD2; Allen R Nisssenson, MD3,5; Joel D Kopple, MD1,2,3; Keith C Norris, MD3; and Kamyar Kalantar-Zadeh, MD, MPH, PhD1,2,3. Racial and Ethnic Differences in Nutritional Status, Dietary Intakes and Inflammation and their Mortality-Predictabilities in Hemodialysis Patients (AJKD)

161. O. Kenrik Duru, MD, MS, Nina T. Harawa, PhD, Dulcie Kermah, MPH, Keith C. Norris,

MD. The Association between Allostatic Load Burden and Racial Disparities in Mortality. JNMA

162. Kamanna VS, Ganji SH, Stanislav Shelkovnikov S, Keith Norris, Nosratola D. Vaziri. Iron

sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration. Am J Neph

163. Adam Whaley-Connell, DO, MSPH,1 Mike Shlipak, MD MPH2, Lesley Stevens, MD, MPH3,

Manjula Kurella Tamura, MD4, Andrew S Bomback, MD MPH5, Georges Saab, MD6, Susanna M. Szpunar PhD7, Samy I. McFarlane, MD, MPH8, Suying Li, PhD9, Shu-Cheng Chen, MS9, Keith Norris, MD10, George L. Bakris, MD11, Peter A. McCullough, MD, MPH7,

69

on behalf of the Kidney Early Evaluation Program Investigators. Awareness of Kidney Disease and Relationship to End-Stage Renal Disease and Death (AJKD)

164. Tripathi B. Rajavashisth, PhD; Magda Shaheen, MD, PhD, MS, MPH; Keith C. Norris, MD;

Deyu Pan, MS; Satyesh K. Sinha, PhD; Juan Ortega, BS; and Theodore C. Friedman, MD, PhD. Decreased Prevalence of Diabetes in Marijuana Users: Data from NHANES III. BMJ Open. 2012 Feb 24;2:e000494. Print 2012.

REVIEWS (IN PEER REVIEWED JOURNALS) 165. Owen W. Jr., Roberts J, Alexander S, Cohen D, Harmon W, Ing T, Kari J, Keen M, King

Karren, Letteri J, Lundin AP, Messana A, Nardini J, Norris K, Politoski G (Work Group Members). NKF-DOQI Clinical Practice Guidelines for Hemodialysis Adequacy. Am J Kidney Dis 1997:30;15S-66S.

166. Norris KC and Fong RL. Hypertension in the African-American elderly. Clinical Geriatrics

1997;5(9):56-71.

167. Owen W. Jr., Roberts J, Alexander S, Cohen D, Harmon W, Ing T, Kari J, Keen M, King Karren, Letteri J, Lundin AP, Messana A, Nardini J, Norris K, Politoski G (Work Group Members).NKF-DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: Update 2000. Am J Kidney Dis 2001:37 (Suppl);1S9-S64.

168. Martins D, Adetola A, Norris KC. Emergency treatment for Electrolyte Disturbances in the

Elderly. Clinical Geriatrics. 2001; 9(8):39-46.

169. Norris KC. Revolutions in Phosphorus Management—Avoiding Soft-Tissue Calcification in Chronic Renal Failure. Nephrology News & Issues 2000;14:32-34.

170. Martins D, Norris KC. Combating Diabetic Nephropathy with Drug therapy. Current

Diabetes Reports 2001;1:148-156.

171. Norris KC. The impact of calcium in phosphorus management. Excess calcium load in chronic renal failure adds risk for patients. Nephrol News Issues. 2001 Nov;15(12):17, 20, 23-4 passim.

172. Martins D, Tareen N, Norris KC. The Epidemiology of Chronic Renal Disease in African

Americans. Am J Med Science 2002;323(2):65-71.

173. Friedman T, Norris KC. The role of vitamin D hormone in mild to moderate chronic kidney disease. Trends in Endocrinology and Metabolism 2002;13(5):189-194.

174. Norris KC, Vaughn C. The Role of Renin-Angiotensin-Aldosterone System Inhibition in

Chronic Kidney Disease. Expert Rev Cardiovasc. Ther. 2003;1(1):51-63.

175. Lea JP, Brown DT, Lipkowitz M, Middleton J, Norris K; (For the AASK Study Group). Preventing Renal Dysfunction in Patients with Hypertension: Clinical Implications from the Early AASK Trial Results. Am J Cardiovasc Drugs. 2003;3(3):93-200.

70

176. Gupta A, Wang J, Norris K. Serum calcium and total calcium load in kidney disease. Nephrol News Issues. 2003 Nov; 17(12): 68-70, 72-4, 76 passim.

177. Tareen N, Zadshir A, Martins D, Nagami G, Levine B, Norris KC. Alterations in Acid-Base

Homeostasis with Aging. J Natl Med Assoc 2004 96(6):921-927.

178. Martins D, Norris KC. Hypertension in African Americans. Cleveland Clinic Journal of Medicine 2004; 71 (9):735-743.

179. Martins D, Tareen N, Nicholas SB, Jones L, Norris KC. Education, Motivation and

Medication for African Americans: Bringing Hypertension Guidelines to Practice. Ethn Dis. 2004;14[suppl 2]:s38-41.

180. Nicholas S, Agodoa LY, Norris K. Ethnic disparities in the prevalence and treatment of

kidney disease. Nephrol News Issues. 2004 Nov;18(12):29-30, 32, 34 passim.

181. Nicholas S, Tareen N, Martins D, Norris KC. Calcium Antagonists: A more expansive role in Treating Persons with Reduced Kidney Function? Ethn Dis. 2004 Autumn;14(4):S2-42-5.

182. Tareen N, Zadshir A, Martins D, Nagami G, Levine B, Norris KC. Sodium Disorders in The

Elderly J Natl Med Assoc. 2005;97:217–224.

183. Tareen N, Zadshir A, Martins D, Pan D, Nicholas S, Norris KC. Chronic Kidney Disease in African American and Mexican American Populations Kidney Int 2005 Aug;(97):S137-40.

184. Nicholas S, Tareen N, Zadshir A, Martins D, Pan D, Norris KC. Management of Early

Chronic Kidney Disease in Indigenous Populations and Ethnic Minorities. Kidney Int 2005 Aug;(97):S78-81.

185. Agodoa, L, Norris K, Pugsely D. The disproportionate burden of kidney disease in those

who can least afford it. Kidney Int 2005 Aug;(97):S1-3.

186. Norris KC, Agodoa, LY. Unraveling the Racial Disparities Associated With Kidney Disease. Kidney Int 2005;68:914–924.

187. Agodoa L, Norris KC, Shahinfar S, Prabhakar KS, Pugsley D. Renal disease in minority

populations and developing nations. Ethn Dis. 2006;16[suppl 2]:S2-1.

188. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: Hemodialysis Adequacy, Peritoneal Dialysis Adequacy and Vascular Access. (Work Group Member for Hemodialysis Adequacy Guidelines) Am J Kidney Dis 48:S1-S322, 2006 (suppl 1).

189. Norris K, Neutel JM. Following in the Experts’ Footsteps: First-Step Use of

Antihypertensive Combination Therapy. J Clin Hypertens. 2007;9(12 suppl 5):5–14)

190. Lea J, Norris K, Agodoa L. The Role of Anemia Management in Improving Outcomes for African Americans with Chronic Kidney Disease. Am J Nephrol. 2008 Apr 24;28(5):732-743.

71

191. Norris K and Nissenson AR. Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol. 2008;19:1261-1270.

192. Norris KC, Tareen N, Martins D, Vaziri N. Implications of ethnicity for the treatment of

hypertensive kidney disease, with an emphasis on African Americans. Nat Clin Pract Nephrol. 2008 Oct;4(10):538-49.

193. Norris KC, Shlipak MG., Bakris GL. The Kidney Early Evaluation Program (KEEP)

launches follow-up initiative aimed at predicting the future. Nephrol News Issues. 2008 Sep;22(10):44-6.

194. Lea JP, Greene EL, Nicholas SB, Agodoa L, Norris KC. Cardiorenal metabolic syndrome

in the African diaspora: rationale for including chronic kidney disease in the metabolic syndrome definition. Ethn Dis. 2009 Spring;19(2 Suppl2):S2-11-4. PubMed PMID: 19537345.

195. Artaza JN, Mehrotra R, Norris KC. Vitamin D and the Cardiovascular System. Clin J Am

Soc Nephrol 4: 1515–1522, 2009. 196. Williams S, Malatesta K, Norris K. Vitamin D and chronic kidney disease. Ethn Dis.2009;

19 [Suppl 5]:s5- 8–s5-11. PMID: 20077598 197. Rettig R, Vargas R, Norris K, Nissenson AR. A 'quiet revolution' in nephrology. Nephrol

News Issues. 2010 Nov;24(12):18-9, 23. 198. Mehrotra R, Norris Keith. Hypovitaminosis D, Neighborhood Poverty, and Progression of

Chronic Kidney Disease in Disadvantaged Populations. Clin Nephrol. 2010 Sup;74(S1):95-98.

199. Rettig RA, Vargas RB, Norris KC, and Nissenson AR, Chronic Kidney Disease—A Quiet Revolution in Nephrology: Six Case Studies, Santa Monica, Calif.: RAND Corporation, TR-826-DREW, 2010 (http://www.rand.org/pubs/technical_reports/TR826.html).

200. Nosratola D. Vaziri and Keith Norris. Lipid disorders and their relevance to outcomes in

Chronic Kidney Disease. Blood Purif. 2011;31(1-3):189-96. Epub 2011 Jan 10. 201. Hammat Z, Nishitani J, Heslin K, Perry MT, Zetela CS, Antoine-lavigne DA, Jones L,

Williams P, Forge N, Norris K. Partnering to Harmonize IRBs for Community-Engaged Research to Reduce Health Disparities. J Health Care Poor Underserved. 2011;22(4 Suppl):8-15.

202. Artaza JN, Contreras S, Garcia LA, Mehrotra R, Gibbons G, Shohet R, Martins D, Norris

KC. Vitamin D and cardiovascular disease: potential role in health disparities. J Health Care Poor Underserved. 2011;22(4 Suppl):23-38. PubMed PMID: 22102304.

REVIEWS (PEER REVIEWED JOURNALS IN PRESS)

203. Martins D, Agodoa L and Norris K. Chronic Kidney Disease in African Americans

Challenges and Opportunities for Advancing the Treatment of Hypertension in Chronic Kidney Disease. Cleve Clin J Med

72

204. Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of

immune system. Journal of Renal Nutrition 205. Martins D, Agodoa L and Norris K. Chronic Kidney Disease in Disadvantaged Populations.

Int J Neph. EDITORIALS (PEER REVIEWED JOURNALS) 206. Norris KC. Translational Research: Moving Scientific Advances into the Real-World

Setting. Ethn Dis. 2005 Summer;15(3):363-4 207. Norris KC, Agodoa LY. The need for health professionals and scientists from

underrepresented minority and disadvantaged communities. Ethn Dis. 2005 Summer;15 (Suppl 4):S1-2.

208. Norris KC. Foreword: The community health improvement collaboration: Building

community-academic partnerships to reduce disparities. Ethn Dis. 2006 Winter;16(1 Suppl 1):S1-2.

209. Norris K. Oral Paricalcitol: A viewpoint. Treat Endocrinol 2006; 5 (5): 1175-6.

210. Norris KC, Agodoa LY. Expanding the minority biomedical pipeline: The NIDDK national

high school student summer research program. Ethn Dis. 2006;16 (Suppl 5):S1-2.

211. Norris KC, Agodoa LY. Increasing diversity in the biomedical sciences and health professions: the NIDDK National High School Student Summer Research Program. Foreward. Ethn Dis. 2007 Autumn;17 (4 Suppl 5):iv.

212. Norris K and Nissenson A. Racial Disparities in Chronic Kidney Disease: Tragedy,

Opportunity or Both? [Invited Editorial]. Clin J Am Soc Nephrol. 2008 Mar;3(2):314-316.

213. Norris K, Mehrotra R, Nissenson A. Racial Differences in Mortality and End-Stage Renal Disease. [Invited Editorial]. Am J Kid Dis. 2008 August;52(2). 205-208.

214. Norris KC, Agodoa LY. Expanding the minority biomedical pipeline--the way forward. Ethn

Dis. 2008 Spring;18(2 Suppl 1): foreward

215. Norris KC, Agodoa LY. How Long Can We Afford to Wait for Equity in the Renal Transplant Wait List? J Am Soc Nephrol. 2009 May 21. [Epub ahead of print]

216. Pugsley D, Norris KC, Garcia-Garcia G, Agodoa L. Global approaches for understanding

the disproportionate burden of chronic kidney disease. Ethn Dis. 2009 Spring;19(1 Suppl 1):S1-1-2.

217. Ferdinand KC, Norris KC. Eliminating disparities in hypertension, metabolic syndrome,

kidney failure, and cardiovascular disease: basic science, clinical practice and community initiatives. Foreword. Ethn Dis. 2009 Autumn;19(4 Suppl 5):S5iii-iv. PMID: 20073296

73

218. Norris KC, Yanagihara R, Tchounwou PB. Research from the Eleventh RCMI International Symposium on Health Disparities. Forward. Ethn Dis. 2010 Winter;20(1 Suppl 1):S1-1-2.

219. Norris KC. Creating healthy African American families. Ethn Dis. 2010 Spring;20[Suppl

2]:S2-1-s1. 220. Pugsley D, Norris KC, García-García G. CKD in disadvantaged populations: the

uncomfortable realities. Clin Nephrol. 2010 Nov;74 Suppl 1:S1-2 221. Norris KC, Kalantar-Zadeh K, Kopple JD. Survival among patients undergoing dialysis:

The Role of Race. [Invited Editorial]. Nephrol News Issues. 2011 Dec;25(13):13-4, 16. 222. Kam Kalantar-Zadeh K, Norris KC. Is Malnutrition-Inflammation Complex the Secret

behind Greater Survival of African American Dialysis Patients? [Invited Editorial]. J Am Soc Nephrol. 2011 Dec;22(12):2150-2. PMID: 22052051

223. Kalantar-Zadeh K, Kovesdy CP, Norris KC: Racial survival paradox of dialysis patients:

Robust and resilient [Invited Editorial]. Am J Kid Dis 2011.

BOOK CHAPTERS

224. Coburn JW, Norris KC, Salusky IB, Andress DL, Crooks PW, Ott SM, Hercz G, Nebeker

HG, Milliner DA, DiDominico NC, Sherrard DJ: Renal Osteodystrophy: Views on Pathogenesis and Management - 1985. In: Norman A.W., Schaefer K, Vitamin D Chemical. Biochemical and Clinical Update. deGruyter Berlin, 1985 pp 926-934

225. Coburn JW, Crooks PW, Norris KC, Andress DL, Salusky IB, Ott SM, Hercz HG, Nebeker

HG, Milliner DA, DiDomenico NC, Sherrard DJ: Parathyroid hormone, vitamin D, and Aluminum: Factors causing osteodystrophy during hemodialysis and peritoneal dialysis. In: Calciotropic Hormones and Calcium Metabolism. Edited by M Cecchettin and G. Segre. Excerpta Medica, Amsterdam, 1986 pp. 181-188

226. Salusky IB, Goodman WG, Horst R, Segre GV, Norris KC and Coburn JW: Plasma

kinetics of intravenous calcitriol in normal and dialyzed subjects and acute effect on nPTH levels. In: Norman AW, Schaefer K, Grigoleit HG, v Herrath D (ed): Vitamin D: Molecular, Cellular and Clinical Endocrinology. Walter de deGruyter & Co., Berlin, 1988 pp. 781-782

227. Salusky IB, Goodman WG, Norris KC, et al: Bioavailability of calcitriol after oral,

intravenous and intraperitoneal doses in dialysis patients. In: Norman AW, Schaefer K, Grigoleit HG, v Herrath D (ed): Vitamin D: Molecular, Cellular and Clinical Endocrinology. Walter de deGruyter & Co., Berlin, 1988 pp. 783-784.

228. Coburn JW, Norris KC: Sporadic aluminum-related bone disease: a syndrome commonly

encountered in the United States. In Catto GRD and Coburn JW (eds;) Renal Osteodystrophy 1989.

229. Norris KC and Coburn JW. Guidelines for management of a patient treated with Rocaltrol.

Excerpta Medica, Princeton, N.J., 1989.

74

230. Norris KC, Yamaguchi D, Levine BS and LLach P: Divalent ion metabolism and renal bone disease. in Gonick H (ed) Current Nephrology, Mosby Year Book, St. Louis Mo, 1990 pp 81-118.

231. Levine BS, Yamaguchi D, Norris KC and LLach P: Divalent ion metabolism and renal bone

disease. in Gonick H (ed) Current Nephrology, Mosby Year Book, St. Louis Mo, 1991 pp 57-107.

232. Coburn JW, Salusky IB, Norris KC and Goodman WG: Oral and parenteral calcitriol for the

management of end-stage renal disease. Mori H (ed) Calcium Regulating Hormones. I. Role in Disease and Aging. Basel, Karger. 1991;90:166-192.

233. Norris KC and Francis CK. Gender and ethnic differences and considerations in

cardiovascular risk assessment and prevention in African Americans. In: Wong N, Gardin JM and Black HR, Practical Strategies in Preventing Heart Disease. McGraw-Hill, New York, 2000; pp. 459-484.

234. Fong R and Norris KC. Hypertensive Crises in the Elderly. In: Yoshikawa TT and Norman

DC. Acute Emergencies and Critical Care of the Geriatric Patient. Marcel Dekker, Inc. 2000 pp. 229-242.

235. Adetola A and Norris KC. Alterations In Electrolytes And Acid-Base Homeostasis With

Aging. In: Yoshikawa TT and Norman DC. Acute Emergencies and Critical Care of the Geriatric Patient. Marcel Dekker, Inc. 2000 pp. 293-322.

236. Norris KC and Martins DS. Diagnosis and treatment of secondary hypertension. In:

Crawford MH and DiMarco JP. International Textbook of Cardiology. Mosby International Limited. 2001, Section 3, pp 10.1-10.10.

237. Martins DS and Norris KC. Diagnosis and treatment of secondary hypertension. In:

Crawford MH and DiMarco JP. International Textbook of Cardiology. Mosby International Limited. 2003, Section 3, pp 553-562.

238. Streeter O, Hylton K, Cuyjet K, Norris K. Research and Clinical Trials Involving African

Americans. In: Livingston I. Handbook of Black American Health (2nd Edition): Policies and Issues Behind Disparities in Health." The Greenwood Publishing Group, Westport Connecticut. 2004, pp 808-834.

239. Martins D, Norris K. Hypertension in African Americans. In: Livingston I. Handbook of

Black American Health (2nd Edition): Policies and Issues Behind Disparities in Health." The Greenwood Publishing Group, Westport Connecticut. 2004, pp 54-64.

240. Norris KC and Francis CK. Gender and ethnic differences and considerations in

cardiovascular risk assessment and prevention in African Americans. In: Wong N, Gardin JM and Black HR, Practical Strategies in Preventing Heart Disease. McGraw-Hill, New York, 2004. pp 415-440.

241. Connor RM, Norris KC. Smoking, substance abuse, and environmental hazards. In

Daugirdas JT. Handbook of CKD Management. Lippincott Williams and Wilkins, Philadelphia. 2011. pp 44-51.

75

242. Martins DS and Norris KC. Hypertension in African Americans. In Nephrology Secrets. Editors: Lerma EV And Nissenson AR. Elsevier Mosby, Phila, PA. 2011. pp 481-485.

243. Williams S, Artaza J, Norris K. Nutritional Genomics of Vitamin D on Cardiovascular

Disease. In: Nutritional Genomics: The Impact of Dietary Regulation of Gene Function on Human Disease. Editors: Bidlack W and Rodriguez R. CRC Press - Taylor & Francis Group; USA. 2011. pp 213-232.

BOOK CHAPTERS (IN PRESS)

244. Martins D, Norris K. Hypertension in African Americans. Current Diagnosis and Treatment

in Nephrology and Hypertension.

245. Martins DS and Norris KC. Diagnosis and treatment of secondary hypertension. In: Crawford MH and DiMarco JP. International Textbook of Cardiology. Mosby International Limited.

246. Martins DS, Vaziri ND and Norris KC. Adherence to Antihypertensive Regimens. In

Handbook on Hypertension, edited: Baliga R and Bakris G. Oxford University Press RESEARCH PAPERS - PEER REVIEWED JOURNALS (SUBMITTED) 1. Cleary SD, Norris K, Nsouli H, Puckrein G. Small-Area Analysis and Health Disparities: A Case Study of the Epidemiology and Outcomes of Treated End-Stage Renal Disease. (JASN). 2. Claudine Jurkovitz, MD, Suying Li, MS, Keith Norris, MD, Janet McGill, MD, Michael Klag, MD, Shu-Cheng Chen, PhD, Alan Collins, MD, Ajay Singh, MD, Andrew Narva, MD, William H. Herman, MD, George L. Bakris, MD, Peter A. McCullough, MD, Pablo Pergola, MD, Wendy Brown, MD. Lack of Insurance is associated with a High Prevalence of Chronic Kidney Disease: Results from the Kidney Early Evaluation Program (AJKD). 3. Tracy J. Mayne, Robert J. Rubin, Keith Norris, Richard Mutell, Mahesh Krishnan, Allen Nissenson. A Racial Case Mix Adjuster is Necessary to Avoid Increasing Racial Disparities in the Dialysis Prospective Payment System. CJASN 4. Calderón JL, Ana M. Castejón, PharmD; Sylvia Raibonet, EdD; Keith C. Norris, MD; Ron D. Hays PhD, Nisa Sangasubana, PhD. Challenges to New Community-Academic Partnering for Participatory Research: Lessons Learned from Project Diabetes LASST. 5. Miklos Z Molnar MD, PhD, Csaba P Kovesdy, MD; Suphamai Bunnapradist, MD; Elani Streja, MPH; Mahesh Krishnan, MD, MPH, MBA; Istvan Mucsi, MD, PhD; Keith C Norris, MD and Kamyar Kalantar-Zadeh, MD, MPH, PhD. African American donor race was associated with increased all-cause and cardiovascular mortality and graft loss, but not with delayed graft function (JNMA) 6. Nicholas SB, Ren Y, Kim J, Basgen JM, Mauer M, Wong J, Liu J, Norris K. Arginine-Glycine-Aspartate (RGD) Peptide Prevents Early Diabetic Nephropathy in db/db mice. J Am Soc Nephrol

76

7. Vanessa A Ravel1,2; Miklos Z Molnar, MD, PhD1,3; Elani Streja, MPH1,2; Jun Chul Kim, MD1; Alla Victoroff1,2; Jennie Jing, MS1; Mahesh Krishnan, MD, MPH, MBA4; Allen R Nissenson, MD4; Keith C Norris, MD5; Csaba P Kovesdy, MD6,7 Joel D Kopple, MD5,8; and Kamyar Kalantar-Zadeh, MD, MPH, PhD1,2,5 Surrogates of Dietary Protein Intake and Survival in 100,088 Maintenance Hemodialysis Patients. JASN 8. Indrani Sinha-Hikim,*¶ Amiya P. Sinha-Hikim,*¶Ruoqing Shen,*H Kim,† Samuel W. French,‡Nostrola D. Vazari,†Albert Crum,§Tripathi B. Rajavashisth,*¶Keith C. Norris *¶

Oxidative stress and Health Disparities. JNMA 9. Keith Norris1,2, David Martins1,2, Indrani Sinha-Hikim1, Albert Crum3, Nosratola D Vaziri5. Oxidative Stress: Implications for Reducing Racial and Ethnic Disparities in Health Outcomes. JNMA 10. Gangadarshni Chandramohan, MD MSc,1 Kamyar Kalantar-Zadeh, MD PhD,1,2 Dulcie Kermah, MSc,3 Sheena Cecille Marie Go, MD,1 Vaziri N, and Keith Norris, MD3. Relationship between obesity and pulse pressure in children: results of the national health and nutrition survey (NHANES) 1988-1994. Archives Pediatrics 11. Randall O, Kwagyan K, Greene T, Pogue V, Jamerson K, Cordin P; Norris K, Xu S, Ketete M, Retta T, Wang X, Agodoa L. An Observational Study of Intensive Blood Pressure Control on Cardiovascular Remodeling in Hypertensive Patients with Nephrosclerosis (Lancet) 12. David Martins, MD1, Nell Forge, PhD1, Loretta Jones, MA 2,1 , Kenneth Wolf, PhD 1 , D’Ann Morris, MA 3,1, Richard Baker, MD 1and Keith Norris, MD 1. Community Faculty: A Novel Model for Community-Academic Partnerships To Advance Medical Education. Academic Medicine 13. Norris K, Hui G, Halpern-Felsher B, Houseal D, McLaughlin S, Pusic K, Fleming D, Agodoa L. Short-Term Biomedical Research Education Program for Underrepresented Persons: Ten years follow-up. Academic Medicine. 14. Sandra F. Williams1, Jorge N. Artaza2,3, David Martins2,3, Keith C. Norris2,3. Vitamin D and cardiovascular disease. Nutrients 15. Norris KC. Clinical Trials and Artificial Kidneys: Adaptive and Dynamic Designs for testing new devices. NDT (invited) 16. Guofen Yan, Keith C. Norris, Alfred K. Cheung, Jennie Z. Ma, Tom Greene, M. Norman Oliver, Wei Yu. Racial disparity and regional variation across U.S. states in receipt of nephrologist care among patients with advanced chronic kidney disease. Annals Int Med 17. S. B. Nicholas, J Yuan3, K.C. Norris, A. Crum, N.D., Vaziri. Salutary effect of a novel antioxidant on adenine-induced chronic progressive tubulointerstitial nephropathy. AJN 18. Manoch Rattanasompattikul, MD1,2*; Miklos Z Molnar, MD, PhD1,3*; Joshua J Zaritsky, MD4; Parta Hatamizadeh, MD1,2; Jennie Jing, MS1; Allen R Nissenson, MD5; Keith C Norris, MD6; Csaba P Kovesdy, MD7,8; and Kamyar Kalantar-Zadeh, MD, MPH, PhD1,2,7. Association of Malnutrition-Inflammation Complex and Responsiveness to Erythropoiesis Stimulating Agents in Long-Term Hemodialysis Patients.

77

19. Vanessa A Ravel, Miklos Z Molnar, Elani Streja, Jun Chul Kim, Alla Victoroff, Jennie Jing,Mahesh Krishnan, Allen R Nissenson, Keith C Norris, Csaba P Kovesdy, Joel D Kopple, and Kamyar Kalantar-Zadeh. Surrogates of Dietary Protein Intake and Survival in 100,088 Maintenance Hemodialysis Patients. AJKD 20. David Martins, Nichole Nicholas, M. A. Shaheen, Lorreta Jones and Keith C. Norris. Development and Evaluation of a Compassion Scale. Evidence-Based Complementary and Alternative Medicine PAPERS - NON PEER REVIEWED JOURNALS (DISSEMINATION TO PROVIDERS AND/OR LAY COMMUNITY) 1. Norris KC, Coburn JW: Rocaltrol: Guidelines for Management. Dialysis and Transplantation. Supplement 1985;July:1-8. 2. Coburn JW, Norris KC: Secondary Hyperparathyroidism in a patient with chronic renal failure. In Zackson D.A. (editor), A CPC Series: Cases in Metabolic Bone Disease. Medical Projects, Inc., 1985;Vol. 1 (December). 3. Norris KC: Clinical trials with intravenous calcitriol. The Nephrology Exchange, 1991;1:19-25. 4. Norris KC. The Use of Calcitriol in Hemodialysis Patients with secondary hyperparathyroidism. The Nephrology Exchange 1996;6(2):5-11. 5. Norris KC. The treatment of renal osteodystrophy: Rebound Hyperparathyroidsm. The Nephrology Exchange 1997;7(1):12-16. 6. Owen W. Jr., Roberts J, Alexander S, Cohen D, Harmon W, Ing T, Kari J, Keen M, King Karren, Letteri J, Lundin AP, Messana A, Nardini J, Norris K, Politoski G. NKF-DOQI Clinical Practice Guidelines for Hemodialysis Adequacy. New York, National Kidney Foundation 2001; pp 1-164. 7. Norris KC. Patient’s guide to vascular access. AAKP Renalife 1998;14(1):12-13. 8. Norris KC. Improving Outcomes for African Americans with End-Stage Renal Disease. American Kidney Fund 1998;5(1):3-11. 9. Norris, KC. Toward a New Treatment Paradigm for Hyperphosphatemia. Proceedings of the Eighth Annual National Kidney Foundation Clinical Nephrology Meetings 1999;355-359. 10. Norris KC. "The Epidemic of End-Stage Renal Disease Among African Americans: Where Do We Go From Here?" AAKP Renalife 1999;14(4):5-13. 11. Norris KC. The AAKP Patient Plan. AAKP Renalife 2000;16(2):9-23. 12. Norris KC. " Cardiac calcification in renal disease – New insights into a common complication"; Contemporary Dialysis & Nephrology 2000;21:28-32. 13. Norris KC. Phosphate Binders: What are they and how do they work. AAKP Renalife 2001;16(5):15-20.

78

14. Owen W. Jr., Roberts J, Alexander S, Cohen D, Harmon W, Ing T, Kari J, Keen M, King Karren, Letteri J, Lundin AP, Messana A, Nardini J, Norris K, Politoski G. NKF-DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: 2000 Update. New York, National Kidney Foundation 2001; pp 1-114. 15. Norris KC. The Internet and Information Technology: Shaping the Future of Nephrology. Contemporary Dialysis & Nephrology 2001;22(3):30-35. 16. Norris KC. " Avoiding the Risks of Secondary Hyperparathyroidism in Chronic Renal Failure: A New Approach and a review" Dialysis & Transplantation 2001;30:355. 17. Norris KC. E-Mail Communications: Are Doctor-Patient E-Mail Communications Viable Modes of Healthcare Delivery For Dialysis patients? Nephrology Incite (web document) 4/02 http://www.ikidney.com/multinl/story.cfm?ID=299&NLID=6912 18. Norris KC. Meditation and Health. Contemporary Dialysis and Nephrology. 2002 19. Norris KC. Post dialytic nausea and vomiting. AAKP Renalife 2002;18(1):14-27. 20. Norris, KC. Kidney disease in the minority community: The Importance of Education & Screening. AAKP Renalife 2004; 19(5). 21. Norris KC. The dangers of drinking alcohol for persons with kidney disease and high blood pressure. Kidney Beginnings 2004; 3 (3), 22. Norris KC. How natural healing works. Vital Choices. August/September, 2004. 26-27. 23. Norris KC. Why Do I Have to Monitor My Protein Intake? Kidney Beginnings 2004; 4:24-29. 24. Norris KC. How do I know if I am taking proper care of my kidneys? Kidney Beginnings 2005;4,(5):

25. Williams S and Norris K. Diabetes and Your Kidneys: Taking Control. Kidney Beginnings 2007 Volume 5 No. (6), 6-7,22-23, 28. 26. Norris K. Hypertension with heart failure and CKD: Case Study. Cardioavscular Consults. University of Chicago Pritzker School of Medicine Continuing Medical Education Series. Volume 1 • Number 4 • December 2011. P 17. [2011. Management of Hypertension. Doctor’s Channel video. Link: http://vimeo.com/33347908 Password: vindico]. PAPERS IN PREPARATION (research completed, anticipated submission within three months) 1. Chandramohan G, Durham N, Norris K and Vaziri N. Effect of Novel Glutathione Precursor on Blood Pressure and Renal MC3 Receptor Expression in Dahl Rats. 2. Peter Chau, *1, Sheena cecille marie Go2, Dulcie Kermah4, Keith C. Norris, MD, FASN1,4, Kamyar Kalantar-Zadeh, MD, PhD, FASN1,2,3 and Gangadarshni Chandramohan, MD1,2,3. Vitamin D Deficiency and Cardio-Renal Risk Factors in Children:

79

3. Adam Whaley-Connell, DO, MSPH,1 Lesley Stevens, MD, MPH2, Andrew S Bomback, MD MPH3, Mike Shlipak, MD MPH4, Manjula Kurella Tamura, MD, MPH5, Georges Saab, MD6, Susanna M. Szpunar PhD7, Samy I. McFarlane, MD, MPH8, Suying Li, PhD9, Shu-Cheng Chen, MS9, Allan J. Collins, MD10 James R. Sowers, MD,1 Keith Norris, MD10, George L. Bakris, MD11, Peter A. McCullough, MD, MPH7, on behalf of the Kidney Early Evaluation Program Investigators. Awareness of Kidney Disease and Relationship to the Development of End-Stage Renal Disease and Death 4. Victor Chaban1,2, Taehoon Cho1, Chris Reed2 and Keith Norris1,2*. Physically disconnected non-diffusible cell-to-cell communication between neuroblastoma SH-SY5Y and DRG primary sensory neurons 5. Hongen Chang*, Ying Sun*, Keith C Norris†, Susanne B Nicholas†, Xiangrong Liu*, Jinyan Lin*, Xiaoyan Bai§, Meng Dai*. Establishing and Implementing Interactive. Assessment Mode for Cardiovascular Risk Factors 6. David Martins, Nichole Nicholas, Magda Shaheen, Aziza Lucas-Wright, Nell Forge, Loretta Jones and Keith Norris. The Development and Validation of a Clinical Scale for Compassion 7. Calderon J, Norris K, et al. Efficacy of Animation at Improving Diabetes Health Literacy among Immigrant Latinos 8. Calderón JL, Ana M. Castejón, PharmD; Sylvia Raibonet, EdD; Keith C. Norris, MD; Ron D. Hays PhD, Nisa Sangasubana, PhD. Challenges to New Community-Academic Partnering for Participatory Research: Lessons Learned from Project Diabetes LASST. 9. Hongen Chang, Ying Sun, Xiangrong Liu, Yuanyuan Wang, Xiaoyan Bai, Nicholas S, Norris K, Meng Dai. Establishing and Implementing Interactive Assessment Mode for Cardiovascular Risk Factors

80

ABSTRACTS 1. Norris KC, Kraut JA, Andress DL, Koffler A, Sherrard DJ, Coburn JW: Intravenous Calcitriol for Severe Secondary Hyperparathyroidism in Dialysis Patients. Kidney Internat. 27:168, 1985. 2. von Albertini B, Miller JH, Gardner PW, Norris KC, Roberts CE, Shinaberger JH: High-flux Hemodiafiltration. Kidney Internat. 27:174, 1985. 3. Norris KC, Crooks PW, Nebeker HG, Hercz G, Milliner DS, Gerzi K, Slatopolsky E, Andress DL, Sherrard DJ, Coburn JW. Clinical and laboratory features of aluminum-related bone disease: Differences between sporadic and “epidemic” forms of the syndrome. Kidney Internat 29:199, 1986. 4. Hercz G, Norris KC, Miller JH, Shinaberger JH, and Coburn JW. Aluminum removal by hemodialysis: critical comparison of dialyzer membranes. Kidney Internat 29:215, 1986. 5. Norris KC, Kraut JA, Andress DL, Agre RL, Sherrard DJ, Coburn JW: Intravenous calcitriol: effects in severe secondary hyperparathyroidism. J Bone and Mineral Research 1:374 (suppl.) 1986. 6. Coburn JW, Norris KC, Salusky IB, Kraut JA and Shinaberger JH. Management of renal osteodystrophy: 1986. Bone and Renal Insufficiency Antwerp Belgium, 1986. 7. Salusky IB, Horst R, Segre G, Goodman WG, Norris KC, Fine RN, and Coburn JW. Acute effects of calcitriol on serum levels of 1,25(0H)2D3 and PTH in uremic patients. Bone and Renal Insufficiency Antwerp Belgium, 1986. 8. Coburn JW, Norris KC, Salusky IB, Kraut JA, Shinaberger JH. Management of Renal Osteodystrophy: 1986. presented at Bone and Renal Insufficiency, Nov. 21/22, Antwerp Belgium. 9. Hercz G, Norris KC, Andress DL, Shinaberger JH, Slatopolsky E, Sherrard DJ, Coburn JW. Changes in aplastic bone disease after substitution of CaC03 for Al-Gels. Kidney Internat 31:349, 1987. 10. Robertson JA, Salusky IB, Norris KC, Coburn JW. Aluminum absorption in man: Comparison of sucralfate and aluminum hydroxide. Kidney Internat 31:215, 1987. 11. Norris KC, Wilkinson AH, Levine BS, Danovitch GM, Tourellotte WW, Coyle J, Iwamoto MM and Belendiuk GW. Renal function is not significantly changed after six months of treatment of multiple sclerosis with cyclosporine. Kidney Internat 31:211, 1987. 12. Salusky IB, R Horst, Segre G, Goodman WG, Norris KC, Fine RN and JW Coburn. Acute response of serum PTH and 1,25(0H)2D to oral, I.V. and intraperitoneal calcitriol in dialysis patients. Clin Res 35:626A, 1987. 13. Hercz G, Norris KC, Andress DL, Shinaberger JH, Slatopolsky E, Sherrard D J, Coburn JW. Improved bone formation after replacing aluminum-gels with calcium carbonate in dialysis patients with aplastic bone disease. American Association of Physicians 1987.

81

14. Klein GL, Norris KC, Forman SJ, Zala JA, Slatopolsky E, and Coburn JW. Lymphocyte function in dialysis patients given parenteral calcitriol: Failure to affect immune function. J Bone and Mineral Research 2:441 (suppl.) 1987. 15. Norris KC, Kraut JA, Andress DL, Agre KL, Sherrard DJ and Coburn JW. Use of intravenous calcitriol for treating severe secondary hyperparathyroidism. Xth International Congress of Nephrology, p. 440, 1987. 16. Norris KC, Wilkinson AH, Levine BS, Danovitch GM, Tourellotte WW, Coyle J, Iwamoto MM and Belendiuk GW. Renal function is unaltered following six months of treatment of multiple sclerosis with cyclosporine. Xth International Congress of Nephrology p. 81, 1987. 17. Robertson JA , Salusky IB, Goodman WA, Norris KC, and Coburn JW. Inhibition of aluminum absorption by ranitidine: probable role of gastric pH. Xth International Society of Nephrology, p. 442, 1987. 18. Levine BS, Kert CJ, Sico CP, Norris KC, and Muallem S. Free cytosolic calcium in platelets: a comparison of Fura 2 versus Quin 2. Kid Int 33:300, 1988. 19. Norris KC, Kert CJ, Muallem S, and Levine BS. Platelet cytosolic calcium in essential hypertension: Quin 2 versus Fura 2. Kid Int 33: 303, 1988. 20. Goodman WG, Salusky IB, Horst R, Segre G, Norris KC, and Coburn JW. Intravenous calcitriol: Plasma kinetics and acute effect on serum PTH in normal and dialyzed subjects. Kid Int 33:339, 1988. 21. Salusky IB, Goodman WG, Norris KC, Horst R, Fine RN, and Coburn JW. Bioavailability of calcitriol: Comparison of intravenous and intraperitoneal routes of administration in CAPD patients. Kid Int 33:250, 1988. 22. Salusky IB, Goodman WG, Horst R, Segre G, Norris KC, and Coburn JW. Intravenous calcitriol: Plasma kinetics of intravenous calcitriol in normal and dialyzed subjects and acute effect on serum nPTH levels. 7th Workshop of Vit D, Rancho Mirage, CA, April 4/24-28, p. 186, 1988. 23. Coburn JW, Robertson JA, Norris KC, Salusky IB and Goodman WG. The effect of ranitidine on aluminum absorption in man. Kid Int 35:398 1988. 24. Norris KC, Sherrard DJ, Maloney N, Slatopolsky E and Coburn JW. Renal Osteodystrophy: Distinguishing osteitis fibrosa from aluminum bone disease by non-invasive means. Bone and Mineral Research 4: , 1989. 25. Norris KC, Nemeh M, Hercz G, Nikhatar B, and Levine BS. Urinary calcium excretion in essential hypertension: The effect of 1,25 dihydroxyvitamin D3. Bone and Mineral Research 4: 1989. 26. Norris KC, Sherrard DJ, Slatopolsky E and Coburn JW. Diagnosis of renal osteodystrophy from non-invasive parameters. Kid Int , 1990. 27. Norris KC, Sherrard DJ, Slatopolsky E and Coburn JW. Symptomatic renal disease: non-invasive parameters for diagnosis. XIth International Congress of Nephrology, 1990.

82

28. Norris KC: Early Renal Failure in Diabetic and Hypertensive Nephropathy. National Medical Association, August 7-12, 1990. 29. Norris KC, Slatopolsky E, Sherrard DJ and Coburn JW. Changing spectrum of renal osteodystrophy: Is aluminum-bone disease disappearing and osteitis fibrosa more prevalent? XIth. International Congress of Nephrology, 1990. 30. Norris KC, Andress DL, Slatopolsky E, Sherrard DJ and Coburn JW: Long-term parenteral calcitriol in dialysis patients with severe secondary hyperparathyroidism. Renal Bone Disease, PTH and Vitamin D Symposium (Singapore), July 22-25, 1990. 31. Norris KC, Ward H: Hypertension, Substance Abuse and Renal Failure: An Inner City Dilemma. National Medical Association (San Antonio, Texas), August 7-12, 1993. 32. Norris KC: Acute Renal Failure in the Critical Care Setting. National Medical Association (San Antonio, Texas), August 7-12, 1993. 33. Norris KC: Renal Effects of Hyperuricemia. National Medical Association (San Antonio, Texas), August 7-12, 1993. 34. Witana SC, Norris KC, and Fisher C: Plasmapharesis for the Treatment of Severe Hypertriglyceridemia in a Patient with Diabetes Mellitus. American College Physicians; Orlando, Florida April, 1994 35. Witana SC, Norris KC, and Ward HJ: Substance Abuse: A Common Cause of Renal Failure in Inner City African-Americans. American College Physicians; Orlando, Florida April, 1994 36. Asuncion M, Norris KC, and Miller R: Marked Eosinophilia in a Young African-American Man who Uses Cocaine. American College Physicians; Orlando, Florida April, 1994 37. Asuncion M, Norris KC, and Antillion M: Hepatic Failure in a Woman with Graves Disease Treated with Propylthiouracil. American College Physicians; Orlando, Florida April, 1994 38. Thornhill-Joynes M, Norris KC, Witana SC, Ward HJ, & Barbour B. The impact of substance abuse on hypertensive end-stage renal disease in inner city African-Americans. J Am Soc Nephrol. 5:342, 1994. 39. Breyer JA, Toto RD, Hall WD, Norris KC, Massry SG for the AASK Pilot Study Investigators: Baseline characteristics of patients entering the pilot African-American Study of Kidney Disease (Pilot-AASK). J Am Soc Nephrol. 5:557, 1994. 40. Lee J, Bernhard S, Douglas, Greene P, Kusek J, Norris KC, Whelton P for the AASK Pilot Study Investigators: Assessing medication adherence in the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. 1995 Annual Meeting of the Society of Clinical Trials. 41. Abisuga O, Marsoobian VS, Grim CE, Norris KC. Low dietary sodium counseling in the management of salt sensitive hypertension in African Americans. International Society of Hypertension in Blacks, St. Thomas, U.S. Virgin Islands; June 24-29,1995.

83

42. Abisuga O, Marsoobian VS, Grim CE, Norris KC. Frequency of salt sensitive hypertension in African Americans in a random study; reliability of 24 hr. urine sodium in comparison to 24 FRR in clinical study; and correlation of blood pressure to 24 hr urine sodium. Inter-American Society of Hypertension, Montreal Canada, June 1995. 43. Abisuga O, Grim CE, Marsoobian VS, Norris KC. Most hypertensive African Americans are salt sensitive and many become normotensive after only three weeks of a 80mM sodium diet. American Heart Association, New Orleans, U.S.A., Sept. 19-22, 1995. 44. Ward H, Grim CE, Norris KC, Abisuga O, Wu Y, Vadgama J. Atrial Natriuretic peptide levels correlates with Blood Pressure and Salt Sensitive Hypertension in African Americans. J Am Soc Nephrol. 6:653, 1995. 45. Ward HJ, Grim C, Norris K, Abisuga O, Wu Y, Fong R, Vadgama JV. Atrial Natriuretic Peptide Levels Correlate with Salt-Sensitive Hypertension and Volume Expansion in African-Americans. The American Journal of Hypertension., April 25-28, 1996 46. Ganesan K, Norris KC. Prevalence of Estrogen Replacement Therapy (ERT) in an inner city Minority Elderly Population. Gerontological Society of America, 1996. 47. Ganesan K, Norris KC. The role of cardiovascular risk in influencing estrogen replacement therapy in postmenopausal minority patients. International Congress of Gerontological, August 1997 48. Cheek D, Bourgoignie, Cleveland W, Kusek J, Norris K and Wang SR. Blood pressure screenees for the African American study of kidney disease and hypertension (AASK). American Society of Hypertension, 1997 49. RS Gavino, SJ Rothenberg, FA Khan, M Manalo, AC Todd and KC Norris. The relationship of blood and bone lead to blood pressure in African American men. Environmental Health & Toxicology Research Symposium Program, New Orleans, LA. April 1997. 50. A. Easley and K. Norris. The changing demographics of end-stage renal disease: the Southern California experience. Ethnicity and Disease 7:1 (supplement), S33, 1997 51. M. Anderson, M. Thornhill-Joynes, A. Jones, G. Hercz and K. Norris. Geographic Variations in Hypertension Related End-Stage Renal Disease Among Black and White Patients. Ethnicity and Disease 7:1 (supplement), S21, 1997 52. RS Gavino, SJ Rothenberg, FA Khan, M Manalo, AC Todd and KC Norris. The relationship of blood and bone lead to blood pressure in African American men. Ethnicity and Disease 7:1 (supplement), S11, 1997 53. HY Peters, RL Fong, S Clare, D Martins, and KC Norris. Comparison of automated versus standard blood pressure measurements in a geriatric population. Ethnicity and Disease 7:1 (supplement), S54, 1997 54. J. Akanno, C. Haney, H Meyers, V Kaushik, C Alexander, R Schneider & K Norris. Baseline characteristics of patients in the “stress reduction and education in the control of hypertension study. Ethnicity and Disease 7:1 (supplement), S17, 1997

84

55. Ojeilo C, Asuncion M, Norris, KC, Kaushik V. Angiographic characteristics of patients admitted with cocaine-associated chest pain. UCLA Solomon Scholars Resident Research Program, # 19, 1997. 56. Fong RL, Norris KC, Pan D, Ward HJ. The correlation between renal function and age-related changes in blood pressure. 1998, American Society of Hypertension 57. Pradhan R, Fong D, RezapourG, Scott C, and Norris KC. Effect of angiotensin converting enzyme inhibition on diabetic retinopathy. (Ethnicity and Disease 8:2; 271, 1998) 58. Olelewe S, Peters HY, Villela AL, Stokes CJ, Smith NC, and Norris KC. A patient targeted high blood pressure survey: results of testing among health care professionals. Ethnicity and Disease 8:2; 271, 1998 59. Robinson C, Bhasin V, Norris K, Kelly P. Dermatologic indicators of coronary artery disease Ethnicity and Disease 8:2; 270, 1998 60. Fong RL, Norris KC, Pan D, Ward HJ. The correlation between renal function and age-related changes in blood pressure in an inner city minority population. Ethnicity and Disease 8:2; 265, 1998 61. Jamerson K, Gassman J, Greene P, Hiremath L, Kusek J, Norris K, Thornley-Brown D, and the AASK Study Group. African Americans have high rates of adherence to therapy in a clinical trial. Ethnicity and Disease 8:2; 274, 1998 62. Phillips R, Faulkner M, Gassman J, Kusek JW, Norris K, Thompson R, Thornley-Brown, and the AASK Study Group: Recruitment in the African-American Study of Kidney Disease and Hypertension. American Society of Nephrology, 1998. 63. Tareen N, Fong RL, Pan D, Martins D, Norris KC. Presenting Clinical Characteristics of Older and Younger Patients with Hypertensive Emergencies. RCMI Program Directors Mtg 3/99 64. Martins D, Fong RL, Pan D, Khan H, Norris KC. Epidemiology of Hypertensive Crises in the Elderly. RCMI Program Directors Mtg 3/99 65. Adetola A, Pan D, Martins D, Norris KC. Magnitude of Acid-base and Electrolyte Disorders in the Elderly. RCMI Program Directors Mtg 3/99 66. Robinson C, Flowers CW, Alperson BL, Norris KC. Urban Telemedicine: Challenges for the Disadvantaged and Elderly. RCMI Program Directors Mtg 3/99 67. Fong RL, Martin D, Pan D, Tareen N, Norris KC. The Vascular Overload Index versus Mean Arterial Pressure: Implications for Treating Older Patients with Hypertensive Emergencies. RCMI Program Directors Mtg 3/99 68. Fong RL, Martins D, Pan D, Tareen N, Norris KC. The Vascular Overload Index Versus Mean Arterial Pressure: Implications For Treating Older Patients With Hypertensive Emergencies. Ethnicity and Disease 9:2; 315, 1999

85

69. Tareen N, Fong RL, Martin D, Pan D, Norris KC. The Vascular Overload Index versus Mean Arterial Pressure: Implications for Treating Hypertensive Emergencies in Aging Populations. UCLA Soloman Scholars Resident Research Forum 5/99 (Oral Presentation) 70. Tareen N, Fong RL, Pan D, Martins D, Norris KC. Age-Related Clinical Characteristics of Patients With Hypertensive Emergencies. Ethnicity and Disease 9:2; 315, 1999 71. Asuncion M, Ojielo C, Kaushik V, Norris KC. Angiographic Features Of Patients With Cocaine-Associated Chest Pain. Ethnicity and Disease 9:2; 314, 1999 72. Martins D, Fong RL, Pan D, Khan H, Norris KC. Hypertensive Crises In The Elderly: An Epidemiologic analysis. Ethnicity and Disease 9:2; 316, 1999 73. Adetola, A; Pan, D; Martins, D; and Norris, K.C.: Magnitude of acid-base and electrolyte disorders in the elderly. Ethnicity & Disease.1999;9:479. 74. Fong RL, Norris KC, Pan D, Ward HJ. Pulse Pressure is a better predictor of risk for progressive renal disease. J Am Soc Nephrol 1999:10:163A. 75. Martins D, Pan D, Karami N, Das D, Norris KC. The Relationship between Body Weight and the Prevalence of Isolated Systolic Hypertension in Subjects 55 Years and Older: Ethn Dis.2000:10:307. 76. Norris KC, Pan D, Owen WF. Risk Factors for Early Renal Disease in Special Populations. Ethn Dis 2000:10:310. 77. Martins D, Pan D, Tareen N and Norris KC. Isolated Systolic Hypertension and Body Mass Index in Older Subjects. (RCMI Conference on Health Disparities, November 2000) 78. Norris KC, Martins D, Klassen P, Pan D, Owen WF. Risk Factors for Early Renal Disease. (RCMI Conference on Health Disparities, November 2000) 79. Nelson, K Norris K, Mangione CM. Disparities in the diagnosis and treatment of high blood cholesterol by race and ethnicity. Data from NHANES III. Submitted to Society of General Internal Medicine 80. Martins, D, Tareen, N, Pan, D, and Norris, K. Body Mass Index and Pulse Pressure in Older Adults with Isolated Systolic Hypertension. American Society of Hypertension May 2001. 81. Norris K, Agodoa L, Douglas M, Gayle R, Greene T, Lea J, Wright J from the African American Study of Kidney Disease in Hypertension (AASK) Study. Renal Outcome Differences Between ACE Inhibitor and Dihydropyridine Calcium Antagonist Based Treatment of Hypertensive Renal Disease. (International society of Hypertension in Blacks Meeting, June 2001) 82. K Nelson, K Norris, CM Mangione. Disparities in the diagnosis and treatment of high blood cholesterol by race and ethnicity. Data from Third National Health and Nutrition Examination Survey (NHANES III). (International society of Hypertension in Blacks Meeting, June 2001) 83. Norris K, Agodoa L, Douglas M, Gayle R, Greene T, Lea J, Wright J and the AASK Study Group. Differences in Renal Outcomes Between ACE Inhibitor (ACEI) and Dihydropyridine

86

Calcium Channel Blocker (DHPCCB) Persist After Adjustment for Blood Pressure (BP) and Add-On Drugs for Hypertensive Kidney Disease. (American Society of Nephrology. San Francisco, 2001) 84. K Nelson, K Norris, CM Mangione Disparities in the Diagnosis and Treatment of High Blood Cholesterol by Race and Ethnicity. Data from NHANES III. Academy for Health Services Research and Health Policy. June 2001, Atlanta, GA. [http://www.academyhealth.org/abstracts/2001/access/nelson.htm] 85. Yan M, Floreza A, Joaquin A, Norris K. Use of ACE inhibitors modifies mortality in ESRD patients. (International Society of Hypertension in Blacks Meeting, June 2002) 86. Yan M, Floreza A, Joaquin A, Tareen N, Norris K. Association of ACE inhibitors and mortality in ESRD patients J. Am. Soc. Nephrol. 13, 444 (2002) 87. Martins DS, Tareen N, Pan D and Norris KC. The Relationship Between Body Mass Index, Hypertension and Resting Pulse Rate. (oral presentation: Eighth RCMI International Symposium on Health Disparities, Honolulu, Hawaii, 12/02) 88. Norris K, Bourgoigne J, Gassman J, Hebert L, Middleton J, Phillips R, Randall O, Rostand S, Sherer S, Toto R, Wright J, Wang X, Lewis J. Cardiovascular outcomes in the African American (AA) Study of Hypertension and Kidney Disease (AASK). J Am S Neph 2003 Nov;14:673A. 89. Norris K, Greene T, Kopple J, Lea J, Lewis J, Lipkowitz M, Miller P, Richardson A, Rostand S, Wang X. Baseline predictors of renal disease progression in the African American (AA) Study of Hypertension and Kidney Disease (AASK). J Am S Neph 2003 Nov;14:190A. 90. Mehrotra R, Budoff M, Christenson P, Ipp E, Norris K, Gupta A, Takasu J, and Adler S: Effect of Nephropathy, independent of disordered mineral metabolism, on Coronary Artery Calcification (CAC) in Type 2 Diabetes. J Am S Neph 2003 Nov;14:692A. 91. JL Calderón, A Zadshir, KC Norris. A survey of the readability of kidney disease information on the world-wide web. (ISN Satellite conference, Prevention of Kidney Disease in Minority Groups and Emerging Nations- Focus on the Americas, November 17-20, 2003 Ensenada, Baja California, Mexico) 92. Tareen N, Martins D, Pan D, Zadshir A, Norris K. The effect of socioeconomic status on the prevalence of proteinuria: data from the third national health and nutrition examination (NHANES III) survey. (ISN Satellite conference, Prevention of Kidney Disease in Minority Groups and Emerging Nations- Focus on the Americas, November 17-20, 2003 Ensenada, Baja California, Mexico) 93. Peter A. McCullough, MD, MPH, Wendy Brown, MD, Janet McGill, MD, Alan Collins, MD, Shu-Cheng Chen, PhD, Ajay Singh, MD, Andrew Narva, MD, William Hermann, MD, George L. Bakris, MD, Claudine Jurkovitz, MD, Keith Norris, MD, Pablo Pergola, MD, Michael Klag, MD. Independent Components of Chronic Kidney Disease as a Cardiovascular Risk Factor: Results from the Kidney Early Evaluation Program (KEEP). American Heart Association, 2004 94. Claudine Jurkovitz, Keith Norris, Suying Lee, Shu-Cheng Shen, Janet McGill, William Herman, Peter McCullough, Andrew Narva, Pablo Pergola, Ajay Singh, George Bakris, Michael

87

Klag, Allan Collins, Wendy Brown. Does obesity modify the association between hypertension and race? An analysis of the national kidney foundation kidney early evaluation program (KEEP) population. CDC Prevention Conference, 2004 95. Peter A. McCullough, MD, MPH, Wendy Brown, MD, Janet McGill, MD, Alan Collins, MD, Shu-Cheng Chen, PhD, Suying Li, MS, Ajay Singh, MD, Andrew Narva, MD, William H. Herman, MD, MPH, George L. Bakris, MD, Claudine Jurkovitz, MD, Keith Norris, MD, Pablo Pergola, MD, Michael Klag, MD. Independent Components of Chronic Kidney Disease as a Cardiovascular Risk Factor: Results from the Kidney Early Evaluation Program (KEEP) (ASN 2004) 96. Peter A. McCullough, MD, MPH, Michael Klag, MD, Janet McGill, MD, Alan Collins, MD, Shu-Cheng Chen, PhD, Suying Li, MS, Ajay Singh, MD, Andrew Narva, MD, William H. Herman, MD, MPH, George L. Bakris, MD, Claudine Jurkovitz, MD, Keith Norris, MD, Pablo Pergola, MD, Wendy Brown, MD. Age Over 30 Becomes a Cardiovascular Risk Factor in Patients Screened for Chronic Kidney Disease: Results from the Kidney Early Evaluation Program (KEEP) (ASN 2004) 97. Ajay Singh, MD, Janet McGill, MD, Peter A. McCullough, MD, MPH, Wendy Brown, MD, Alan Collins, MD, Shu-Cheng Chen, MS, Suying Li, MS, Sarbani Bhaduri, MD, Andrew Narva, MD, William H. Herman, MD, MPH, George L. Bakris, MD, Claudine Jurkovitz, MD, Keith Norris, MD, Pablo Pergola, MD, Michael Klag, MD. Pre-Menopausal and Elderly Women with Renal Disease at Highest Risk of Anemia in a Large Community Screening Program: Results of the NKF Kidney Early Evaluation Program (KEEP) Study. (ASN 2004) 98. Ajay Singh, MB, Janet McGill, MD, Peter A. McCullough, MD, MPH, Wendy Brown, MD, Alan Collins, MD, Shu-Cheng Chen, MS, Suying Li, MS, Andrew Narva, MD, William H. Herman, MD, MPH, George L. Bakris, MD, Claudine Jurkovitz, MD, Keith Norris, MD, Pablo Pergola, MD, and Michael Klag, MD. Advanced Stages of Chronic Kidney Disease (CKD) Detected Among Screened Individuals with Diabetes Mellitus, Undiagnosed Diabetes, and Mildly Elevated Glucose Values: Results from the NKF Kidney Early Evaluation Program (KEEP) Study (ASN 2004) 99. Ajay Singh, MD, Janet McGill, MD, Peter A. McCullough, MD, MPH, Wendy Brown, MD, Alan Collins, MD, Shu-Cheng Chen, MS, Suying Li, MS, Andrew Narva, MD, William H. Herman, MD, MPH, George L. Bakris, MD, Claudine Jurkovitz, MD, Keith Norris, MD, Pablo Pergola, MD, Michael Klag, MD. Glycemic Control among KEEP participants with Self Reported Diabetes and Mildly Elevated Glucose Values: Results from the NKF Kidney Early Evaluation Program (KEEP) Study (ASN 2004) 100. Claudine Jurkovitz, MD, Suying Li, MS, Keith Norris, MD, Janet McGill, MD, Michael Klag, MD, Shu-Cheng Chen, PhD, Alan Collins, MD, Ajay Singh, MD, Andrew Narva, MD, William H. Herman, MD, George L. Bakris, MD, Peter A. McCullough, MD, Pablo Pergola, MD, Wendy Brown, MD. Family History Of Kidney Disease: A Risk Factor For Obesity? Analysis Of The Kidney Early Evaluation Program (ASN 2004) 101. K. Norris, J. Lindberg, L. Garrett, J.Roman-Latorre, P. Qiu, L. William5, F. Liach. Achievement of NKF-K/DOQITM Bone Metabolism and Disease Targets with Paricalcitol (Zemplar®) Therapy (ASN 2004)

88

102. Otelio Randall, John Kwagyan, Tom Greene, Velvie Pogue, Kenneth Jamison, Keith Norris, Shichen Xu, Xuelei Wang, Lawrence Agodoa. The Impact of Pulse Pressure on Target Organ Function in African-Americans With Nondiabetic Kidney Diseases. 58th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research in association with the Council on the Kidney in Cardiovascular Disease. Chicago, IL, October 9 - 12, 2004. 103. L. Jones, A. Wright, K. Norris, K. Wells. Witness for Wellness: Increasing Community Awareness of Depression in Los Angeles. American Public Health Association 132nd Annual Meeting - November 6-10, 2004 104. A. Wright, L. Jones, K. Norris, R. Bluthenthal. Witness for Wellness: A Synergistic Approach to Address Depression in Communities of Color in Los Angeles – 90139. American Public Health Association 132nd Annual Meeting - November 6-10, 2004 105. R. Bluthenthal, M.A. Ellison, P. Koegel , L. Jones, K. Norris, K. Wells. Witness for Wellness: Evaluation of a Community-University Participatory Research Initiative on Depression 90148. American Public Health Association 132nd Annual Meeting - November 6-10, 2004 106. Kalpana Ganesan, Deyu Pan, Senait Teklehaimanot, Merlyn Asuncion & Keith Norris. Predictors of Disposition of Hip Fracture Patients to Extended Care Facilities. RCMI RCMI 9th International Symposium on Health Disparities Dec 8-11, Baltimore, MD December 2004. 107. K Ganesan, S Teklehaimanot, T Tran, Merlyn Asuncion, Keith Norris. Relationship of C-Reactive Protein and Bone Mineral Density in Community Dwelling Elderly Females. RCMI 9th International Symposium on Health Disparities Dec 8-11, Baltimore, MD December 2004. 108. Sarkisian CA, Brusuelas RJ, Steers WN, Davidson MB, Brown AF, Norris KC, Anderson RM, Mangione CM. Using focus groups of older African Americans and Latinos with diabetes to modify a self-care empowerment intervention. JGIM Supplement 2004;19:234 109. D. Martins, M. Yan, A. Joaquin, A. Floreza, N. Taureen, K. Norris. The Use of Angiotensin Converting Enzyme Inhibitors (ACEI) and Mortality in End-Stage Renal Disease (ESRD) Patients. RCMI 9th International Symposium on Health Disparities Dec 8-11, Baltimore, MD December 2004. 110. M. Cottrell, D. Martins, D. Pan, S. Williams, K. Norris. The Relationship of 25-Vitamin D (25-D) levels and Glomerular Filtration Rate (GFR) by Race and Ethnicity: Data from the third National Health & Nutrition Examination Survey (NHANES III). RCMI 9th International Symposium on Health Disparities Dec 8-11, Baltimore, MD December 2004. 111. Zadshir A, Martins D, Tareen N, Pan D, Norris KC. The impact of vitamin D supplementation on serum levels of 25 (OH) D3 among adult patients with chronic kidney disease. RCMI 9th International Symposium on Health Disparities Dec 8-11, Baltimore, MD December 2004. 112. Tareen N, Zadshir A, Martins D, Pan D, Vargas R, Nissenson A, Norris KC. The Effect of Poverty and Education on the Prevalence of Albuminuria: Data from the Third National Health and Nutrition Examination (NHANES III) Survey. RCMI 9th International Symposium on Health Disparities Dec 8-11, Baltimore, MD December 2004.

89

113. Martins D, Zadshir A, Dhamija R, Tareen N, Pan D, Norris KC. Low levels of serum 25 (OH) D3 are associated with high prevalence of cardiovascular risks factors across race and ethnicity: Data from NHANES III. RCMI 9th International Symposium on Health Disparities Dec 8-11, Baltimore, MD December 2004. 114. Tareen N, Zadshir A, Martins D, Pan D, Norris KC. Association Between low levels of 25(OH) D3 and the Prevalence of Cardiovascular Risk Factor Among White American Adults using NHANES III. RCMI 9th International Symposium on Health Disparities Dec 8-11, Baltimore, MD December 2004. 115. José L. Calderón, Erik Fleming, Keith Norris, Roseann Harrigan, José Conde, MaBustillo, Jin-mann Lin, José Torres, Rhonda Belu, David Grandison, Pamela Daniels. Minority Involvement in Clinical Research Opportunities-Project MICRO. RCMI 9th International Symposium on Health Disparities Dec 8-11, Baltimore, MD December 2004. 116. D. Pan, R.S. Baker, K. Norris. Association of Blood Lead and Chronic Kidney Disease in the US Population: Results from Current NHANES. RCMI 9th International Symposium on Health Disparities Dec 8-11, Baltimore, MD December 2004. 117. D Martins, M Wolf, R Dhamija, A Zadshir, N Tareen, D Pan, B Levine, KC Norris. Relationship of low serum 25 (OH) D3 levels and the prevalence of cardiovascular risk factors by race and ethnicity: Data from NHANES III. World Congress of Nephrology, Singapore June 26-30, 2005. 118. N Tareen, A Zadshir, M Wolf, R Dhamija, D Pan, B Levine, KC Norris, D Martins. Cardiovascular risk factors and 25(OH) D3 levels among white American adults: Data from NHANES III. World Congress of Nephrology, Singapore June 26-30, 2005. 119. M. Cottrell. S. Williams, D. Martins, D. Pan, K. Norris. 25-Vitamin D (25-D) And Glomerular Filtration Rate (GFR): Data from the Third National Health & Nutrition Examination Survey (NHANES III). World Congress of Nephrology, Singapore June 26-30, 2005. 120. Nilka Rios Burrows, MPH, Claudine Jurkovitz, MD, MPH, Andrew Narva, MD, Suying Li, MS, Keith Norris, MD, Janet McGill, MD, George Bakris, MD, Shu-Cheng Chen, MS, Pablo Pergola, MD, Peter McCullough, MD, MPH, Ajay Singh, MD, Michael Klag, MD, MPH, Allan Collins, MD and Wendy Brown, MD, MPH. Early Kidney Disease is more Prevalent in African and Native Americans: National Kidney Foundation Kidney Early Evaluation Program (KEEP) Results. (2005 ASN). 121. Claudine Jurkovitz, MD, MPH, Harold Franch, MD, Keith Norris, MD and Nancy Kutner, PhD. Effect of Body Mass Index Level on the Association between Race and Risk of Death in Incident Hemodialysis Patients: Results from the Dialysis Morbidity and Mortality Wave 2 Survey. (2005 ASN). 122. Mangione CM, Seifu M, Steers WN, Brown AF, Brusuelas RJ, Norris K, Davidson M, Anderson RM, Seeman T, Sarkisian C. Self-efficacy and participation in diabetes self-care among Older African-Americans and Latinos. SIGM 29

th Annual Meeting, 2005.

123. Brown AF, Goodman E, Steers WN, Brusuelas RJ, Sarkisian C, Norris K, Davidson M, Anderson RM, Mangione C. Use of evidence based therapies in a community-based sample of

90

older African-Americans and Latinos with diabetes. SIGM 29th

Annual Meeting, 2005. 124. O. Kenrik Duru, Claudine Jurkovitz, Andrew Narva, Janet McGill, George Bakris, Shu-Cheng Chen, Suying Li, Pablo Pergola, Peter McCullough, Ajay Singh, Michael Klag, Allan Collins, Wendy Brown, Keith Norris. Racial And Gender Differences In Hypertension Control In Chronic Kidney Disease: Results From The Kidney Early Evaluation Program (KEEP). NKF Spring Clinical Meeting April 19-23, 2006. 125. D. Ganz, S. Ettner, N. Steers, A. Brown, C. Sarkisian, M. Davidson, K. Norris, M. Funnell, R. Anderson, C. Mangione. Economic Evaluation Of A Community-Based Participatory Research Intervention To Improve Self-Management Of Diabetes. Accepted, RWJ Clinical Scholars Program, Nov 2006 Mtg 126. Mehrotra R, Kermah D, Fried L, Adler SA, Norris K. Racial Disparities in Mortality Outcomes in Chronic Kidney Disease (CKD). (ASN Nov 2006) 127. Mehrotra R, Salusky I, Norris K, Budoff M, and Adler S. 25 hydroxy vitamin D (25-OH-D) deficiency, bone mineral density (BMD) and coronary artery calcification (CAC) in non-dialyzed diabetic chronic kidney disease (CKD). (ASN Nov 2006) 128. Mehrotra R, Kermah D, Fried L, Kalantar K, Norris K, Nissenson A. Declining Utilization and Improving Outcomes of Chronic Peritoneal Dialysis (CPD) in US. (ASN Nov 2006) 129. Claudine Jurkovitz, Suying Li, George Bakris, Wendy Brown, Peter McCullough, Joseph Vassalotti, Janet McGill, Ajay Singh, Keith Norris. Effect of Obesity on Mortality in Patients at High Risk for Kidney Disease: Results from KEEP. (KEEP). (ASN Nov 2006) 130. Lawrence J. Appel, MD, MPH, G. Bakris, F. Gabbai, G. Gassman, T. Greene, J. Kopple, J. Kusek, M. Lipkowitz, K Norris, M. Rahman, S. Rostand, G. Shulman, X. Wang, J. Wright. Relentless Progression Of Hypertensive Chronic Kidney Disease Despite Excellent Blood Pressure (BP) Control And Use Of Angiotensin Converting Enzyme Inhibitor Therapy (ACEI): Results From The African-American Study Of Kidney Disease And Hypertension (AASK) Cohort Study. (ASN Nov 2006) 131. G. Chandramohan, N. Durham, R. Mei, K. Norris, ND. Vaziri. Renal Melanocortin 3 Receptor Expression and Synthesis in Dahl Salt Sensitive Rat. (ASN Nov 2006) 132. G. Chandramohan, Y. Bai, K. Norris, N.D. Vaziri. Differential Effects of High-Salt Diet on Renal Expressions of AT1 receptor, NAD(P)H Oxidase, COX1, COX2, SOD, GPX, MCP-1 and PAI-1 in Salt-Sensitive and -Resistant Rats. (ASN Nov 2006) 133. C. Mangione, A. Brown, C. Sarkisian, Brusuelas R, K. Norris, N. Steers, M. Davidson, S. Ettner, D. Ganz, M. Funnell, R. Anderson. Randomized Community-Based Intervention To Improve Self-Management Of Diabetes Among Older African Americans And Latinos. SGIM 30th Annual Meeting, 2007. 134. Khawar O, Kermah D, Fried L, Kalantar K, Norris K, Nissenson A and Mehrotra R. Improving chronic peritoneal dialysis (CPD) Outcomes but Unchanged Maintenance hemodialysis (MHD) Outcomes in United States (Internat Soc Peritoneal Dialysis – Ft. Lauderdale, Florida June 2-4, 2007)

91

135. Osman Khawar, Dulcie Kermah, Linda Fired, Kamyar Kalantar-Zadeh, Keith Norris, Allen Nissenson, Rajnish Mehrotra. Improving Chronic Peritoneal Dialysis (CPD) Outcomes but Unchanged Maintenance Hemodialysis (MHD) Outcomes in United States. ASN Nov 1-5, 2007, San Francisco, CA. 136. Rajnish Mehrotra, Dulcie Kermah, Keith Norris. Hypovitaminosis D and Chronic Kidney Disease. ASN Nov 1-5, 2007, San Francisco, CA. 137. Stacey Jolly, Claudine Jurkovitz, Keith Norris, Michael Shlipak. Risk Factors for CKD among American Indian and Alaska Natives. ASN Nov 1-5, 2007, San Francisco, CA. 138. Claudine Jurkovitz, Suying Li, Keith Norris, KEEP Investigators Progression of Kidney Disease in Hispanic Patients: Results from KEEP. ASN Nov 1-5, 2007, San Francisco, CA. 139. Debra Lotstein, Molly Maidenberg, Roberto Vargas, Keith Norris. Perspectives on the Transition to Adulthood for Hispanic Youth with ESRD. ASN Nov 1-5, 2007, San Francisco, CA. 140. Artaza JN and Norris KC. 1α, 25-(OH)2D3 inhibits cell proliferation and promotes cell cycle arrest without inducing apoptosis in C3H 10T1/2 multipotent cells. American Federation for Medical Research 2008 Western Regional Meeting, January 30 - February 2, 2008 Carmel, California. 141. Artaza JN and Norris KC. 1a, 25-(OH)2D3 promotes the adipogenic commitment and an anti-fibrotic phenotype in C3H 10T1/2 mesenchymal multipotent cells. American Federation for Medical Research 2008 Western Regional Meeting, January 30 - February 2, 2008 Carmel, California. 142. Sinha-Hikim I, Shen R, Lee P, Crum A, Norris K. Evaluation of Glutathione Precursors in Modifying Metabolic and Cellular Response to Increased Oxidative Stress. American Federation for Medical Research 2008 Western Regional Meeting, January 30 - February 2, 2008 Carmel, California. 143. Peter A. McCullough, MD, MPH, FACC,1 Suying Li, PhD,2 Claudine T. Jurkovitz, MD,3 Lesley A. Stevens, MD,4 Changchun Wang, MS,2 Allan J. Collins, MD,2 Shu-Cheng Chen, MS,2 Keith C. Norris, MD,5 Samy McFarlane, MD,6 Bruce Johnson, MD,7 Michael G. Shlipak, MD,8 Chamberlain I. Obialo, MD,9 Wendy W. Brown, MD,10 Joseph A. Vassalotti, MD,11 Adam T. Whaley-Connell, MD,12 on Behalf of the KEEP Investigators. Chronic Kidney Disease and Cardiovascular Disease in Volunteer and Randomly Selected Populations: KEEP and NHANES. NKF Clinical meeting. Dallas, Tx. April 2008. 144. Artaza JN and Norris KC. 1a,25−(OH)2D3 (1,25D) Inhibits Cell Proliferation and Promotes an Anti−Fibrotic/Anti−Inflammatory Phenotype in Mesenchymal Multipotent Cells. Poster presentation - June 17, 2008; Endocrine Society Meetings, San Francisco, CA 145. Mehrotra R, Kermah D, Salusky I, Wolf M, Thadhani R, Martins D, Adler S, Norris K. Hypovitaminosis D and Mortality in the United States. ASN 2008. 146. Chandramohan G, Durham N, Norris K and Vaziri N. Effect of Novel Glutathione Precursor on Blood Pressure and Renal MC3 Receptor Expression in Dahl Rats. Platform Presentation - 2009 Pediatric Academic Societies’ Annual Meeting, Baltimore, Maryland, May 2 - 5.

92

147. JN Artaza, KC Norris. Vitamin D (1.25) Inhibits Cardiomyoblasts Cell Proliferation by promoting Cell cycle arrest and enhances Cardiomyotubes Formation without Inducing Apoptosis. Presented at the Western Regional Meeting of the AFMR, January 28-31, 2009. Carmel, California. Journal of Investigative Medicine, Vol 57, Issue 01, January 2009. Abstract # 53, p 112. 148. Indrani Sinha-Hikim1, Ruoqing Shen1, Albert Crum2, Keith Norris. FT061452TM, a novel antioxidant, prevents vascular smooth muscle cell apoptosis through suppression of oxidative stress and JNK-mediated intrinsic pathway signaling. American Federation for Medical Research 2008 Western Regional Meeting, January 30 - February 2, 2009 Carmel, California. 149. Michael Fischer, MD, MSPH*1, Paul Kimmel, MD2, Tom Greene, PhD3, Jennifer Gassman, PhD4, Xuelei Wang, MS4, Deborah Brooks, RN5, Jeanne Charleston, RN6, Donna Dowie, MD7, Denyse Thornley-Brown, MD8, Lisa Cooper, MD, MPH6, Marino Bruce, PhD9, John Kusek, PhD2, Keith Norris, MD10 and James Lash, MD1.Depressive Affect and the Risk of End-Stage Renal Disease, Hospitalization, and Death among African Americans with Chronic Kidney Disease. ASN Nov 2009, San Diego, CA. 150. Jessica E Miller, MPH1; Joni Ricks, MPH1; Elani Streja, MPH1; Keith Norris, MD4; Allen R Nissenson, MD2; Csaba P Kovesdy, MD3; and Kamyar Kalantar-Zadeh, MD, MPH, PhD1 Higher Doses of Administered Paricalcitol is Associated with Greater 5-Year Survival in African American Hemodialysis Patients Compared to other Races. ASN Nov 2009, San Diego, CA. 151. Chandramohan G, Durham N, Norris K and Vaziri N. Amelioration of hypertension (HTN), oxidative stress, inflammation and renal injury with a glutathione precursor in Dahl salt-sensitive rats. ASN Nov 2009, San Diego, CA. 152. Joseph A. Vassalotti, MD, Allan J. Collins, MD, Suying Li, PhD3, Shu-Cheng Chen, MS3, Peter A. McCullough, MD, MPH4, George L Bakris, MD5 and Keith C. Norris, MD6, and Kidney Early Evaluation Program Investigators. Longitudinal Analysis of a U.S. Population at Risk for Chronic Kidney Disease. ASN Nov 2009, San Diego, CA. 153. Jessica E Miller, MPH1; Elani Streja, MPH1; Joni Ricks, MPH1; Keith Norris, MD4; Allen R Nissenson, MD2; Csaba P Kovesdy, MD3; and Kamyar Kalantar-Zadeh, MD, MPH, PhD1. Examining Survival Benefits of Higher Doses of Paricalcitol in Hemodialysis Patients: Propensity Score Matching and Overadjustment Bias. ASN Nov 2009, San Diego, CA. 154. Kamyar Kalantar-Zadeh, MD, MPH, PhD1; Jessica E Miller, MPH1; Elani Streja, MPH1; Joni Ricks, MPH1; Keith Norris, MD4; and Csaba P Kovesdy, MD3. Potential Impacts of Bundling System on Active Vitamin D Administration for African American Hemodialysis Patients. ASN Nov 2009, San Diego, CA. 155. Nell Griffith Forge1, Loretta Jones1,2, Keith Norris1. Community Faculty: Community Engagement and Education Partnership (C.E.E.P). APHA 137th Annual Meeting & Exposition, Society for the Analysis of African American Public Health Issues. November 7-11, 2009 156. Terry A Brown-Bryan, Taehoon Cho, Jason Kim, Keith Norris, Valerie Kickhoefer, Leonard Rome3, Susanne B Nicholas. Development of a novel RGD-vault nanocapsule for drug delivery and investigation of signaling mechanisms in type 2 diabetic nephropathy. American Federation

93

for Medical Research 2008 Western Regional Meeting, January 30 - February 2, 2010 Carmel, California. 157. S. B. Nicholas, T.A. Brown-Bryan, T. Cho, KC Norris, VA Kickhoefer, L. Rome. Novel RGD-Vault Nanocapsule with Therapeutic Potential for Type 2 Diabetic Nephropathy. American Society of Nephrology 2009 (Free Communication) 158. T.A. Brown-Bryan, S. B. Nicholas, K. C. Norris. Role of Ped/Pea-15 Anti-apoptotic Protein in High Glucose-Mediated Hypertrophy In Human Proximal Tubular Epithelial Cells. American Society of Nephrology 2009 159. I Sinha-Hikim1, R Shen1, H Kim4, AP Sinha Hikim2, ND Vaziri3, A Crum4, K Norris1 E (APOE) -/- mice. American Federation for Medical Research 2008 Western Regional Meeting, January 30 - February 2, 2010 Carmel, California. 160. JN Artaza, F Sirad, D Vernet, KC Norris. Vitamin D induces Cell differentiation by down-regulating the Expression of members of the Wnt signaling pathway in mesenchymal multipotent cells Submitted to the Western Regional Meeting of the AFMR, January 27-30, 2010. Carmel, California. Journal of Investigative Medicine, January 2010. 161. Nell Griffith Forge, Loretta Jones, Keith Norris. Community Faculty: Community Engagement and Education Partnership (C.E.E.P). APHA 137th Annual Meeting & Exposition, November 7-11, 2009 162. Anna Porter, Michael Fischer,1Deborah Brooks, Marino Bruce, Jeanne Charleston, William Cleveland, Tonya Corbin, Donna Dowie, Marquetta Faulkner, Jennifer Gassman, Tom Greene, Leena Hiremath, Cindy Kendrick, John Kusek, Denyse Thornley-Brown, Xulei Wang, Keith Norris, Mark Unruh, James Lash1 for the AASK Study Group. Quality Of Life In African Americans With CKD. NKF Spring Clinical Meetings, April 2010. 163. J N. Artaza, S. Fara, MG Ferrini and K C. Norris. 1,25D inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells linked to decrease in Rho and Rhou/wrch-1 expression. NIDDK/NIH. NMRI (Network of Minority Research Investigators) West Regional Workshop. November 19-20. 2010. San Diego, CA. Abstract winner of Excellence in Research Award; 164. JN Artaza, F Sirad, D Vernet, KC Norris. Vitamin D induces Cell differentiation by down-regulating the Expression of members of the Wnt signaling pathway in mesenchymal multipotent cells. Regional Meeting of the AFMR, January 27-30, 2010. Carmel, California. Journal of Investigative Medicine, January 2010. AFMR Scholar Award Winner) (WAFMR) 165. Azziz R, Davidson P, Morrison J, Wang C, Salusky I, Norris K, Braun J. The UCLA clinical & translational sciences institute (CTSI) leadership in research organizations development program: determining the competencies. ACRT-SCTS 2010 meeting 166. T.A. Brown-Bryan, T. Cho, J. Kim, K.C. Norris, V.A. Kickhoefer, L. Rome, S.B. Nicholas. Development of a Novel RGD-Vault Nanocapsule for Drug Delivery and Investigation of Signaling Mechanisms inType 2 Diabetic Nephropathy. Western Conferences, January 2010. (Free Communication)

94

167. I Sinha-Hikim, R Shen, H Kim, AP Sinha Hikim, S French, ND Vaziri, A Crum, K Norris. Attenuation of oxidative stress and liver pathology by a novel glutathione precursor in a mouse model of dietary steatosis. Endocrine Society meeting. June 19-22, 2010 San Diego, California 168. Azziz R, Davidson P, Morrison J, Wang C, Salusky I, Norris K, Braun J. The UCLA Clinical & Translational Sciences Institute (CTSI) Leadership In Research Organizations Development Program: Determining The Competencies. 2010 ACRT/SCTS Joint Meeting, Washington, DC; A-165. Clin Transl Sci 2010; 3:S35 169. Anna Porter,1 Michael Fischer,1 Deborah Brooks, Marino Bruce, Jeanne Charleston, William Cleveland, Tonya Corbin, Donna Dowie, Marquetta Faulkner, Jennifer Gassman, Tom Greene, Leena Hiremath, Cindy Kendrick, John Kusek, Denyse Thornley-Brown, Xuelei Wang, Keith Norris, Mark Unruh, James Lash1 for the AASK Study Group. 1Medicine, U. Illinois, Chicago, IL. USA. Health related quality of life as a predictor of adverse outcomes in African Americans with chronic kidney disease. ASN. November 2010. 170. Kamyar Kalantar-Zadeh, MD, MPH, PhD1; Uyen Duong, MPH1; Csaba P Kovesdy, MD3; Allen R Nissenson, MD2; Keith Norris, MD4; and Rajnish Mehrotra, MD. Association of Mortality with Serum Alkaline Phosphatase (AlkPhos) and Parathyroid Hormone (PTH) in a Chronic Peritoneal Dialysis (CPD) Patients. ASN. November 2010. 171. Stacey Jolly, MD*1, Nilka Rios Burrows2, Shu-Cheng Chen3, Suying Li, PhD3, Claudine T. Jurkovitz, MD4, Keith C. Norris, MD, FASN5 and Michael G. Shlipak, MD6. Racial and Ethnic Differences in Mortality among Individuals with Chronic Kidney Disease (CKD): Results from the Kidney Early Evaluation Program (KEEP). ASN. November 2010. 172. Elani Streja, MPH1; Csaba P Kovesdy, MD3; John J. Sim, MD4; Anuja Shah, MD1; Ramanath Dukkipati, MD1; Allen R Nissenson, MD2; Sander Greenland, DrPH6, Keith Norris, MD4; and Kamyar Kalantar-Zadeh, MD, MPH, PhD1. Increased Platelet Count and Mortality in Hemodialysis Patients: The Link between Relative Thrombocytosis and the Malnutrition Inflammation-Cachexia Syndrome. ASN. November 2010. 173. Elani Streja, MPH1; Csaba P Kovesdy, MD3; Lilia R Lukowski, MPH;, Ramanath Dukkipati, MD, Allen R Nissenson, MD2; Keith C Norris, MD4, and Kamyar Kalantar-Zadeh, MD, PhD1. Dissociation of Relative Thrombocytosis Associated with Higher Erythropoietin Stimulating Agents (ESA) Dose vs. Hemoglobin Levels in Hemodialysis Patients. ASN. November 2010. 174. Jessica E Miller, MPH1; Usama Feroze, MD1; John J. Sim, MD5; Sameer B. Murali, MD1; Christian S. Shinaberger, PhD1; Debbie Benner, RD2; Allen R Nissenson, MD2; Keith Norris, MD4; Csaba P Kovesdy, MD3 and Kamyar Kalantar-Zadeh, MD, MPH, PhD1. Novel Dietary Protein and Phosphatemia Score to Combine Competing Risks in Maintenance Hemodialysis Patients. ASN. November 2010. 175. Elani Streja, MPH1; John J Sim, MD; Jessica E Miller, MPH1; Allen R Nissenson, MD2; Keith C Norris, MD;4 Csaba P Kovesdy, MD3; and Kamyar Kalantar-Zadeh, MD, MPH, PhD1 Moderately High Hemodialysis Dose is Associated with Lower Platelet Count. ASN. November 2010. 176. Joni L. Ricks, MPH1; Csaba P Kovesdy, MD3; Allen R Nissenson, MD2; Joel D Kopple, MD1; Keith C. Norris, MD4; and Kamyar Kalantar-Zadeh, MD, MPH, PhD1. Racial and Gender

95

Differences of the Survival Advantage of Obesity in Maintenance Hemodialysis Patients. ASN. November 2010. 177. Gangadarshni Chandramohan, MD*1,2, Kamyar Kalantar-Zadeh, MD, PhD, FASN1,2 and Keith C. Norris, MD, FASN3.Relationship Between Waist Circumference and Pulse Pressure in Children: National Health and Nutrition Survey (NHANES) 1988 1994 Data. ASN. November 2010. 178. Peter Chau, *1, Sheena cecille marie Go2, Dulcie Kermah4, Keith C. Norris, MD, FASN1,4, Kamyar Kalantar-Zadeh, MD, PhD, FASN1,2,3 and Gangadarshni Chandramohan, MD1,2,3. Vitamin D Deficiency and Cardio-Renal Risk Factors in Children: National Health and Nutrition Survey (NHANES) 1999-2004. ASN. November 2010. 179. JN Artaza, PhD; L. Garcia, BS; G. Gibbons, MD; R. Shohet, MD; K. Norris, MD. 1,25D induces cardiac differentiation through Wnt signaling pathway. RCMI International symposium, Nashville, TN. Dec 6-9, 2010. 180. JN. Artaza, PhD; L. Garcia, BS; D. Vernet, PhD; K. C. Norris, MD. 1,25D induces osteogenic differentiation of multipotent cells. RCMI International symposium, Nashville, TN. Dec 6-9, 2010. 181. F Haq, PhD; R Yanagihara, MD; E Fleming, MPH; S Ordinado, BBA; Z Hammatt, JD; ME Barnett, MD, PhD; O Aldaoud, MS; L Irons, MDiv; J Perkins, PhD; GH Gibbons, MD; K Norris, MD. Translational Research Clusters: A Health Disparities Cybernetwork. 12th RCMI International Symposium on Health Disparities. Nashville, Tenn. December 6-9, 2010 182. I Sinha-Hikim, PhD; R Shen, MD; H Kim, PhD; AP Sinha Hikim, PhD; S French, MD; ND Vaziri MD; A Crum, MD; KC Norris, MD. Therapeutic Modulation Of Obesity And Hepatic Steatosis In Mice. 12th RCMI International Symposium on Health Disparities. Nashville, Tenn. December 6-9, 2010. 183. D Kermah, MPH; P Chau; S Go; K Norris, MD; K Kalantar-Zadeh, MD; G Chandramohan, MD. Vitamin D Deficiency And Cardio-Renal Risk Factors In Children. 12th RCMI International Symposium on Health Disparities. Nashville, Tenn. December 6-9, 2010. 184. JE Lee, K Norris, G Gibbons, J Perkins, ME Barnett, JH Sung. “Evaluating Impact of Modifying Inclusion/Exclusion (I/E) Criteria on Enrollment and Study Goal”, 12th RCMI International Symposium on Health Disparities, Nashville, TN. December 6-10, 2010.

185. Leah Garcia, Monica Ferrini, Gary Gibbons; Ralph Shohet, Keith C. Norris, Jorge N. Artaza. Vitamin D Inhibits cell proliferation without inducing apoptosis of heart-derived cells, enhancing cardiac differentiation by modulating the expression of key Wnt signaling family members. Regional Meeting of the AFMR, January 27-30, 2012. Carmel, California. Journal of Investigative Medicine, January 2011.

186. Keisha King, Leah Garcia, Monica Ferrini, Keith C. Norris, Jorge N. Artaza. Vitamin D inhibits proliferation and induces differentiation of C2C12 skeletal myoblast cells by modulating the expression of pro-myogenic and angiogenic growth factors. Regional Meeting of the AFMR, January 27-30, 2012. Carmel, California. Journal of Investigative Medicine, January 2011.

96

187. Anna Porter,1 Amishi Patel, Deborah Brooks, Marino Bruce, Jeanne Charleston, William Cleveland, Donna Dowie, Marquetta Faulkner, Jennifer Gassman, Tom Greene, Leena Hiremath, Cindy Kendrick, John W. Kusek, Denyse Thornley-Brown, Xuelei Wang, Keith Norris, Michael Fischer, James Lash for the AASK Study Group. Low Social Support Is Associated With Increased All-Cause Mortality In African Americans With Hypertensive CKD. NKF Spring Clinical Meetings. April 26-30, 2011; Las Vegas, NV. 188. Indrani Sinha-Hikim,*¶ Amiya P. Sinha-Hikim,*¶Ruoqing Shen,*H Kim,† Samuel W. French,‡Nostrola D. Vazari,†Albert Crum,§Tripathi B. Rajavashisth,*¶Keith C. Norris *¶. A novel cystine based antioxidant attenuates high fat diet-induced oxidative stress and hepatic steatosis in apolipoprotein E knockout mice. 3rd International Conference on Drug Discovery & Therapy. February 7– 10, 2011, Dubai Women’s College, Dubai, UAE 189. Kamyar Kalantar-Zadeh, MD, MPH, PhD1; Martin L Lee, PhD2; Ramanath Dukkipati, MD1; Rachelle Bross, PhD, RD1; Jennie Jing; MS1; Claudia Luna1, Amanda Luna1; Myra Gomez1; Youngmee Kim, PhD, RN1; Anne C. Voss, PhD, RN3; Debbie Benner, RD4: Miklos Z Molnar MD, PhD1, Keith C Norris, MD2; Csaba P Kovesdy, MD5; Joel D Kopple, MD1. Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) Study: A Double-Blind Randomized Placebo-Controlled Trial. ISN Vancouver, April 11-14, 2011. 190. Indrani Sinha-Hikim,*¶ Amiya P. Sinha-Hikim,*¶Ruoqing Shen,*H Kim,† Samuel W. French,‡Nostrola D. Vazari,†Albert Crum,§Tripathi B. Rajavashisth,*¶Keith C. Norris *¶. A novel cystine based antioxidant attenuates high fat diet-induced oxidative stress and hepatic steatosis in apolipoprotein E knockout mice. Current Medicinal Chemistry. Special issue abstracts. 3rd International Conference on Drug Discovery and Therapy. p 38. 191. Calderón JL, Ana M. Castejón, PharmD; Sylvia Raibonet, EdD; Keith C. Norris, MD; Ron D. Hays PhD, Nisa Sangasubana, PhD. Challenges to New Community-Academic Partnering for Participatory Research: Lessons Learned from Project Diabetes LASST. NIDDK/NIH. NMRI (Network of Minority Research Investigators) National Workshop. April 21-22. 2011. Bethesda, MD. 192. Leah A. Garcia, Keisha K. King, Monica G. Ferrini, Keith C. Norris, and Jorge N. Artaza. Vitamin D promotes myogenic differentiation by inhibiting cell proliferation and modulating the expression of pro-myogenic growth factors and myostatin in skeletal muscle progenitor cells. NIDDK/NIH. NMRI (Network of Minority Research Investigators) National Workshop. April 21-22. 2011. Bethesda, MD. (Excellence award) 193. Adam Whaley-Connell, DO, MSPH,1 Mike Shlipak, MD MPH2, Lesley Stevens, MD, MPH3, Manjula Kurella Tamura, MD4, Andrew S Bomback, MD MPH5, Georges Saab, MD6, Susanna M. Szpunar PhD7, Samy I. McFarlane, MD, MPH8, Suying Li, PhD9, Shu-Cheng Chen, MS9, Keith Norris, MD10, George L. Bakris, MD11, Peter A. McCullough, MD, MPH7, on behalf of the Kidney Early Evaluation Program Investigators. Disease state awareness, kidney disease, and relationship to ESRD and Death. NKF Spring Clinical Meetings. April 26-30, 2011; Las Vegas, NV. 194. ND Vaziri1, J Yuan1, S Nicholas2,3, A Crum4, K Norris2,3 Department of Medicine, UC-Irvine, CA1, Department of Medicine, David Geffen School of Medicine at UCLA2, Charles Drew University, Los Angeles, CA3, and Proimmune® Rhinebeck, NY4. Salutary effect of a novel glutathione precursor on chronic progressive tubulointerstitial nephropathy. ASN. Phila, PA. November 2011.

97

195. Miklos Z Molnar MD, PhD, Csaba P Kovesdy, MD; Suphamai Bunnapradist, MD; Elani Streja, MPH; Mahesh Krishnan, MD, MPH, MBA; Istvan Mucsi, MD, PhD; Keith C Norris, MD and Kamyar Kalantar-Zadeh, MD, MPH, PhD. African American donor race was associated with increased all-cause and cardiovascular mortality and graft loss, but not with delayed graft function ASN. Phila, PA. November 2011. 196. Usama Feroze, MD, Miklos Z. Molnar, MD, PhD, Rammanth Dukkipati, MD, Csaba P Kovesdy, MD; Allen R Nissenson, MD; Keith C Norris, MD; Joel D Kopple, MD and Kamyar Kalantar-Zadeh, MD, MPH, PhD. Mortality-Predictability of Charlson Comorbidity Score in Maintenance Hemodialysis Patients and the Role of Race. ASN. Phila, PA. November 2011. 197. Sinha-Hikim I3, Sinha-Hikim AP3, Shen R3, A Crum4, K Norris2,3, ND Vaziri1Department of Medicine, UC-Irvine, CA1, Department of Medicine, David Geffen School of Medicine at UCLA2, Charles Drew University, Los Angeles, CA3, and Proimmune® Rhinebeck, NY4. Long-term administration of a novel glutathione precursor attenuates age-related oxidative stress and kidney damage. ASN. Phila, PA. November 2011. 198. Kamyar Kalantar-Zadeh, MD, PhD; Martin L. Lee, PhD; Ramanath Dukkipati, MD; Rachelle Bross, PhD, RD; Jennie Jing; MS; Youngmee Kim, PhD, RN; Anne C. Voss, PhD, RD; Debbie Benner, RD: Usama Ferozoe. MD; Miklos Z. Molnar MD, PhD1, Ian MacDougal, MD; John A Tayek, MD; Keith C. Norris, MD; Csaba P. Kovesdy, MD; Joel D. Kopple, MD. Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID): Results of the Double-Blind Randomized Placebo-Controlled Trial. ASN. Phila, PA. November 2011.

199. Joni L. Ricks, MPH1; Jessica E Miller, PhD1; Onyebuchi Arah,PhD3, Miklos Z Molnar, MD,PhD; Elani Streja, MPH; Csaba P Kovesdy, MD2; Sander Greenland, DrPH; Keith C Norris, MD; Kamyar Kalantar-Zadeh, MD, MPH, PhD. Comparing Mortality-Predictability of ESA in Hemodialysis Patients Using Doubly-Robust Marginal Structural Model vs. Proportional Hazard Regression. ASN. Phila, PA. November 2011. 200. X.J. Zhou, I. Sinha-Hikim, T. Ye, D. Rakheja, A. Crum, K. Norris, N. D. Vaziri. Long-term administration of a novel glutathione precursor attenuates age-related oxidative stress and kidney damage. ASN. Phila, PA. November 2011. 201. M. Edwina Barnett, Barbara E. Hayes, PhD; Paul B Tchounwou, James Perkins, and Keith C. Norris. RCMI Translational Research Network (RTRN) – a collaborative environment to address health disparities and bioterrorism. 8th International Symposium on Recent Advances in Environmental Health Research scheduled for September 18-21, 2011. 202. Leah A. Garcia, Monica G. Ferrini, Keith C. Norris, Jorge N. Artaza. Vitamin D Enhances Myogenic Cell Differentiation Of C2C12 Skeletal Myoblast Cells By Modulating The Expression Of Key Angiogenic Growth Factors And Angiogenic Growth Factors Inhibitors. Regional Meeting of the AFMR, January 27-30, 2012. Carmel, California. Journal of Investigative Medicine, January 2012. 203. I Sinha-Hikim, AP Sinha Hikim, Peter Tran, M Cornford, R Shen, AB Crum, KC Norris. Prolonged use of a novel antioxidant reverses age-specific increase in oxidative stress, lipogenesis, and loss of skeletal muscle mass in mice. 10th International Conference on

98

Functional Foods and Bioactive Compounds in Health and Disease at the University of California at Santa Barbara, California, USA. March 13th-15th, 2012. 204. Vanessa A Ravel, Elani Streja, Molnar Z Molnar, Jennie Jing, Jinan Li, Alla Victoroff, Mahesh Krishnan, Allen R Nissenson, Csaba P. Kovesdy, Keith C Norris, Joel D Kopple, Kamyar Kalantar-Zadeh. Association of Surrogate Measures of Dietary Protein Intake and Survival in 100,088 Chronic Hemodialysis Patients. 6th Cachexia Conference, Milan, Italy. 8-10 Dec. 2011.

Documents

Keith C. Norris, M.D. CURRICULUM VITAE (3-10-12) · 2005-07 Vice President of Research, Charles Drew University 2008- Executive Vice President, Research and Health Affairs, Charles